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Chapter 1 

General Introduction 
1. HUMAN HERPES VIRUSES 
History and Classification of Human Herpes Viruses 
The identification of human herpes virus (HHV) infections can be traced back to ancient 
Greece where Herpes simplex vims (HSV) infections in humans were first documented. 
Hippocrates used the word "herpes", meaning to creep or crawl, to describe spreading skin 
lesions. Although the vesicular nature of lesions associated with HSV infections had been 
well documented in the late eighteenth century, person-to-person transmission of HSV was 
only first recognised by Vidal in 18931 HSV was first isolated in 1919,2 but decades passed 
before it was demonstrated that there were in fact two serotypes ofHSV, HSV-1 and HSV-
2.3 Over time, several other members of the HI-IV family have been identified. The latest 
member, HHV-8, was only identified last decade. 4 The major laboratory advances of the past 
20 years have enabled a torrent of new insights into the biological properties ofHHV. 
Herpes viruses infect members of all groups of vertebrates, and the same host can be 
infected with multiple distinct and unique types. Initially classified on the basis of tissue 
tropism and more recently based on DNA sequence homology, the herpes viruses have been 
typically grouped into three subfamilies: 1 
(I) The alpha-herpes viruses generally have a rapid replication cycle and a broad host cell 
range. Alpha-herpes viruses are fwiher characterised by their neurotropic prope1iies and 
tendency to establish latent infections in neural tissue. 
(2) The beta-herpes viruses, which differ in genome size and structure, have a much more 
restricted range of host cells and replicate more slowly in culture. 
(3) The gamma-herpes viruses are lymphotropic, infecting predominantly T- or B-
lyrnphocytes, and causing either lytic or latent infection. Herpes vimscs in this group are 
furthermore characterised by their oncogenic properties. 
To date, eight distinct HHV have been described, each causing a characteristic disease. 1 
Among the alpha-herpes viruses, HSV -1 and -2 are the primary agents of recurrent facial and 
genital herpetic lesions, respectively, while varicella zoster virus (VZV) is the causative 
agent of chicken pox and shingles. The prototypic member of the group of beta-herpes 
vimses is human cytomegalovims (HCMV), which is linked to congenital infections of the 
nervous system. In contrast, infections with two other lymphotropic beta-herpes vimses, 
human herpes viruses -6 and -7 (HHV -6 and -7), generally cause mild early childhood 
diseases. Infections with two human gamma-herpes viruses, Epstein-Barr virus (EBV) and 
human herpesvirus-8 (HHV -8) are associated with human cancers. The most common 
disease caused by infection with EBV is generally known as "infectious mononucleosis", 
while HHV-8 is believed to play a causative role in Karposi's sarcoma. 
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Herpes Simplex Virus Morphology and Genomic Organisation 
Herpes Simplex viruses were the first of the HHV to be discovered and are among 
the most intensively investigated of all viruses. Their characteristic features are their 
biological properties and their strategies to evade the host immune system. Particularly their 
ability to cause a variety of infections, to remain latent in their host for life, and to be 
reactivated to cause new lesions have challenged many investigators. 
Glycoprotein Spikes 
Herpes viruses are among the largest 
animal viruses known, both in structural size and 
genomic content.5 The size of the HSV virion 
varies and its capsid is approximately 100 nm in 
diameter. The HSV virion consists of four 
elements (see Fig.l): (a) the core, containing the 
genome, (b) an icosadeltahedral capsid 
surrounding the core, (c) an amorphous and largely 
unstmctured tegument surrounding the capsid, and 
(d) an outer envelope consisting of a lipid bilayer 
with about 12 different viral glycoproteins 
embedded in it. 
The genome of HSV consists of double-
stranded DNA containing 152 kilo-base pairs (kb) 
Figure I: Electron microscopic inwge of" the for HSV-1 and 154 kbp for HSV-2, with a G+C 
HSV-1 virion. content of 68% and 69% for HSV-1 and HSV-2 
respectively. 6 The HSV-1 genome can be viewed 
as consisting of two covalently linked components, designated as long (L) and short (S) 
unique sequences, flanked by inveiied repeats (see Fig. 2A). These flanking repeats enable 
the inversion of the L and S components, yielding four linear isomers, which are found in 
equal concentrations in populations of wild-type vims-infected cells. 7.s The HSV -1 genome 
is a linear, double stranded DNA duplex that circularises upon release from the capsid into 
the nucleus of the host cell. HSV-1 encodes at least 84 different polypeptides9 (see Fig. 2B). 
Most proteins have multiple properties; hence HSV genes can encode several hundred 
different functions. Of the 84 known polypeptides, at least 47 are not essential for viral 
replication in cultured cells, 10 although they are not completely dispensable. Some execute 
essential functions in differentiated cells or alter cellular metabolism to ensure high yields of 
progeny vims. Mutant viruses lacking these genes thus can only survive in fully permissive 
cultured cells but not in their natural host. The tegument proteins and the glycoproteins are 
amongst the major targets for the host defence system. For example, viral surface 
glycoproteins are a major target for virus neutralising antibodies, while cellular immunity is 
often targeted to epitopes within both glycoproteins and tegument proteins.5 
Next to the inte1iypic variation between HSV-1 and -2, intratypic variation exists 
within each sero-type. At the DNA level, differences between HSV-1 strains appear to result 
from base substitutions and variability in the number of repeated sequences present in a 
number of regions of the genome. Variations in the number of these reiterated sequences 
have been used to distinguish between different HSV-1 strains in epidemiological 
studies. 11.1 2 Hayward eta!. were the first to find that restriction endonuclease patterns could 
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Figure 2: 
(Aj Schematic l'epresentmion 
of the HSV genome vvith its 
unique long (UL) and short 
(USj regions. which ore 
flanked by inverted repeats 
(IR and TRj. (B) Genetic 
map ofHSV-1, indicating the 
locations o{ genes ond the 
proteins they encode. 
be used to genetically 
differentiate unrelated 
HSV strains. 13 With this 
technique, known as 
restriction fragment length 
polymorphism (RFLP) 
analysis, it has been 
shown that individuals can 
be infected with multiple 
different strains of HSV at 
the same anatomical site. 14 
This demonstration that a 
target organ 1s not 
unmune to reinfection is 
an important issue from a 
public health viewpoint 
and provides maJor 
difficulties for vaccme 
GENERAL INTRODUCTION 
A 
rC:J...._ ___ ).i!lJI.~----~ [, • 
B 
• .. 
II 
.. 
\ 
development. Although probably suitable for most clinically related studies on HSV 
reinfection, RFLP has as a major disadvantage that it is very laborious and depends on the 
isolation of viable virus. To overcome these shortcomings we developed a PCR-based 
technique for the differentiation of HSV -1 strains, as described in chapter 1 of this thesis. In 
the following chapters (chapter 2 and 3), this technique was employed to investigate the 
transmission of HSV -1 in humans. 
Herpes Simplex Virus Replication 
Entry of HSV into a host cell involves the attachment of the virion to the surface of 
the cell, mediated through viral glycoproteins C (gC) and gB, and interaction of gD with 
cellular receptors. This interaction results in the subsequent fusion of the viral envelope and 
the plasma membrane to release the capsid-tegument structure into the cytoplasm (see Fig. 
3). From here, the capsid is transported to the nucleus where it releases the viral DNA. Upon 
entry of the host cell, the tegument proteins are released into the cytoplasm and execute some 
crucial functions for the initiation of viral replication. The VP16 tegument protein (also 
known as aTIF) induces the gene transcription of the earliest set of viral genes. The virion 
3 
CHAPTER 1 
host shutoff (vhs) protein, which is also embedded in the tegument, causes non-specific 
degradation of mRNA and shutoff of host protein synthesis.) Transcription of the viral 
genome, replication of viral DNA, and assembly of new caps ids take place in the nucleus of 
the host celL 
The productive replication cycle of HSV gene expression is tightly regulated and 
ordered in a cascade fashion of increasing complexity (see Fig. 3). 15 The earliest genes to be 
expressed in the replication cycle of HSV are the immediate early- or a-genes, which act to 
activate subsequent viral gene expression. Alpha genes appear to have solely regulatory 
functions and are responsible for the initiation of viral replication. Two of these immediate-
early genes, US! and US12, encoding for proteins ICP22 and ICP47, have been reported to 
be involved in evasion of immune recognition by both CD4- and CDS+ T cells, 
respectively. 16' 17 
This first phase of gene 
transcription is followed by the 
expression of the early- or J3-
genes that are either directly or 
indirectly involved m viral 
genome replication. Finally, 
upon genome replication, viral 
structural proteins are expressed 
in high abundance during the 
late- or y- phase. These proteins 
are involved in assembling the 
capsid m the nucleus and 
modifying the membranes for 
virion formation.5 
Viral capsids assemble in the 
nucleus, and bud through the 
Uptake.· ·~ o:.gene Genome expression P-gene 
.._,v 
u-TIF 
Envelopment 
and release 0 
circularizes 
OCircular HSV 
DNA 
Cellular proteins 
Assembly of 
nucleocapsids 
(J!Oplasm 
Figure 3: Replication cycle ofHSV. 
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nuclear membrane, which contain the viral glycoproteins. During the maturation process, the 
capsids are surrounded by tegument proteins that may functionally interact to aid in 
envelopment. Enveloped infectious virions can either remain cell associated and spread 
directly from cell-to-cell, or can be released from the cell for infection of other host cells. 
Latency and Reactivation of HSV 
The ability of HSV to persist lifelong in the human host is one of the most striking 
aspects of HSV infection. This ability of HSV to persist in its host is perhaps best illustrated 
by the fact that in up to 80% of healthy adult individuals HSV-1 DNA can be detected in the 
trigeminal ganglia, the main site of HSV-1 neuronal latency.5 After a primary productive 
infection in epithelial cells, the vims spreads through the tissue and some virions enter 
sensory neuron axons. The virions are then translocated by retrograde axonal transport to the 
cell body in the innervating sensory ganglion. In the ganglion, vims either replicates 
productively or establishes a latent infection in the neuronal cell nucleus. During this latent 
phase, viral gene expressing is shut down with the exception of expression of the latency-
associated transcripts (LATs). Although the function of these transcripts is not well known, 
4 
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they are believed to play a role in down-regulation of lytic gene expression, thus promoting 
latency. Because of this relative lack of viral gene expression and the target cell of latency 
(i.e. neuronal cells), HSV is able to evade eradication by the immune system. In humans, 
latent virus can reactivate after local stimuli such as local trauma and tissue damage, or by 
systemic stimuli like stress, hyperthermia, exposure to ultraviolet light, hormonal imbalance 
and so forth. When the virus reactivates it restarts viral replication after which progeny 
viruses travel back through the neurons, usually to the site of initial infection. The frequency 
of reactivation has been related to the severity of the primary infection and the number of 
neural cells harbouring latent virus. 18 
2. HSV INFECTIONS 
Epidemiology and Disease Manifestations 
The spectrum of disease caused by HSV infections includes a wide variety of 
primary and recunent infections in mucous membranes, skin tissue and the central nervous 
system (CNS). HSV-1 and HSV-2 are usually acquired by different routes and affect 
different areas of the body, but the signs and symptoms that they cause over1ap19 While 
HSV-2 is more frequently associated with genital infections, HSV-1 infections are best 
known for causing herpes labialis. Intra-oral lesions are indicative for primary HSV-1 
infection, lip lesions are more characteristic for recunent infection. Although most genital 
HSV infections are caused by HSV-2, an increasing proportion is attributable to HSV-1. 10 
Most individuals contract HSV infection during the first decades of life. The prevalence of 
HSV -1 antibodies varies from 45% to 88% in adult populations and is influenced by sex, 
geographic location, socio-economic status and age. 10 Antibodies to HSV -2 are rarely found 
before the age of onset of sexual activity, but HSV-2 seroprevalence increases to 35-60% by 
age 60.2021 This prevalence has increased dramatically since the late 70's and is highest 
among prostitutes (75%) and male homosexuals (83%).20 
Apart from these most common orofacial and genital infections, HSV can also cause a 
variety of other diseases. Other cutaneous HSV -1 lesions generally manifest as eczema 
herpeticum, but can also be more disseminated. Viral infections of the eye are usually caused 
by HSV-1, most commonly presenting as conjunctivitis, blepharitis or herpetic epithelial 
keratitis (HEK).22·23 More severe cases of corneal HSV infections can also lead to potentially 
blinding diseases like herpetic stromal keratitis (HSK). A more detailed description of ocular 
HSV infections is given in the section below. Infection of the CNS can result in herpetic 
encephalitis, which is one of the most devastating manifestations of HSV infections. HSV 
encephalitis causes case fatality rates that exceed 70% among older children and adults if left 
untreated, and only a small minority regain nonnal neurological function.9 HSV infections 
can also cause serious complications in neonates, frequently associated with encephalitis or 
disseminated infection and a lethal outcome. The incidence of neonatal HSV seems to be 
directed related to seroprevalence of HSV-2 and is most commonly acquired when the 
mother experiences a primary genital infection during child birth. 10 Finally, another group of 
individuals at risk for severe HSV infections are immunocompromised patients like organ 
transplant recipients and AIDS patients.24 Because of their inability to mount an adequate 
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immune response to the virus, frequently reactivating HSV can cause severe local or 
systemic infections in these individuals. 
Nowadays, most HSV infections can be efficiently counteracted by treatment with 
aciclovir, a synthetic purine-nucleoside analogue that disrupts viral DNA replication. It is the 
most effective clinically used antiviral drug to date and has become the standard of therapy 
for HSV infections. 10 
Transmission of HSV 
Transmission of HSV usually occurs by close contact via the mucosal surfaces. The 
type and severity of HSV infection that results depends on the host's immune status. Primary 
HSV infections are commonly subclinical. Most episodes of clinical disease are 
manifestations of recurrent HSV infections. Although many HSV infections are 
asymptomatic, around one-third of the world's population have recunent HSV infections, 
capable of transmitting HSV during episodes of productive viral replication. Viral shedding 
and thus transmission can however also occur without clinical symptoms, which pmiicularly 
holds for genital infections. 
Transmission of herpes viruses through organ transplantation poses a serious health 
problem. The most frequent cause of herpes virus transmission through organ transplantation 
involves CMV. Although probably rare, transmission of HSV through organ transplantation 
may also occur.25~27 Corneal transplantation, in medical practice refened to as penetrating 
keratoplasty (PKPL), is the most common type of tissue transplantation in the Netherlands, 
with usually successful outcome and few side effects. In few cases however, patients may 
develop corneal HSV infections after comeal transplantation performed for reasons unrelated 
to HSV. Such cases are referred to as newly acquired herpetic keratitis.2g.:;o Although the 
origin of HSV infection in these cases is unknown, data from animal studies have suggested 
that transmission of replication-competent HSV through corneal transplantation is possible. 31 
Although HSV latency in sensory ganglion neurons is well documented, studies by the group 
of Dunkel eta!. have also suggested the existence of extraneuronallatency in the comea.32J 3 
In these studies, HSV gene expression was detected in corneas of latently infected rabbits 
and human quiescent herpetic comeas. Especially the detection of LAT expression in 
quiescent human HSK comeas33 implicates the cornea as an extraneuronal site of HSV 
latency and reactivation. If corneal latency is for real, it probably reflects a low level of HSV 
replication causing a quiescent HSV infection rather than representing the "classical" 
conditions of reactivation of latent HSV residing in ganglion neuronal cells. 
The data presented in chapter 4 indicate that PKPL may be a risk factor for the 
development of HSK. In the same chapter, we also provide direct proof that donor to 
recipient transmission of HSV and subsequent replication in the patient can occur in human 
corneal graft recipients. 
Epidemiology of Ocular HSV infections 
HSV appears to be the most common infectious cause of blindness in developed 
countries, 23 largely because of its recurrent nature. Ocular HSV infections are mainly 
confined to the anterior segm.ent of the eye, including the conjunctiva and the eyelids. The 
6 
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overall prevalence of ocular HSV infections has been estimated at 149 cases per 100.000 
person-years. 23 Ocular manifestations are only observed in about I% of exposed individuals, 
and only 5% of ocular HSV disease represent primary infections. 23 Despite the relative rarity 
of ocular HSV disease, its outcome can have a rather profound morbidity. Primary ocular 
HSV infections usually result in mild-to-moderate diseases like conjunctivitis, blepharitis 
and HEK. However, recurrent manifestations of ocular infections can result in more serious 
disease like herpetic stromal keratitis (HSK). Recurrence rates of ocular HSV infections have 
been recorded in one-third up to 63% of patients and were more frequent in children and 
young adults.233435 Half of these patients had more than one recunence over a follow-up 
period of 15 years, with 10% of the patients experiencing 6-15 recurrences during this time 
period. Studies on visual outcome following recunences have indicated that more than 90% 
of patients maintain good visual acuity despite prolonged disease. 36 For a significant 
minority of patients with recunent herpetic episodes however, the resulting come a] scaning 
may require comeal transplantation to regain sight. The pathologic characteristics of HSK 
and the development of comeal scaning resulting in blindness are dealt with in the next 
section. 
Although the risk factors for ocular HSV disease are largely ill defined, a large-scale 
study in 326 patients showed that the risk of recurrent HEK was not affected by previous 
episodes of HEK. In contrast, a previous episode of HSK increased the risk of a recurrence 
of HSK by 1 0-fold, with a strong relation between risk and the number of previous 
episodes.37 Fmihermore, the interval between recunences appears to shmien with time. 22 
One of the more severe ocular infections caused by a-herpes vimses is acute retinal necrosis 
(ARN). Although this disease is rare, retinal detachment or destruction due to a localised 
immune response can leave patients blinded for the rest of their lives. Most cases of ARN are 
caused by VZV, while in younger patients HSV is often the causative agent?u9 An 
association between ARN and a past or concunent history of herpes simplex encephalitis has 
1 1 40-4! been repmied by severa aut 1ors. -
In chapter 3 we describe the analysis and relation ofHSV-1 strains found in both the 
brain and eye of two patients with ARN and a previous episode of herpes simplex 
encephalitis. 
3. IMMUNITY TO HSV INFECTIONS 
Host Immune Responses 
Many viruses and their hosts have coexisted for millennia during which both have 
been constantly adapting. Despite effective and rapid responses of the immune system, 
herpesviruses are still common infectious agents in all groups of vetiebrates. Acute and 
chronic viral infections are a constant battle between viral replication and the immune 
response of the host. If the immune system reacts too slow or in an inadequate manner, the 
host may suffer severe morbidity or die. On the other hand, an effective immune response 
will ultimately eradicate the virus or at least limit its replication. Despite the development of 
a usually highly effective immune system, some tissues of the host like the eye are poorly 
accessible to the immune system. These tissues are termed immune privileged sites. 
Moreover, throughout evolution herpes viruses have adapted several mechanisms to escape 
from immune detection. Nevertheless, effective immune responses do develop upon viral 
7 
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Figure 4: ,Hechanisms and cellular events involved in ii?flammorory responses to 
viral il?(ections of the eye. (reprinted with permission fi'om: Streilein JW (ed.): 
Immune re.1ponse and the eye. Chem. lmmuno/. 1999;73:9(}-1 19. Karger. Basel). 
directed towards the site of infection. Innate responses start almost immediately after viral 
infection and provide a cmcial first line of defence, especially in infection of naive hosts. 
Clearing of the vims however depends on a vims-specific immune response (i.e. adaptive 
immunity) in which both T- and B-lymphocytes are involved and takes several days to 
develop. 
Innate Immunity 
Leukocyte populations, excluding the classical T- and 8-lymphocytes, as well as 
soluble factors, contribute to the innate immune response to viral infections. These cell types 
are widely distributed in the body and are critical in controlling the overall extent of viral 
replication and to limit the spread of virus immediately after infection. Macro phages exert 
their antiviral function directly through phagocytosis of viral patiicles and subsequent 
degradation, and through the secretion of anti-viral cytokines like TNF-a and IFN-a. In an 
indirect manner, macrophages can mediate a number of impotiant immune-regulatory effects 
through the secretion IL-12, TNF-a and IL-la.43 The importance of NK cells in early 
defence against HSV infection has been clearly established.44 Severe herpesvirus infections 
occur in individuals with genetic defects in NK function and in immunocompromised 
individuals.45 A6 In HSV infection, NK cell-derived IFN-y exe1is an anti-viral effect through 
inhibition of viral replication.47 Virus-infected cells can be recognised and actively killed by 
NK cells through opsonization by vims-specific antibodies following interaction with Fe 
receptors, and through a MHC-independent recognition of viral antigen.48 Infection with 
HSV also results in a downregulation of MHC class I expression, 17 making infected cells 
more susceptible for killing by NK cells.49 
8 
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Soluble factors like cytokines and chemokines are the non-cellular components of 
the innate immune system. All cell types of both the innate and adaptive immune system 
contribute to the production of these factors, as well as some virus-infected or activated non-
immune cells such as fibroblasts. For example. type I IFNs (IFN-a and IFN-~) are produced 
by the infected cell itself to induce protection against infection in neighbouring cells. The 
functions of these cytokines in anti-viral immunity include inhibition of viral replication, 
activation ofNK cell cytotoxic activity and induction ofMHC class I expression.43·50 Besides 
cytokines, molecular chemotactic factors known as chemokines are produced upon viral 
infection by a variety of both immune and non-immune cells. These chemokines have 
important pro-inflammatory functions and contribute to innate immunity by attracting 
leukocytes to infected tissue. 51.52 Overall, innate immunity functions not only to protect the 
host in the early stages of infection, but also to direct the qualitative and quantitative nature 
of adaptive immunity. 
Adaptive Immunity 
The humoral and cellular adaptive immune responses mediated by antibodies and I 
cells, respectively, are the two main antigen-specific effector systems for resolving viral 
infections.43 Antibodies control virus replication by neutralising free viral particles or killing 
vims-infected cells through complement-mediated cytotoxicity or antibody-dependent cell-
mediated cytotoxicity (ADCC). This mechanism of ADCC has been validated as a critical 
component of antiviral defence against HSV infections, especially in immunocompromised 
individuals and neonates. 53 
The major targets for antibodies are the surface glycoproteins and outer capsid proteins of 
HSV.54·55 Binding ofneutralising antibodies to glycoproteins prevents viral attachment to and 
infection of host cells. Although the protective role of antibodies in HSV infection is not 
completely clear, they seem to exert a major effect during primary infection. Especially 
secretory immunoglobulins of the IgA isotype may be important in neutralising HSV 
particles that enter via the mucous membranes. However, high titres of neutralising 
antibodies do not always prevent or diminish recurrent HSV infections. 
Antibodies serve as a major defence against free viral particles, while the main 
function ofT cells is the recognition and elimination of virus-infected cells. T cells can be 
subdivided into two subsets, CD4+ and CD8+ T cells, which recognise viral antigen in 
association with host major histocompatibility complex (MHC) molecules II and I, 
respectively. In HSV -infected cells, viral proteins are degraded into short peptides that 
subsequently bind to MHC molecules. These MHC/peptide-complexes are then translocated 
to the cell surface for recognition by antigen-specific I cells.43 Both CD4' and CDS+ I cells 
play a central role in antiviral immunity either directly by their cytolytic properties or 
indirectly by their secretion of cytokines upon activation or in case of CD4+ T cells by the 
induction of a specific humoral immune response. Remarkably, in HSV infections in 
humans, CD4+ I cells have emerged as the predominant killer cell phenotype. 56 
Severe HSV infections are common in patients with impaired I cell immunity (e.g. AIDS 
patients or transplant recipients), indicating that I cells play an essential role in controlling 
HSV infections.57 For HSV infections, both clinical observations in humans and studies 
performed in experimental animal models have clearly indicated the importance of CDS' 
cytotoxic I cells (CTL) in the resolution of HSV disease. Likewise, CD4- I cells probably 
play an equally critical role in the resolution of HSV, given the importance of this cell type 
9 
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in mediating delayed type hypersensitivity responses and clearing local infections. 56 
Similarly, in several mouse models of HSV infections, both CD4+ and CDS" subsets ofT 
lymphocytes have been shown to be important in protection against lethal infection and to 
enhance viral clearance. 58 
Immune Evasive Mechanisms of HSV 
HSV has developed various strategies to evade host immune surveillance and persist 
in vivo. This capability of HSV to circumvent defensive mechanisms of the immune system 
enables it to avoid detection and elimination by the immune system. One key adaptation of 
the vims to do this is to infect the CNS, a tissue that is not readily accessible to the immune 
system, and to establish latency within ganglion cells. The fact that during a latent infection 
no or very limited viral protein expression takes place and because of a lack of MHC class I 
expression on neural cells makes the virus impassive forT cell mediated recognition. During 
active viral replication however, HSV also has several "tricks" to evade the immune system. 
During lytic infection the HSV ICP47 protein, encoded by the US12 gene, interferes with the 
transporter associated with antigen presentation (TAP). 17 Through this action peptide 
translocation into the ER is blocked resulting in inhibition of viral antigen presentation 
through MHC class I and recognition by CDS+ T cells. Additionally, HSV has recently also 
been shown to inhibit recognition of infected cells by CD4+ T cells. Barcy eta/. showed that 
HSV -infected B cells exhibited a strongly reduced capacity to stimulate antigen-specific 
CD4+ T cells16 Although its mode of action is not yet known, this inhibitory effect on APC 
function is most likely mediated by the HSV ICP22 protein, encoded by the US 1 gene. 
Another strategy of HSV to evade immune responses involves interference with 
complement-mediated virus neutralisation and lysis of infected cells through binding of 
complement component C3 by gC.59 
When a host cell gets infected by a virus it will usually go into apoptosis. 
Alternatively, infected cells can be induced by T cells to enter the apoptotic phase. To be 
able to complete viral replication and produce progeny viral particles, HSV like many other 
viruses has adapted methods to inhibit this suicidal tendency of cells.60 On the other hand, 
HSV infection ofT cells results in elimination of virus-specific T cells by inducing apoptosis 
of neighbouring T cells in a F as-dependent fashion. This of immune evasion is referred to as 
fratricide. 61 
Ocular Immune Privilege 
The immunological consequences of viral infections of the eye usually differ from 
those in other tissues because the eye is an immune-privileged site. The eye has acquired this 
immune-privilege status through evolution in order to allow local immune mediators to 
provide protection without interfering with tissue function. Especially for the eye this is an 
important issue since its precise microanatomy can be disturbed as a result of local 
inflammation. Even minor tissue destruction -as a consequence of inflammation- might 
interfere with the transmission of visual images, resulting in visual impairment or complete 
blindness. 
Immune privilege in the eye is accomplished by structural features, soluble 
immunosuppressive factors and cell surface modifiers of immune function. 62 Next to a tight 
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blood-ocular barrier to prevent entrance of vims into the eye, the comea of the eye lacks 
blood and lymph vessels that usually provide the main route of accessibility of inflammatory 
ceUs or immunological factors to other tissues. The aqueous humour in the anterior chamber 
of the eye, which is in close contact with the cornea, also contains several 
immunomodulatory factors. 63 Their functions include suppression ofT cell activation and 
their differentiation towards the Thl phenotype, modulation of T cells to suppress 
reactivation of bystander T cells as well as the suppression of macrophage and neutrophil 
function to fmiher limit potential destructive inflammatory reactions. 64·65 Finally, expression 
of Fas ligand by ocular cells can trigger apoptosis of infiltrating Fas -expressing 
inflammatory cells.66·67 
4. PATHOLOGY OF CORNEAL HSV INFECTIONS 
Corneal HSV Infections 
Primary ocular HSV infections most likely result from direct infection of the co meal 
surface. The majority of these cases involve lesions in the superficial epithelial layer of the 
comea (see Fig. 5). These lesions result from the direct cytopathic effect of the virus, and 
typically heal without pennanent loss of vision. Recurrent comeal HSV infections are 
generally confined to the epithelial layer. However, about 20% of individuals with recurrent 
cornea HSV infections go on to develop disease in the deeper stromal layer of the comea. 
Involvement of the stromal 
layer of the cornea probably 
follows loss of integrity of 
Bowman's membrane resulting 
from recurrent infections. This 
membrane forms a tight and 
strong physical barrier situated 
between the epithelial and 
stromal layer of the comea. 
One type of stromal disease is a 
necrotising form of herpes 
stromal keratitis (HSK), which 
leads to scarring of the comea 
and progressive loss of vision 
with each recunence. Comeal 
scarring and oedema fonnation 
associated with HSK rs a 
frequent reason for comeal 
transplantation. 
Cornea 
Iris 
' ~-----~~treous bo:: ____ _ Stroma / Endothelium \ Epithelium 
chamber 
Figure 5: Cross-sectional vievF of the human eye. Enlargement show-'s 
the anatomiwl make-up of the cornea with three distinctive layers of 
cells. 
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Pathology of Herpetic Stromal Keratitis 
HSV-1 corneal infections are a leading cause of non-traumatic blindness in 
developed countries. 68 The virus can replicate and cause lesions in the epithelial layer of the 
cornea (HEK), but permanent loss of vision is associated with a cell-mediated inflammatory 
response in the corneal stroma known as HSK. This immunopathologic process is the cause 
of the corneal scarring seen in HSK and involves both innate and adaptive immune responses 
to the infecting virus. 69 
Studies on HSK have greatly benefited from the availability of several animal 
models of the disease. The most extensively used models involve HSV-1 infection of the 
mouse cornea. Following inoculation of HSV-1 on the scarified cornea of a susceptible 
mouse, the animal develops a delayed onset of corneal inflammation that resembles many of 
the characteristics of recurrent HSK in humans. The main events in the development of 
murine HSK are schematically reflected in figure 6. 
HSK in the mouse model is characterised by a hi-phasic cellular infiltrate of mainly 
neutrophils into the stromal layer (see Fig. 6).70 The first wave of neutrophils invading the 
cornea is only transient and is involved in viral clearance,"·" while the second wave of 
neutrophil infiltration coincides with clinical manifestations of the disease. Essential for the 
development of HSK is the involvement of CD4+ T cells, orchestrating the extravasation and 
activation of these neutrophils, considered to be directly involved in corneal destruction.73-75 
prc:-clinical nl1asc clinical phase 
Viral 
HSV rcplicutionl 
events 
Humoral 
events 
I , Lnngcrhan's cells I 
Cellular ~---~===t==='='ll='-='='="=''========~i I events I'M:--J 
6 9 12 \) 21 
Days post Infection 
Figure 6: Key events in the development ofHSK as observed in the 
experimental mouse model. (adaptedfrom ref70) 
l 
In addition to T cells, 
infiltrating macrophages 
and corneal Langerhans 
cells have also been 
implicated as important 
mediators m the 
immunopathology of 
experimental munne 
HSK76-79 One of the key 
events m the 
irnmunopathogenic 
processes in HSK is the 
interaction of infiltrating 
T cells and macrophages 
with resident corneal 
fibroblasts. Through this 
interaction, the corneal 
fibroblasts are activated 
and induced to secrete 
multiple pro-inflammatory cytokines and chemokines. In chapter 5, this activation of resident 
human corneal fibroblasts was investigated by mimicking their interaction with infiltrating T 
cells and macrophages in an in vitro culture system. In addition, cytokines and chemokines 
can be secreted by cornea infiltrating inflammatory cells. This induction of chemokines 
ultimately and inevitably results in the large-scale attraction and activation of additional T 
cells and neutrophils. Such massive cellular infiltrate into the cornea results in substantial 
swelling of the stromal layer of the cornea and causes the destruction of the stromal tissue 
integrity (see Fig. 7). 
12 
Figure 7: 
Immunohistological cross-section of the mouse cornea showing (A) a healthy cornea 
and (B) the immunopathologic reactions in HSK. The top (dark) cell layer is the 
outer epithelia/layer, the middle (grey) layer is the stroma and the thin lower layer 
represents the endothelial layer of the cornea. 
GENERAL INTRODUCTION 
The essential involvement of cornea infiltrating T cells in the development of HSK 
was first recognised by the observation by Metcalf et a/. that the inflammation does not 
develop in T cell -deficient, athymic nude mice80 Subsequent studies established that the 
chronic inflammation in murine HSK is regulated by CD4+ Thl cells, 81 . 83 although the 
involvement of CDS. T cells has also been implicated84 Although little is known about the 
characteristics of HSK development in humans, they seem to resemble those found in the 
experimental mouse model. Limited studies have been performed on the characterisation of 
cornea infiltrating T cells in human HSK. 85-87 Results from these studies seem to relate well 
with the characteristic influx of CD4' T cells with a Thl or ThO phenotype in the murine 
cornea after HSV infection. However, these studies included a limited number of patients 
involved and few numbers of individual T cells analysed. Therefore, more detailed and 
broader analyses are required to get a better insight into the immunopathologic situation in 
human HSK. 
In chapter 6 we describe a more elaborate characterisation at the single-cell level of HSV-
specific T cells recovered from corneas of HSK patients. 
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ABSTRACT 
Herpes simplex virus type 1 (HSV-1) related disease ranges from localized, self-
limiting illnesses to fatal disease in immunocompromised individuals. The corneal disease 
herpetic keratitis may develop after reactivation of a latent virus or reinfection with an 
exogenous herpes virus. Molecular analysis of the virus involved may allow distinction 
between these two options. The HSV-1 genome contains several hypervariable regions that 
vary in numbers of reiterating regions (Rei to Re VIII) between individual strains. Twenty-
four HSV-1 clones, derived by subcloning of HSV-1 (strain F) twice in limiting dilutions, 
were tested in a PCR based assay to analyze the stability of Rei, Reiii, Re!V and ReVII. Rei 
and Reiii proved to vary in size upon subcloning, whereas Re!V and Re VII were stable. 
Subsequently, 37 unrelated isolates and ten sequential isolates from five patients, all with 
HSV-1-induced keratitis, were genotyped for Re!V and ReV!!. Of the 37 unrelated samples, 
34 (92%) could be discriminated, while the genotypes of tbe sequential samples were 
identical for each individual. Conclusively, the data show that the approach presented allows 
the rapid and accurate discrimination between HSV -1 strains, in studies addressing the 
transmission and pathogenesis of HSV -I infections. 
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1"\TRODUCTION 
HSV -1 infections are widespread in the human population and may cause a variety 
of disease symptoms, including localized recurrent ocular lesions like uveitis and keratitis. 16 
Clinical manifestations associated with herpetic corneal infections are herpetic epithelial 
keratitis (HEK) and the development of the potentially comea blinding disease herpetic 
stromal keratitis (HSK). 
It may be of clinical importance to know whether recurrent corneal HSV -1 
infections are caused by reactivation of a latent vims or reinfection with an exogenous vims. 
Genetically different HSV -1 strains can induce different types of ocular lesions. ~.3 3 Intratypic 
differences between HSV strains have been demonstrated by plaque morphology, serology 
and DNA restriction analysis. 5· 1522 The method generally used to discriminate between HSV-
l strains is restriction fragment length polymorphism (RFLP) analysis. 7·15.1 7- 19·24·29-31 Since 
this technique depends on virus culture to obtain sufficient quantities of viral DNA, it is 
unsuitable for rapid diagnosis or when no virus can be isolated. Vogel et a/.31 reported an 
alternative method for clinical HSV strain differentiation using PCR amplification and 
subsequent RFLP analysis. 
We have chosen to develop a different strategy, based on the variability of reiterated 
sequences within the HSV-1 genome. The genome of HSV -1 conststs of a unique long (UL) 
and a unique short (Us) sequence, each of which is flanked by inverted repeat sequences. 14·32 
Several hypervariable regions, designated reiteration I-VIII (Rei-VIII), have been identified 
within the HSV-1 genome (Fig. 1). These regions contain multiple repeating sequences, 
which vary in numbers between unrelated HSV-1 strains.3·9J 0·1324·252834·35 The stability of 
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DISCRIMINATION BETWEEN HSV-1 STRAINS 
these regions varies. Re-I, -III, -IV and -VII have been demonstrated to be relatively stable 
during a short period of viral replication and it has been suggested that several of these 
hypervariable regions could be used as markers to discriminate between HSV-1 strains. 27·28 
Re- I and IU are located within the 11 a" sequence of the repeat regions flanking the unique 
short sequence. ReiV is present twice within the HSV- 1 genome, located within introns of 
both the genes US! and USI2, whereas ReVII is located within the protein-coding region of 
US I 0 and US 11.3.11 13 
This repori describes the development of a PCR method to discriminate between 
HSV -1 strains, based on the variability of reiterated sequences within the HSV -1 genome. 
This approach was successfully used to discriminate between 3 7 unrelated co meal HSV -1 
isolates obtained from patients with herpetic co meal disease. Additionally, sequential HSV -1 
isolates from five herpetic keratitis patients were compared. 
MATERIALS AND METHODS 
Clinical samples and viruses. 
Comeal swabs were obtained from 37 patients with herpetic keratitis at the 
Rotterdam Eye Hospital (The Netherlands) for diagnostic purposes. From 5 patients 
sequential samples (n=2) were obtained (mean time interval 19 months, range 9-38 months), 
in four cases from the same eye, and in one case from different eyes. Virus was grown on 
human embryonic lung fibroblasts and harvested when approximately 75% of the monolayer 
displayed a cytopathic effect. All culture samples were confinned HSV-1 positive by PCR 
(data not shown). To determine the stability of the hypervariable regions, 24 subclones were 
generated from HSV-1 strain F (ATCC VR-733) by subcloning twice in limiting dilution as 
described before. 26 
Nucleic acid extraction. 
DNA was extracted from 100 ~I of virus culture samples by a guanidinium 
thiocyanate-celite binding method, as described before (1 ). Briefly, a sample was added to a 
tube containing 1 ml of lysis buffer and 40 ~I of celite suspension (Janssen Chemika, The 
Netherlands), mixed, and incubated for 10 min at room temperature. The celite-bound DNA 
was washed twice with wash buffer, twice with 70% (v/v) ethanol, once with acetone and 
subsequently dried. DNA was extracted by resuspending the pellet in !50 fil water at 56'C 
for 10 min. A volume of5 !J-l of the resulting DNA suspension was used per PCR reaction. 
PCR amplification. 
Primers were designed to amplify distinct regions in the HSV-1 genome, containing 
Re-I, III, IV or VII. PCR amplification was perfonned using several combinations of primers 
(Table 1). The PCR reactions were performed in 50 )li volumes. The reaction mixture 
contained 1.25 U cloned Pji1 DNA polymerase (Stratagene Europe, Amsterdam, The 
Netherlands), corresponding buffer supplemented with 5% (v/v) dimethyl sulfoxide 
(DMSO), 1 JlM of each of the primers and 200 JlM of each dNTP, containing an equimolar 
amount of dGTP and 7-deaza-2'-dGTP (Boehringer Mannheim, Mannheim, Gennany). A 5 
).11 sample of DNA suspension was added and the reaction mixtures were overlaid with 50 ).11 
mineral oil. PCR amplification was caiTied out as follows: an initial denaturation step of 
95'C for 5 min, followed by 45 cycles of alternating denaturation (I min, 95"C), primer 
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annealing (1 min at the appropriate temperature; see Table l) and primer extension (1 min, 
72°C). A final extension step of 7 min at 72°C was included. For negative control samples, 
the DNA suspension was replaced by water. All PCR reactions were performed in a Perkin 
Elmer 480 thennocycler (PE Biosystems, Nieuwerkerk a/d !Jssel, The Netherlands). 
Table 1. Primers used for amplification and detection ofHSV-1 reiterations. 
Genome Primera Anneal Sequence (5' 3') Position in genomeb 
re ion tern ("C) 
" 
sequence Rc!F 72 GCCGCCACCGCTTTAAAGGGCCGC 125976-125999 152234-152257 
RdR GTGCTCTGTTGGTTTCACCTGTGGC AGC 12636S-l26395 151838-151865 
.. 
" 
sequence RclllF 72 TCTCT ACCTC AGTGCCGCCAA TCTC AGGTC 126742-126771 i 151462-151491 
Rcll!R CGAAGACGCAATAAACGGCAACAACCTG 127171-12719~ 151035-151062 
est RciVUSIF 
" 
TCCGACGACAGAAACCCACC 132333-132352 
Rc!VUSIR GTCCCGGAGGACCACAGTGG 132615-132634 
US12 Rc!VUS12F 5~ TTTTTGCACGGGTAAGCAC 145853-145871 
Rc!VUS12R TGGTGTCCAGGAAGGTGTCC 145535-145554 
USI0/11 RcVJIUSIOllf 56 AGCGTATGCTCCATGTTGTG 144697-144716 
RcVIlUSIOIIR CGAGAACCTAGGGAACCCA 144928-144946 
Rei Rcl probe 37 CCGCTCCTCCCC 
Rei II Relll probe 37 CCGCCCCTCGCCCCCTC 
RdV Rc!V probe 37 CCCCCTCCTCCACCCCCGCGTC 
RcVIl ReV! I probe 37 CCCCGGTCTCCCCGGGAG 
"F, forward; R, reverse. 
h Positions correspond to the genomic HSV-1 sequence HEI CG (NID nr. G 1944536). 
Detection of amplified products. 
Amplicons were size-fractionated in 2% agarose gels and visualized by ethidium 
bromide staining. Specificity of the amplicons was confirmed by Southern blotting20 Briefly, 
the electrophoresed samples were transferred onto Hybond N+ (Amarsham, Pharmacia 
Biotech). Hybridization was performed overnight at 37"C using [y-32P] ATP-labeled Re-
specific oligonucleotides (Table 1). Posthybridization washes were perfonned twice with 2x 
SSC, 0,1% SDS at 37°C for 10 min. The filters were exposed with intensifying screens at-
SO'C. In case of small differences in length between amplicons of individual samples, the 
DNA fragments were electrophoresed on denaturing (8 M urea) 6% acrylamide gels.20 The 
length of the amplicons was estimated by comparison to a 100-bp DNA ladder (Gibco BRL). 
To confirm differences in amplicon length, all samples tested were finally electrophoresed in 
order of increasing length. 
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RESULTS 
Amplification qf hypervariable genomic HSV-1 regions containing reiterations I, III, IV and 
VII. 
On basis of documented variability and stability,27·28 hypervariable regions 
containing Rei, -III, -IV and -VII were selected as candidate templates for PCR-mediated 
discrimination between unrelated HSV -1 strains.Amplification of these regions was not 
possible or insufficient using standard PCR reaction conditions (data not shown). Alternative 
conditions, selected to decrease the formation of secondary structures due to the high G/C 
content of these sequences, improved amplification of the target sequences and allowed 
direct visualization of the amplicons with ethidium bromide. Specificity of the amplicons 
was confim1ed by hybridization with a [yYP]-labeled Re-specific probe following Southern 
blotting (Fig. 2). Consistent results were obtained in all cases in subsequent experiments. 
To test the stability of Re-I, -III, -IV and -VII, PCR amplification of these regions 
was performed on 24 separate subclones of the HSV -1 strain F and compared with the 
amplicons of the parental strain (Fig. 2). For the regions containing Re-IV and -VII, 
amplicons from all 24 subclones were identical in size to those of their parental strain, 
indicating the stability of Re-IV and -VII during the two limiting dilution rounds. For the 
regions containing Re-I and -III, 
not all separate subclones 
showed the same amplicon 
length as their parental strain, 
differences being greatest for 
Reiii (Fig. 2). Consequently, 
Re-IV and -VII were further 
used to discriminate between 3 7 
unrelated HSV -1 isolates 
obtained from keratitis patients. 
The results of the analyses 
perfonned on all 37 clinical 
corneal HSV-1 isolates are 
summarized in Table 2. As an 
example, differences m 
amplicon lengths between 
unrelated clinical isolates from 
ten patients are shown in Fig. 
3A. The variability m the 
US 10111 region (Re VII) was 
low, showing only three 
different alleles. Regions US 1 
and US 12 (Re!V) showed a 
wider variety with 14 and 15 
different alleles detected among 
the 3 7 samples analyzed 
respectively (Table 2). 
Combining the results 
of the three amplified regions 
showed that 34 of the 3 7 
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Figure 2. 
Ampliflcotion ofh;pervariable regions •vithin the HSV-1 genome. (A) 
PCR amplification on regions containing Re-I, -III, -IV and -VII was 
performed on Dlv'A ji-mn various HSV-1 (1·train F) subclones. 
Amp/icons were electrophoresed on a 2% agarose gel and visualized 
by ethidium bromide staining. Ten representative samples ji-mn 24 
subclones analyzed are shown. Lane F, HSV-1 parental strain F; 1-10, 
HSV-1 (strain F) subclones; lane C water co/11rol; lanes M, 100 bp 
molecular size marker. Numbers on the left are in bp. (B) 
Autoradiogram o{ DNA in gel fi"om panel A after Southern blot 
transfer and hvbridizotion vvith a Re-svecific nrobe. 
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Table 2. Length of reiteration 
specific amplicons of corneal 
HSV -1 isolates. 
Estimated ampliconlength (bp) 
Isolate and patient Region Region Region CSI0/11 USI US12 
"'· (ReVII) (RelV) (RelV) 
Unrelated 
HSV-1 islllates 
215 27[1 370 
215 2~[1 22[1 
215 28[1 270 
215 29[1 28[1 
215 295 230 
215 305 300 
220 210 310 
220 220 220 
220 220 220 
10 220 260 260 
11 220 260 290 
12 220 260 290 
" 
220 no 260 
14 220 280 260 
15 220 290 260 
16 220 290 280 
n 220 305 230 
18 220 305 310 
19 220 370 370 
20 220 380 300 
21 220 380 390 
22 220 410 220 
23 220 410 460 
24 220 420 300 
25 220 420 420 
26 225 260 270 
27 225 260 280 
28 225 290 260 
29 225 290 27[1 
30 225 295 220 
31 225 295 290 
32 225 320 220 
33 225 320 320 
34 225 320 380 
35 225 340 220 
36 225 340 340 
37 225 370 370 
Sequential 
HSV-1 islllates 
1o 215 280 270 
16 215 280 270 
2a 215 280 220 
26 215 280 220 
39 215 295 230 
3b 215 295 230 
4a 215 3(}5 300 
4b 215 305 300 
s~ 225 220 220 
5b 225 220 220 
a Three pairs of patients (patients 8 and 9, 
patients 10 and 11, and patients 12 and 
13) were infected with clinically unrelated 
strains with identical DNA patterns. 
isolates (92%) displayed a unique combination of 
amplicons. For some clinical samples, no PCR 
product could be detected with ethidium bromide 
staining, or multiple fragments appeared. This was 
probably due to poor quality of template DNA. 
Hybridization with the labeled probe, however, 
readily enabled the detection of the Re-specific 
amplicon in these samples (data not shown). 
Analysis ofsequential corneal HSV-1 isolates. 
Sequential comeal HSV-1 isolates, obtained 
from five patients with recunent herpetic corneal 
infections, were analyzed (Fig. 3; Table 2). The 
RelY and ReVII-specific amplicons showed 
interindividual variance in length. However, the 
amplicons from the sequential samples from each 
individual were identical. 
DISCUSSION 
In the present paper, we present a PCR 
based approach that allows the rapid and accurate 
discrimination between unrelated HSV-1 strains. The 
method generally used to discriminate between 
HSV-1 strains is RFLP analysis. 7· 15 ·17- 19·24·29-31 This 
method requires virus culture, is time-consuming and 
highly labor-intensive. Furthermore, culture requires 
viable virus, which is not always obtainable from 
certain types of clinical samples (e.g. cerebrospinal 
and intra-ocular fluids). More recently, a system 
using PCR amplification and subsequent RFLP 
analysis has been developed to facilitate 
discrimination between HSV -1 strains, eliminating 
the necessity of virus culture. This method, however, 
is not significantly less time-consuming and labor-
intensive than conventional strain differentiation. 31 
Conventional RFLP analysis, usmg 
restriction endonucleases recognizing 6 base pairs 
( 6-bp REs), is insufficient to differentiate HSV -I 
strains of a predominant genotype. Using 4-bp REs 
and RFLP analyses of reiteration sequences greatly 
improved the differentiation rate. 28 As in our study, the RFLP analysis of reiterated 
sequences was based on varying numbers of repeats. Usage of both techniques generated 
similar results, verifYing the applicability of either method in molecular epidemiological 
studies.27.28_Similar hypervariable regions have been used successfully to discriminate 
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between strains of other herpes VIruses like Epstein-Barr vtrus and Human 
Cytomegalovims. 23 ·36 
To be applicable in a PCR based assay to discriminate between different HSV-1 strains, 
these regions should show a considerable degree of variability, and remain stable during a 
relatively short time of replication. We tested the suitability of several HSV-1 hypervariable 
regions to discriminate 
between unrelated HSV -1 
strains. 
Due to their G/C-
rich sequences, standard 
PCR protocols failed to 
reproducibly amplify the 
regions tested. The high 
G/C-content increases the 
formation of secondary 
stmctures, preventing 
consistent amplification of 
the repeats. We tested a 
number of PCR conditions 
m order to obtain 
consistent DNA 
amplification. Addition of 
DMSO as a cosolvent to 
the reaction mixture has 
previously been shown to 
facilitate DNA 
amplification of G/C-rich 
sequences. 12 Introduction 
of the exonuclease activity 
of the Pji1 DNA 
polymerase enzyme in the 
PCR reaction prevents 
"skipping" of the repeats, 
which could result in the 
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fonnation of products smaller than the actual size of the template repeat.2 Another 
modification was the introduction of 7-deaza-2'-dGTP. This analogue of dGTP is equally 
well incorporated into DNA but exetis a lesser binding strength to dCTP than normal 
dGTP 6 ·21 The use of P(i1 polymerase, 50% 7-deaza-2'-dGTP replacing 100% dGTP, and 5% 
DMSO resulted in the most consistent amplification of the large alleles. Specificity of the 
amp !icons was confirmed by hybridization with aRe-specific probes after Southem blotting. 
Analysis of subclones of HSV -1 strain F showed that stability of the sequences Re-I 
and III was too low to be used for discrimination between HSV-1 strains. In contrast, ReiV 
and ReVII were shown to be stable during this procedure. Thus, regions USI (Re!V), US12 
(Re!V) and US I 0/11 (Re VII) were chosen for the discrimination between unrelated corneal 
HSV-1 isolates. 
In agreement with previous studies, the variability in the US 10/11 region was found 
to be relatively low.n29 We detected only three different alleles among 37 unrelated clinical 
HSV-1 isolates, which is not surprising since ReVII is located within a protein coding 
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region, making it a target for selective pressure. More drastic changes in the length of 
USl0/11 could influence the translation or function of the proteins encoded by genes USlO 
and US 11. In contrast, the ReiV containing sequences are located in the introns of genes US 1 
and US12. We found 14 and 15 different alleles for regions US! and US12, respectively, in 
the 37 corneal HSV-1 isolates analyzed. Comparison of the alleles from the three regions for 
all 37 corneal HSV-1 isolates revealed 34 unique combinations. The isolates with identical 
combinations were obtained at different time points, indicating that this was most likely not 
due to contamination during virus isolation or culture procedures. 
From five individuals with recurrent herpetic corneal infections, sequential corneal 
isolates were analyzed. For each individual, sequential samples showed identical DNA 
patterns while differing bem.·een patients. These results implicate that the recurrent infections 
were most likely caused by the same virus. A comparative sequence database search revealed 
several point mutations between different HSV -1 strains, in addition to varying numbers of 
repeats. More detailed analysis, like sequencing the amplicons, might provide more 
conclusive evidence for this assumption. This also demonstrates that these hypervariable 
regions remain stable during reactivation and replication of latent HSV-1 in the corneas of 
these individuals. 
Additionally, we have also analyzed clinical samples in which usually no viable 
virus can be detected4 Re-specific PCR analyses were performed on DNA isolated from 
affected corneal buttons and rims obtained from HSK patients during therapeutic 
keratoplasty. The PCR approach proved to be sensitive enough to amplify the low levels of 
viral DNA present in these samples (unpublished data). The major advantage of the approach 
presented is that it provides the opportunity to discriminate between HSV-1 strains without 
virus culture or RFLP analysis, making it convenient for rapid diagnostic testing. Although 
not suitable for classification of HSV-1 strains, it provides a powerful tool to address 
questions regarding reactivation and the modes of transmission of HSV -1. For example, it 
could be used in assessing the risk ofHSV-1 transmission through cornea transplantation and 
other manifestations of HSV -1 recurrent infections. 
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Herpes Simplex Virus type 1 (HSV-1) Induced Retinitis 
Following Herpes Simplex Encephalitis: 
Indications for Brain-to-Eye Transmission of HSV -1 
Jeroen Maertzdorf, Allegonda Vander Lelij, G. Seerp Baarsma, 
Albert D.M.E. Osterhaus, Georges M.G.M. Verjans 
Annals ojNeurology 2000;48:936 
ABSTRACT 
Herpes simplex encephalitis (HSE) is a severe neurological disease with high 
mortality and morbidity. Reactivated herpes simplex virus (HSV) can cause relapses and 
might even spread to the retina where it can induce a potentially blinding eye disease, known 
as acute retinal necrosis (ARN). In the present study, the HSV-l strains in the brain and eye 
of two patients with ARN following an episode ofHSE were genotyped. The HSV-l strains 
in both the brain and eye were identical in each patient, but differed interindividually. The 
data suggest brain-to-eye transmission of HSV -1 in these patients. 
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INTRODUCTION 
Herpes simplex encephalitis (HSE), caused by an infection of the brain by herpes 
simplex virus (HSV) is a severe disease with high mortality and morbidity', Reactivation and 
neuronal translocation of HSV can result in relapses of HSE or new infections at 
anatomically different sites like the eye. Clinical data suggest that HSE may be a risk factor 
for the development of acute retinal necrosis (ARN), a rapidly progressing and potentially 
blinding eye disease induced by HSV2-4. 
Two patients with HSE who later in life developed ARN were included in this 
study. The HSV-1 strains involved in both disease manifestations of each patient were 
genotyped using a newly developed PCR method5 and subsequent nucleotide sequence 
analyses. The data implicate that in both patients HSE and ARN were caused by a single 
HSV -1 strain, suggesting trans-neuronal spread of the vims from brain to eye. 
PATIENTS AND METHODS 
Patients 
Patient #l was a 68 year-old male who had been admitted to hospital in a somnolent 
state. A viral encephalitis was suspected and computed tomographic scans showed a 
hypodense in the right temporal region. A CSF sample showed leukocyte counts of73xl 0611. 
Diagnosis of HSE was confirmed by detection of HSV-1 DNA, determined by PCR using 
virus-specific primers as described6, and HSV -specific antibodies in the cerebrospinal fluid 
(CSF). Intravenous treatment with 10 mg/kg acyclovir three times daily for 2 weeks resulted 
in slow recovery. However, nine months after discharge from the hospital he developed a 
unilateral acute decrease of visual acuity (VA). The diagnosis ARN was made on clinical 
grounds and confirmed by detection of HSV -1 DNA and local HSV -specific antibody 
production in the aqueous humor (AH) as described previously6 Again the patient was 
treated with acyclovir and maintenance therapy with valcyclovir resulted in a slight 
improvement with a remaining visual acuity of 0.5. 
Patient #2 was a 64 year-old female hospitalized because of progressive headache 
with vomiting and aphasia. Scans showed a hypodense and space occupying process in the 
left temporal region. A CSF sample showed a leukocyte count of 44xl06/l and the diagnosis 
of HSE was confirmed by detection of HSV-1 DNA6 and HSV-specific antibodies in the 
cerebrospinal fluid (CSF). A slow recovery was achieved after intravenous treatment with 10 
mg/kg acyclovir three times daily for 2 weeks. Only ten days after being discharged from the 
hospital this patient developed a unilaterally decreased VA and ARN was diagnosed two 
weeks later. An AH sample contained HSV-1 DNA as determined by PCR whereas no local 
HSV-specific antibody production could be detected6. Again, this patient was given antiviral 
treatment with acyclovir. However, despite maintenance therapy, the remaining visual acuity 
was only finger counting at 3 meter. 
HSV-1 strain differentiation 
Isolation of DNA from the CSF and AH samples from both patients, taken for 
diagnostic purposes, was perfonned as described previousl/. The HSV -1 strains in these 
samples were genotyped with a recently developed PCR-based DNA fingerprint assay which 
allows the rapid and accurate discrimination of up to 92% of unrelated HSV -1 strains5. The 
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assay is based on the amplification of hypervariable regions within the HSV-1 genes US! 
and US12. These regions contain strain-to-strain differences in the number of DNA repeats, 
termed reiteration IV (Re IVf, resulting in variable arnplicon lengths between HSV-1 
strains. Size and specificity of the PCR products were determined on an agarose gel and 
Southern blotting with RelY-specific probes. Nucleotide sequence analyses of gel-purified 
HSV -I US 12 gene amplicons was perfonned with both PCR primers on a Perkin Elmer 
automated sequencer using a commercially available kit according to the manufacturer's 
instructions (DYEnamic™ ET Tenninator; Amersham Pharmacia, Cleveland OH). 
RESULTS 
The CSF- and AH-derived HSV-1 strains from both patients were genotyped using 
a recently developed PCR assay5 Whereas different between the patients, the HSV-1 US! 
and US12 amplicons amplified from both CSF- and AH-derived DNA samples from each 
patient were of similar size (Fig. I). 
US1 -······~, US12 , 
Figure 1: PCR-mediated genotypic analyses of HSV-1 strains located 
in cerebrospinal fluid (CSF) and aqueous humor (AH) samples of' two 
ARN patients with a history of HSE. Amplification and detection oj 
hypervariable regions in the HSV-1 genes US1 and USJ2 was 
pe1formed as described previom)"'/. Left lane: 100-bp molecular size 
The nucleotide 
sequences of the US 12 
amplicons were determined and 
aligned with the corresponding 
sequence of HSV -1 strain 17 
(HS 1 US; GenBank accesswn 
number 291490) (Fig. 2). The 
DNA sequence analyses revealed 
identical nucleotide sequences in 
CSF and AH samples from each 
patient. Comparison between the 
patients revealed, next to a 
difference in the number of Re!V 
elements (2- and 3-times for 
patient # 1 and #2, respectively), 
four separate and unique point 
mutations (Fig. 2). These data 
suggest that in each patient the same HSV-1 strain was involved in the pathogenesis of both 
HSE and ARN. Interestingly, next to the 22-bp long repeating elements (Re!V), a new 45-bp 
long repeating element was identified in the US12 sequences. This 45-bp element 
(designated here as ReVIll) was repeated 2- and 3-times in the HSV-1 strains obtained from 
patients #I and #2, respectively. In the US12 gene sequence ofHSV-1 strain 17 the number 
ofRe!V and VIII repeats are 5 and 1, respectively. 
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Figure 2: DNA nucleotide sequences of the HSV-1 US12 gene amp!icons obtninedfimn the AH and CSF 
samples oft~t·o ARlv' pntients >vith a history ofHSE.Comparison of the sequences between the patients 
and the homologous sequence ofHSV-1 strain 17 revealed a high degree of variety vvithin the US12 region. The 
HSV-1 strain 17 US12 sequence wns obtnined_fi-om the GenBank database (HSIUS: accession G1 291490: 
nuc!eotides 6683-6391 ). Reiterations (Re) IV and Vlll are hoxed and unique point mutations are shaded. The starr 
codon and the encoded US12 amino acid sequence are indicated. The Dli/A sequences obtained have been 
submitted to the Genhank database (accession AF 290017 and AF290018f0r patient #I and# 2 respective!)). 
DISCUSSION 
Several studies have reported on the development of HSV-induced ARN following 
an episode of HSE2-'- It has been hypothesized that the induction of ARN in these patients 
was due to reactivation of latent HSV within the brain and subsequent infection of the retina. 
Studies on the experimental ARN mouse model have provided evidence for this assumption. 
Herein, intra-ocular inoculation of mice with HSV -1 resulted in infection of the brain and 
subsequent ARN in the contralateral eye. The virus was shown to reach the retina of the 
contralateral eye by transaxonal spread via the optic nerve8. 
Here, two ARN patients with a previous episode of HSE were studied to determine 
whether a similar mode of brain-to-eye transmission of HSV -1 had occurred. Detailed 
genotypic analyses of the HSV -1 strains located in the brain and eye samples from these 
patients strongly suggest that the vimses found in both anatomic sites of each patient were 
identical, but differed interindividually. To our knowledge, this is the first study to provide 
molecular evidence that a single HSV-1 strain can cause HSE and subsequently ARN in a 
single individual. Analogous to the ARN mouse model, this suggests that the virus may have 
spread from the brain to the eye, probably through the optic nerve. 
The potential of HSV -1 to establish latency in the brain9 and reactivate from neural 
cells poses a lifetime threat of recurrent infections. Our findings should alert neurologists to 
the possibility that HSE may be followed by ARN, since only prompt and specialized 
medical care may prevent the loss of sight in such patients. Patients recovering from HSV 
brain infections should be closely monitored for viral eye infections, probably for the rest of 
their lives. 
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Patients with Recrudescent Herpetic Keratitis 
ABSTRACT 
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Albert D.M.E. Osterhaus, Georges M.G.M. Verjans 
Investigative Ophthalmology & Visual Science 2002;43:358 
Purpose: Herpetic keratitis is a common sequel of a corneal infection with herpes simplex 
virus type 1 (HSV-1). Recmdescent herpetic keratitis may result in in-eversible damage of 
the cornea. Recunences may be caused by reactivation of endogenous HSV -1 or reinfection 
with exogenous HSV-1. The objective of this study was to determine the incidence and risk 
factors involved, of HSV-1 superinfection in patients with recmdescent herpetic keratitis 
(RHK). 
Methods: From 30 RHK patients sequential corneal HSV-1 isolates were gcnotyped by PCR 
amplification of the hyper-variable regions located within the HSV-1 genes US I, US lOili 
and US12. The clinical data of the patients scored retrospectively were: ophthalmologic 
history, clinical picture during recurrences, number and time points of penetrating 
keratoplasty (PKP) and steroid/acyclovir treatment. 
Results: Whereas the sequential corneal HSV-1 isolates of 19 (63%) out of30 patients had 
the same genotype (designated as group 1 ), the sequential isolates of 11 patients (37%) were 
genetically different (designated as group 2). Among the clinical data analyzed, only the time 
point of penetrating keratoplasty (PKP) was significantly different between the patient 
groups. While no patients of group 1 had been transplanted between sampling, 4 out of II 
patients of group 2 underwent PKP in the inter-recurrence period of the same eye from which 
the co meal HSV -1 isolates were obtained. 
Conclusions: The data demonstrate that RHK is frequently associated with comeal 
reinfection with a different HSV-1 strain and suggest that PKP is a risk factor for comeal 
HSV -1 superinfection. 
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INTRODUCTION 
Herpes simplex virus (HSV) infections may elicit a variety of serious diseases in 
humans, including chronic herpetic keratitis 1.2 A hallmark of HSV and other neurotropic 
herpes viruses is their ability to establish latency in sensory nerve ganglia of the host1• 
Despite the induction of an acquired state of immunity following primary HSV infection, 
recrudescent herpetic lesions are often observed1• Patients who have had corneal HSV -1 
infection risk recurrent corneal disease throughout life. Particularly prolonged or recurrent 
episodes of herpetic keratitis can result in decreased vision or blindness due to the 
development of herpetic stromal keratitis (HSK)23 
Recrudescent HSV infections are thought to result form reactivation of the HSV 
strain acquired during primary infection4-6. However, reinfection with a new HSV strain (i.e. 
superinfection) at the site of primary infection has also been documented6·7 . The route or 
mode of HSV superinfection and its clinical consequences remain enigmatic. Genetically 
different HSV strains have been shown to induce different types of ocular lesions8. 
Furthermore, newly acquired herpetic keratitis may develop after penetrating keratoplasty 
(PKP) in patients transplanted for reasons unrelated to HSV infection, suggesting the 
possibility of HSV-1 transmission through cornea transplantation9 These issues underline 
the clinical importance to know whether recurrent corneal HSV -1 infections are caused by 
reactivation of latent virus or superinfection with a different virus strain. Molecular analyses 
of corneal HSV -1 isolates may allow distinction between both options. 
The genome of HSV-1 consists of a unique long (UL) and a unique short (Us) 
component, each of which is flanked by a pair of oppositely oriented repeat elements. 
Several hypervariable regions have been identified in the HSV-1 genome. These regions 
encompass unique tandemly repeated sequences, reiterations (Re), which vary in copy 
number and nucleotide sequences (Fig. 1)uo.ll. Generally, two types of restriction fragment 
length polymorphism (RFLP) analyses are used to differentiate HSV -1 isolates. One type is 
the variation due mostly to a gain or loss of a restriction enzyme cleavage site. The other 
variation appears as variation in length of cleaved fragments derived from Re-containing 
genomic HSV -1 regions 11 • Among the 8 Re described for HSV -1, Re!V and VIII (both 
located within the introns of genes US! and US12) and ReVII (located within the protein 
coding region of genes US 10 and US 11) have been shown to remain stable during in vitro 
culture and have been used as sensitive and reliable markers to differentiate HSV-1 strains 12-
ts 
We have recently developed a PCR method, based on the stability and strain-to-
strain differences of Re!V, VII and VIII, that facilitated the differentiation of up to 92% of 
unrelated HSV-1 strains 12J 5. The aim of the present study was to determine the incidence and 
risk factors involved in corneal HSV -1 superinfection in patients with recrudescent herpetic 
keratitis (RHK). 
MATERIALS AND METHODS 
Patients and clinical samples 
Corneal swab specimens were obtained for diagnostic reasons from suspected 
herpetic corneal lesions and were inoculated on human embryonic lung fibroblasts. Virus 
was harvested when approximately 75% of the monolayer showed cytopathic effect and was 
subsequently typed for HSV-1 or ~2 by immunocytology and PCR15 . Serial samples from 30 
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Figure 1 
Map of' the herpes simplex virus 
(HSV-lj genome including the 
location and sequences of the 
reiterated sequences (Re) tested. (A) 
The prototypic HSV-1 genome 
encompasses rhe covalently linked 
components LandS. Each component 
consists of unique sequences (UL and 
Us) bracketed by inverted repeat 
sequences (TRL, JR~_, IRs and TR5). A 
short sequence, "a.. is repeated 
directly at the termini of the genome 
and located at the L-S junction. The 
enlargement of the S component 
shows the 5 '----?3' orientations oj 
mRNA .1pecies as horizontal arro-,vs 
with introns as V-shaped indents. 
Protein coding regions {tre shown as 
open boxes. Vertical arroMw indicate 
locations of" reiterations, and Roman 
numerals indicate their locations as 
defined previously11u:. (B) 
Reiteration-specific sequences have 
been described previously/II_IJ_ 
Reiteration IV exists as two forms 
tho! d!ffi?rfi"om each other in a single 
residue10. 
immunocompetent patients with recurrent corneal HSV infections were found in a databank 
of 408 frozen corneal HSV-1 cultures collected since 1980 at the Rotterdam Eye Hospital 
(Rotterdam, The Netherlands). The clinical items scored retrospectively were: anatomical 
location (i.e. left or right eye), previous history of ocular disease, clinical picture at 
presentation of each recun·ence, therapy regimen preceding the culture dates, total number of 
PKP and PKP betvveen vims culture dates. The classification of herpetic keratitis was 
defined on clinical criteria2. The present study was performed according to the Declaration of 
Helsinki and infonned consent was obtained. 
Genotypic analyses ofcorneal HSV-1 isolates 
Genotypic analyses of the viral strains were performed by amplification of the 
hypervariable regions within the HSV-1 genes US!, USlO/USll and US12. This method is 
based on strain-to-strain differences in the number of Re and point mutations within these 
hypervariable genomic regions 10·12· 13 · 15 . DNA was extracted from the primary corneal HSV-1 
cultures, lysed in a guanidine isothiocyanate buffer using Celite solution (Jansen Chemika, 
Beers, Belgium), as described previousli 5 The PCR primers and conditions for amplifying 
and detection by Southern blotting of the hypervariable regions of the HSV-1 genes USJ, 
US I 0/US II and US 12 have been described 15 . In case of small differences in length between 
amplicons (i.e. PCR products) from individual samples, the PCR products were run on 
denaturating (8 M urea) 6% acrylamide gels. The lengths of the amplicons were estimated by 
comparison to a 100- and 25-bp DNA ladder (Gibco BRL). To confirm similarities or 
differences in amplicon length, all samples were finally electrophoresed in order of 
increasing length. 
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Statistical anal_vses 
The statistical evaluation of the results was perfonned using the Fisher's exact test. 
Results were considered statistically significant atp < 0.05. 
RESULTS 
Patients characteristics and genotypic analyses ofsequential corneal HSV-1 isolates 
The group of 30 RHK patients included in this study consisted of 13 female aud 17 
male patients (mean age 58.1 years, range 17- 78 years). From each patient, two (n= 25) or 
three (n~ 4) sequential corneal HSV-1 isolates were obtained (mean time interval 29.8 
months, range 0- 170 months). Patient 22 had a bilateral herpetic keratitis (Table 1). 
Table L Patient characteristics and genetic characterization of sequential comeal HSV-1 isolates from patients 
with recrudescent herpetic keratitis. 
US!0/11 rc~lon 
c 
Estimated ampllcon length fhpl 
US! re~lon US12 region HSV-1 isolates" 
l';lticnt Sn a b b 
-\<'C 
<l-b b-e c Difference 
b 
d 
4 
10 
II 
12 
13 
14 
15 
1(, 
17 
I~ 
19 
20 
21 
22 
23 
24 
25 
26 
27 
46 
II 
M 
M 
\1 
\1 
.\'1 
F 
M 
M 
M 
F 
F 
M 
F 
II 
II 
II 
M 
M 
M 
M 
17 
34 
(,4 
54 
44 
59 
39 
72 
" 1>9 
n 
29 
60 
67 
G9 
74 
52 
55 
63 
46 
69 
32 
75 
38 
72 
65 
77 
46 
215 215 295 295 240 240 
220 220 320 320 305 305 
215 215 2~0 2~0 220 220 
225 225 2RO 280 260 260 
225 225 225 420 420 420 27() 27() 27() 
215 215 215 270 270 27() ]7() 370 370 
215 215 2~0 2~0 270 270 
220 220 -1-10 411} 220 220 
225 ~25 321) 320 310 310 
225 225 220 220 200 200 
220 230 230 240 240 
215 215 305 305 3()0 300 
220 22() 280 280 2MI 260 
225 225 220 220 220 220 
225 22S 295 295 290 290 
225 225 360 360 310 310 
231} 230 260 260 260 260 
210 210 520 520 240 2.t0 
no = = ~ ~ ~ M ~ ~ 
225 225 260 lL!l 250 300 
225 220 470 425 210 JJ_Q 
220 220 290 360 270 290 
225 225 EQ 300 270 270 
225 225 350 430 370 320 
215 215 320 410 J3~0 320 
225 225 370 300 3 70 291) 
220 220 ~so 420 ~.QQ 390 
225 225 340 490 220 220 
225 225 350 4.2.Q 210 210 
225 225 225 290 290 290 260 280 2~0 
L female and M. male. 
Age in years. 
II 
15 
F 
17 
56 
170 
7~ 
22 
12 
28 
22 
21 
II 
36 
40 
22 
85 
38 
2 
2~ 
125 
II 
4) 
a, b and c represent the time points at which comea! HSV~ 1 isolates >vere obtained. Data showing differences in 
amplicon length between sequential samples of individual patients are underlined. Based on the genotypic 
analyses. patients I - 19 were designated as group 1 (genotype sequential isolates identical) and patients 20 -
30 as group 2 (genotype sequential isolates different). 
Patient 22 had a bilateral herpetic keratitis. In case of patient 5, the first and second isolate were obtained from 
the left eye and the third isolate was sampled from the right eye. 
-and+ indicate that comeal HSV-1 isolates obtained v,.·ere from the same or contralateral cornea, respectively. 
HSV-1 SUPERINFECTION OF THE HUMAN CORNEA 
To differentiate whether RHK is due to reactivation of latent HSV-1 or super-
infection with another HSV-1 strain, the sequential corneal HSV-1 isolates of the RHK 
patients were genotyped using a recently developed PCR-based DNA fingerprint assay15 . 
The results of the PCR analyses, on the hypervariable regions of the genes US!, USI0/11 
and USI2, performed on the corneal HSV-1 isolates are summarized in Table I. 
As an example, 
the size fractionation and 
Southern blot analyses of 
the US!- and US12-
specific 
obtained 
amplicons 
from the 
sequential samples of 
patients 1-5 and 20-24 are 
shown in Fig. 2. The 
sequential corneal HSV-1 
isolates of 19 ( 63%) out 
of the 30 patients and 11 
(37%) out of 30 patients 
showed either identical 
(patients 1-19; designated 
patient group 1) or 
different genotypes 
(patients 20-30; 
designated patient group 
2), respectively (Table 1). 
The data suggest that 
more than one-third of 
the corneas of the RHK 
patients analyzed was 
superinfected with a 
--··----
•• 
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Figure 2 
Amphcons of the hypervariable regions USJ and US12 amplified from 
sequential corneal HSV-1 isolates from patients with recrudescent herpetic 
keratitis. Left panel, Amp/icons were electrophorezed on a 2.5% agarose gels 
and were visualized hy ethidium bromide staining. Representative sequential 
samples (a. band c) of 10 patients [patient 1-5 (A; group 1) and 20-24 (B; 
group 2)} are shown. A 25-bp molecular size marker was mn in parallel. 
Numbers on the left are in base pairs. Right panel, Autoradiograph of DNA in 
gel afier Southern blot hybridization with appropriate reiteration-specific probe. 
different HSV-1 strain. In case of patient 30 the newly acquired HSV-1 strain was cultured 
pending two post-PKP recurrences. This suggests that the newly acquired HSV-1 strain had 
colonized the recipient. Combining the results of the 3 amplified genomic regions showed 
that the majority of the distinguishable HSV-1 isolates displayed unique combinations of 
amp !icons (Table 1). In case of patient 22, the data indicate that the bilateral herpetic keratitis 
was due to infections with different HSV -1 strains in either cornea. Patient 30 had two 
different HSV-1 strains identified. In the third sampling episode the strain identified during 
the second recurrence was isolated (Table I). 
Comparison of clinical characteristics of RHK patients in patient group 1 and 2 
Compared to previous reports on RHK patients2·9, our cohort consisted mainly of 
patients with severe entities of HSV-induced keratitis like herpetic stromal and necrotizing 
keratitis. This is also reflected in the high number of PKP in the patient cohort (Table 2; 
mean PKP 1.4 per patient, range 0- 6). 
The clinical characteristics of the patients in group 1 and 2 were compared to identify the 
factors predisposing for corneal HSV -1 superinfection. Overall, the immune status and 
ophthalmic condition did not differ significantly between both groups (data not shown). 
Additionally, gender, inter-recurrence period, anatomic location of the lesions (left or right 
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eye), previous ocular history and clinical picture at time of recurrences were not statistically 
different between both groups (Table I and 2). 
Comparison of therapeutic regimen of RHK patients in patient group I and 2 
The clinical outcome of corticosteroid treatment before or during the convalescence 
period was not statistically different between both groups. The potential effects of long-tenn 
(val)acyclovir treatment were not numerous enough to be interpreted (data not shown). 
While the mean number of PKP per patient did not significantly differ between both 
groups, indicating that both groups were comparable in disease severity, a correlation 
between corneal HSV -1 superinfection and time point of PKP was observed. Whereas no 
patient in group 1 received a corneal transplant between the sampled recurrences, 4 out of the 
11 patients of group 2 underwent a PKP during the inter-recurrence period of the same eye 
from which the sequential corneal HSV-1 isolates were obtained (Table 2;p~ 0.012). Patient 
30 received a corneal allograft between the first and second sampled recurrence. 
DISCUSSION 
Herpes simplex viruses have the ability to reside in latent fonn within neurons of 
the sensory ganglia that innervate the initial site of infection. It is therefore assumed that 
recurrent herpetic lesions are due to reactivation of the HSV strain acquired during the 
primary infection 1.4-6. In contrast, HSV superinfection in patients with recrudescent herpetic 
lesions has been documented6'7 . Patients with recurrent herpetic keratitis risk the 
development ofHSK, a leading cause of comeal blindness worldwide2·3 The objective of the 
present study was to address the two types of etiologies, and risk factors involved in corneal 
HSV-1 superinfection, in 30 patients with HSV-1-induced RHK. 
Genotypic analyses of sequential corneal HSV-1 isolates of 30 RHK patients 
demonstrated that 63% of the patients (patients 1-19; designated as group I) had evidence for 
reactivation of the same HSV-1 strain. From 5 patients of group 1, the isolates were obtained 
from separate eyes. HSV -1 infection of the contralateral cornea has most likely occurred via 
the external route (cross-infection). Interestingly, sequential isolates of 37% of the patients 
(patients 20-30; designated as group 2) had a different genotype, suggesting corneal HSV-1 
superinfection in the inter-recurrence period. 
Alternatively, the instability of the analyzed hypervariable regions may account for 
these differences. HSV, like other DNA viruses, have less genomic variability than RNA 
viruses and are genetically more stable after in vitro passages 11. 15 . In addition to standard 
RFLP, several hypervariable regions within the HSV-1 genome have been used to 
differentiate HSV-1 isolates genetically 11 • Intratypic variation of the regions results from 
differences in the number of Re and point mutations 10·12· 13 The stability of the 8 HSV-1-
specific Re described varies extensively". Genotypic analyses of HSV-1 single-plaque 
clones compared to their parental strain have shown that the hypervariable regions located 
within the HSV-1 genes US!, USI2 and USl0/11 remain stable during in vitro culture 13 ·15 
This, together with the mean inter-recurrence period of patient group 1 (30.4 months), and 
the proofreading activity of Pfu DNA polymerase, implicate that the intra-individual HSV-1 
genotype differences are most likely not due to a genetic alteration of the initial strain or 
errors in amplifying these highly GC-rich DNA sequences, respectively. 
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Analogous to our study, reinfection with new HSV -2 strains has been described in 
two of three patients with recurrent HSV-2 genital herpes7 The latter study and our data 
indicate that HSV superinfection is not as rare as previously suggested4~6 . To differentiate 
HSV strains, most studies have used RFLP analyses using 6-bp recognizing restriction 
enzymes (RE)"-6 The lower efficacy of 6-bp RE, compared to 4-bp RE, to differentiate HSV ~ 
1 strains may account for the different frequencies of HSV superinfection described 11 • 
b 
c 
d 
Table 2. 
Clinical characteristics and cornea transelantations eerformed on eatients with recrudescent he!J:2Ctic keratitis 
0 
History ofHSV- Diagnosis at time point of sampling Penetrating keratoplasty Anatomical site 
a mediatedb c PKP Patient eye disease Time point a Time point b Time point c No. PKP behveen samples 
Non~ blepharitis blcphnriti> No 
None IEK IEK '0 
R~c ISK IEK IEK 
'" Rc<: lSK IEK IEK 
'" 13il1SK JEK IEK IEK '0 
Rcc JSK and uveitis IEK 'ISK l\'SK 
""'o 
Rcc ISK IEK and ISK IEK and ISK No 
NSK in PKP IEK ~nd ISK IEK and ISK No 
Rcc ISK lEK ond ISK IEK Nc 
10 billrec ISK IEK in PKP IEK in PKP Nc 
II bil/rcc ISK and uveitis IEK in PKP IEK in PKP No 
12 ""'ew HSV in PKP IEK in PKP IEK in PKP No 
13 'ISK in PKP IEK in PKP NSK in PKP No 
14 Rec ISK NSK in PKP IEK in PKP No 
15 New I-ISV in PKP 1\cw 1-!SV in PKP IEK in PKP No 
16 NSK IEK ~nd uvciti> IEK No 
17 Rec ISK in PKP IEK in PKP IEK in PKI' No 
18 None IEK in ISK IEK ~nd HKU '0 
19 J\SK IEK in PKP IEK in PKP IEK in PKP '0 
20 ISK and uveitis Blepharitis IEK 
'" 21 Endothditi.l IEK IEK No 
21 Rcc JEK and ISK in PKP IEK IEK No 
23 'lew HSY in PKP IEK IEK No 
24 IEK IEK NSK No 
25 'ISK in PKP IEK in PKP IEK in PKP Yc, 
26 NSK IEK m PKP IEK in PKP No 
21 'ISK in PKP IEK and ISK IEK ~nd ISK Yes 
28 J\SK 1'1 PKP AJ\D IEK and m·citi> IEK <tnd uvcili8 No 
29 NSK in PKP ISK in PKP IEK in PKP Yc.\ 
30 l\"ew 1-!SV in PKP :-.ISK 1""1 PKP ISK in PKP NSK in PKP Yc.; 
The sequential comeal HSV-1 isolates of patients I - 19 (designated as group 1) and 20-30 (designated as 
group 2) had identical or different genotypes, respectively. 
d 
HSV-mediated comeal diseases diagnosed were: immune stromal keratitis (ISK), necrotizing stromal keratitis 
(NSK), infectious epithelial keratitis (IEK) and herpetic keratouveitis (HKU). PKP, penetrating keratoplasty; 
LKP, laminar keratoplasty and GR, graft rejection. The prefixes ''Rec", "Bil" and "New·· indicate recurrent. 
bilateral and newly acquired. respectively. 
Total numbers of preceding penetrating keratoplasty (PKP) performed on each patient are given. 
PKP between sample dates in the patient cohort with identical versus different HSV-1 genotypes of the 
sequential comeal HSV -I isolates \Vere statistically significant (Fisher's exact test; p= 0.0 12). The PKP of 
patient 30 was performed between time point a and b. 
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In general, comeal HSV-1 infections result in the development of herpetic epithelial 
keratitis in about two-third of the patients2 . In the present study, however, the patient cohort 
consisted predominantly of patients with severe entities of herpetic keratitis (Table 2). 
Selection for individuals with a higher susceptibility for corneal HSV -1 infection may have 
occurred. Alternatively, the patients of group 2 may have been superinfected with a more 
virulent HSV -1 strain. 
Among the clinical data analyzed, only the time point of PKP was significantly 
different between the patient groups. While no patients of group 1 had been transplanted 
between sampling, 4 out of 11 patients of group 2 underwent PKP during the inter-recurrence 
period of the same eye from which the co meal HSV -1 isolates were obtained. The data 
suggest that PKP is a risk factor for corneal HSV -1 superinfection. Primm)' graft failure and 
endothelial abnormalities of cultured eye bank corneas have been associated with the 
presence of HSV-1 DNA in affected corneal allografts 16 . The high prevalence of HSV-1 
DNA in eye bank comeas (- 10%)16 has led to the hypothesis ofHSV-1 latency in corneas. 
Although expression of HSV-1 latency associated transcript, a marker of latency, has been 
detected in latently infected rabbit comeas and human HSK corneas, corneal HSV -1 latency 
remains controversial 16' 17 • Recently, Zheng et a!. have demonstrated HSV-1 transmission 
through PKP in an experimental rabbit model 18 HSV-1 DNA was detected in recipient 
corneal rims and the innervating TG of naive rabbits that received corneal allografts from 
latently infected rabbits. Moreover, infectious HSV -1 was recovered from the tear film of the 
transplanted rabbits 18. Besides true ocular viral latency, putative HSV-1 transmission through 
PKP may be due to coincidental shedding of small amounts of infectious virus from the 
allograft or a low-level of viral replication in corneal resident cells in the allograft at time of 
PKP18.19. 
Alternatively, the TG may harbor a mixture of HSV-1 strains with which the 
patients were previously latently infected, prior to PKP. In animal model studies, corneal 
trauma (like PKP) has been shown to induce reactivation ofHSV-1 causing corneal HSV-1 
infection2021 Assuming that the human TG can be latently infected with multiple HSV-1 
strains, PKP may serve as a powerful reactivation stimulus to certain portions of the TG, 
allowing multiple strains to reactivate22 . 
In conclusion, this study is the first to demonstrate a high frequency of corneal 
HSV -1 superinfections in RHK patients. Although we could not determine the source or 
mode of corneal HSV -1 superinfection in patient group 2, the data suggest that PKP might be 
a risk factor for transmission of HSV -1 with subsequent reactivation of the donor-derived 
HSV-1 strain in the corneal allograft. Recently, we have genetically characterized HSV-1 
DNA isolated from a donor cornea before and after PKP in a patient with newly acquired 
herpetic keratitis. The DNA sequences were identical for both strains, providing conclusive 
evidence for graft-to-host transmission ofHSV-1 through a corneal allograft''-
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Herpes Simplex Virus Type 1 Transmission Through 
Corneal Transplantation 
ABSTRACT 
Lies Remeijer, Jeroen Maertzdorf, Peter Doornenbal, 
Georges M G M Verjans, Albert D ME Osterhaus 
Lancet 2001:357:442 
Genetic characterisation of herpes simplex virus type 1 (HSV-1) DNA isolated from 
a donor cornea before and after corneal transplantation demonstrated the transmission of 
HSV-1 through transplantation. This study is the first to provide conclusive evidence for the 
transmission of HSV-1 by penetrating keratoplasty with subsequent reactivation of donor-
derived HSV-1 in the transplanted comea. 
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Herpetic keratitis represents a leading cause of blindness worldwide 1• The current 
therapy of choice for this condition is penetrating keratoplasty (PKP). Infectious agents 
reported to be transmitted by PKP are the Creutzfeldt-Jakob agent, hepatitis type B and C 
viruses, cytomegalovims and rabies virus2• Corneal graft donors are routinely screened for 
these pathogens, but not for the presence of HSV in their comeas. HSV DNA has, however, 
been detected in non-herpetic and eye bank donor comeas3• In patients without a clinical 
history ofHSV keratitis, the emergence of herpetic keratitis has been documented after PKP, 
suggesting graft-to-host transmission of HSV through PKPH. 
A 28-year-old man with 
congenital glaucoma underwent 
a third PKP 111 his only 
functional eye. Post-operative 
treatment consisted of 
prednisolone 0.5% eye drops 8-
times daily. Immediately after 
surgery, an epithelial defect 
developed which showed only 
slow recovery despite additional 
treatment with bandage lenses 
and frequent lubrication with 
autologous serum. Three months 
post PKP, a large epithelial 
defect re-occurred from which 
HSV -I could be isolated (data 
not shown). After 3 months, the 
eye lost visual function due to 
uncontrollable herpetic keratitis 
with graft failure in combination 
with choroidal effusion after 
Figure 1 
DiVA nucleotide sequences ri the HSV-1 USJ and USJ2 gene 
amp!icons obtained _fi-om the donor-derived corneoscleral rim and 
post-PKP corneal HSV-1 isolate of the recipient. 
Comparison of the HSV-1 USI (A) and US!2 (B) Div'A sequences qj 
the donor (rim) and potient (comeo) derived samples and the 
homologous sequence r?( HSV-1 strain 17 revealed a high degree of 
variety within both genomic regions. The HSV-1 strain 17 sequences 
·were obtained from the GenBank database (HSI US: accession GI 
291490)_ Reiterations (Re) IV and VIII are boxed and unique point 
mutations are shaded The start codon and the encoded US/2 amino 
acid sequence are indicated 
glaucoma surgery. Diagnostic HSV-1 PCR and serologic tests were perfonned 
retrospectively on the donor-derived comeoscleral rim and serum of the patient, respectively. 
HSV-1 DNA was detected in the rim, and no HSV-specific IgM and IgG antibodies were 
found in his sentm before surgery (data not shown). Collectively, the data suggested 
transmission of HSV -1 from the allograft to the HSV naive recipient with subsequent 
reactivation of donor-derived HSV -1 in the transplanted cornea. To test this assumption, the 
donor (D)- and recipient (R)-derived HSV-1 strains were genotyped using a recently 
developed PCR-based DNA fingerprint assay5. This method is based on strain-to-strain 
differences in the number of DNA repeats and point mutations within the hypervariable 
regions of the HSV-1 genes US! and US125 The PCR products of the D- and R-derived 
HSV-1 strains were of the same size (data not shown). The respective US! and US12 PCR 
products were sequenced. The DNA sequences were identical for both strains, with multiple 
unique mutations as compared to the corresponding sequences of the HSV-1 F strain (Fig. 1). 
Donor-to-host transmission of infectious agents via corneal transplantation poses a 
real risk to the recipient. Serological screening of cornea donors for a number of viruses, as 
well as bacterial and fungal culturing prior to transplantation, is currently standard practice in 
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most eye banks to limit transmission of infections by PKP. Although the prevalence ofHSV-
1 DNA in eye bank corneas is high (~10%) 1 , only a minority of patients receiving such 
contaminated comeas have been shown to develop HSV -related eye diseaseJA. This may 
result from the antiviral immunity of the recipient following a preceding HSV-1 infection. 
Alternatively, it may be due to low infectious virus loads or poor reactivation of putative 
latent vims in the allograft. Since extra-neuronal HSV-1 latency in the cornea remains 
enigmatic, it is generally assumed that post-PKP HSV keratitis arises from reactivation of the 
recipient's HSV-1 u However, HSV-1 related graft morbidity in patients without previous 
history of HSV infection has also been described, implicating the possibility of HSV-1 
transmission by PKP3.4_ Here, we present a HSV naive patient who lost his vision in his only 
functional eye due to graft-to-host transmission of HSV-1, leading to graft failure in 
combination with choroidal effusion after glaucoma surgery. To our knowledge, this is the 
first study to provide conclusive evidence for graft-to-host transmission ofHSV-1 through a 
corneal allograft. Although apparently rare, this mode of transmission of HSV -1 should be 
taken seriously. Especially transmission of HSV -1 to a seronegative recipient may be 
dangerous, as the virus may cause - among other complications - potentially blinding eye 
infections in patients under immunosuppressive treatment. To prevent HSV -1 transmission to 
HSV-1 naive donors, serologic matching of donor and recipient is an option. If for a HSV 
seronegative patient PKP is urgently requested and no seronegative donor is available, at 
least during immunosuppressive regimen, administration of prophylactic doses of acyclovir 
would be recommended. Our observations stress the need for further studies on the 
localisation and latency of HSV -1 in comeoscleral tissue. 
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Characterization of Herpes Simplex Virus Specific intra-
Corneal T Cells at the Single-Cell Level in Human 
Herpetic Stromal Keratitis 
ABSTRACT 
Jeroen Maertzdorf, Georges M.G.M. Ve1jans, Lies Remeijer, 
Alexander van der Kooi, Alber1 D,M£ Osterhaus 
Journal oflnfectious Diseases (in press) 
Purpose. Herpetic stromal keratitis (HSK) is a T cell-mediated inflammatory disease 
triggered by herpes simplex virus (HSV) infection of the come a. Although this inflammatory 
process has been well characterized in experimental mouse models, little is known about the 
specificity and subsets of intracorneal T cells in human HSK. Here we describe a more 
elaborate characterization of HSV-specific T cells recovered from human HSK-diseased 
corneas at the single-cell level. 
Methods. T cell lines (TCL) were generated from inflammatory cells recovered from 
corneas of 12 HSK patients. Characterization of individual T cells in the TCL was perfonned 
by stimulating TCL with mock -infected or HSV type I and 2 -infected autologous BLCL 
and subsequent flow cytometric analyses. Virus-specificity, phenotype and clonality of the T 
cells were identified by simultaneous detection of intracellular IFN-y, CD4 and CDS, and T 
cell receptor (TCR) vp gene expression, respectively, 
Results. lntra-comeal TCL from I 0 of the 12 patients contained HSV-specific T cells, Both 
CD4- and CDS+ HSV -reactive T cells were identified in these TCL The majority of the 
TCL showed a restricted V~ usage. T cells expressing a single TCR V~ domain dominated 
the HSV-1 reactivity in TCL of some of the patients analyzed. 
Conclusions. Comeas ofHSK patients were shown to be infiltrated by both CD4- and CDS+ 
HSV -specific T cells, which might play a role in the immunopathogenesis of humans HSK. 
The data suggest that the intracorneal HSV -reactive T cell response is dominated by a 
restricted number ofT cell clones. 
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INTRODUCTION 
HSV -1 corneal infections are a leading cause of non-traumatic blindness in 
developed countries1 Replication of the virus within the cornea can lead to an 
immunopathologic disorder, known as HSK, which results in the development of comeal 
lesions and blindness. Current knowledge on the immunopathogenic processes in the 
development of HSK has greatly benefited from studies in experimental mouse models, 
which mimic the human situation. Investigators in the field generally agree that HSK in the 
mouse model is induced by activated CD4+ T cells of the Th1 phenotype2 -4 These cells are 
believed to orchestrate the major influx of neutrophils into the corneal stroma characteristic 
for HSK. These cornea infiltrating neutrophils are considered to be the main cell type 
directly involved in corneal destruction3 ·5 Other cell types that play an important role in the 
immunopathogenesis of HSK are Langerhans cells (LCs )6 and macrophages. 7'8 
Studies in murine models have shown that both vims and host factors play a role in 
the susceptibility for, and the severity of HSK development. Although the crucial 
involvement of CD4+ Th1 cells has been clearly established in the HSK mouse model, there 
is still debate concerning the antigen-specificity of the T cells involved. The group of Cantor 
et al. has proposed that HSK is an autoimmune disease triggered by a cross-reactivity 
between a corneal autoantigen and an HSV-1 UL6 peptide9 ·10 In sharp contrast are the 
findings by the group of Rouse et al. indicating an inflammatory process in HSK in the 
absence of viral antigen recognition, referred to as bystander T cell activation. 1 1"14 
Functional studies on cornea infiltrating T cells in human HSK are limited. Studies 
by our group 15·16 have shown the presence ofHSV-1 ~specific T cells and surprisingly high 
percentages of CDS+ T cells in the majority of corneas form HSK patients. This was 
confirmed by the isolation of HSV-1 ~specific CD4- and CDS+ T cell clones (TCC) by 
Koelle and co-workers-" Most of the human HSV -specific TCC isolated by both groups 
appeared to be CD4+ T cells of the Th1 or ThO phenotype. 15· 17 Neither group could detect any 
reactivity against the UL6 peptide or a corneal autoantigen. 16·17 
A major drawback of these studies on cornea infiltrating T cells in human HSK is 
the relatively low number of TCC analyzed, which does not provide an accurate insight into 
the phenotype and clonality ofT cells involved in the inflammatory process in human HSK. 
We therefore aimed to make a more broadened analysis of the TCL generated from human 
HSK diseased corneas. In the present study we analyzed the phenotype and clonality of 
intracorneal HSV-specific T cells, using four colour flow cytometry. Staining of intracellular 
IFN-y was used as a marker forT cell activation and antigen-specificity. Staining on CD4 
and CDS indicated the subtype ofT cell involved while staining with mAbs against different 
TCR VJ3 domains was used as an indication for the clonality of the HSV -1 specific T cells 
present within the TCL. 
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MATERIALS AND METHODS 
Clinical samples and processing 
Heparinized peripheral blood and corneal buttons were obtained from 13 patients 
with HSK at the time of therapeutic corneal transplantation. Patient characteristics and 
disease classifications are outlined in Table 1. Corneal buttons were obtained immediately 
after surgery and divided in two. One half was used for DNA extraction and standard 
diagnostic detection of HSV DNA by PCR as described previously. 16 The other corneal half 
was used for recovery of intra-corneal inflammatory cells. Generation of TCL from these 
specimens by mitogenic stimulation of recovered inflammatory cells, isolation ofPBMC and 
generation ofBLCL by transformation with Epstein-Ban virus were essentially performed as 
described previously." Virus stocks with cell lysate antigen preparations of the HSV-l 
Macintyre strain (American Type Culture Collection [ATCC] VR-539) and the HSV-2 MS 
strain (ATCC VR-540) were generated and titrated on Vero cells. Mock infections were 
performed with preparations from similarly treated Vero cells only. The present study was 
perfonned in agreement with the Declaration of Helsinki, and informed consent was obtained 
from all patients. 
Table 1. HSK patients' characteristics 
Patient Sex' Ageh 
M 
4 
M 
M 
M 
M 
10 
II 
12 
13 
aM: Male. F;Female 
b Age in years 
25 
68 
78 
72 
71 
72 
28 
56 
4) 
64 
50 
52 
40 
Diagnosis' 
1SK 
NSK 
NSK 
1SK 
NSK 
1SK 
1SK 
NSK 
1SK 
1SK 
1SK 
1SK 
1SK 
Disease 
status 
Quiescent 
Active 
Acti\'C 
Quiescent 
Quiescent 
Quie:<cccm 
Quic~ccnt 
Aeli\·C 
Quiescent 
QliiCSCCnt 
ACll\·C 
Quiescent 
Quiescent 
Topical pre-operative 
HSV-1 Time since HSK Time since last treatment 
PCR first diagnosed '1 recurrence' 
Steroids Acyclovir 
10 17 Yes Yc~ 
17 Ye> Yes 
25 Yes Yes 
12 Yes Yes 
II 36 Yes Yes 
59 28 Yes Ko 
22 No Yes 
13 Yes Yes 
16 Yes Ko 
36 Yes Ko 
No Ko 
40 14 No Ko 
13 17 Ye.; Ko 
ciSK: immune stromal keratitis, NSK: necrotizing stromal keratitis. PNU: perforated neurotrofic ulcer 
d Time in years 
e Time in months 
Stimulation of intra-corneal TCL 
BLCLs were infected with cell lysate antigen preparations of HSV-l, HSV-2 or 
uninfected cell control (mock) for I hour at 37"C in pure virus stock preparation and left 
overnight in an incubator (37"C; 5% C02) in RPMI-!640 medium supplemented with 10% 
FCS. After UV-irradiation of the BLCLs, 2xl05 virus- or mock -infected BLCLs were 
cocultured with 3xl05 T cells from the cornea-derived TCL in 96-well tissue culture plates in 
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RPMI-1640 supplemented with 10% heat-inactivated human pooled serum. After 1 hr., 
monensin (2 ~tg/ml; BD Phanningen, San Diego, CA) was added to block the transport of 
newly synthesized proteins to the cell surface. Accumulation of intracellular IFN-y was 
allowed for 6 hrs. or overnight at 37°C before staining with fluorescent label conjugated 
mAbs and subsequent flow cytometric analyses. As a positive control for stimulation, TCL 
were incubated with phorbol myristate acetate (PMA; 50 ng/ml) and calcium-ionophore (500 
ng/ml) (both obtained from Sigma, StLouis, Ml). 
Staining and FACS analyses 
Fluorescent staining of TCL was perfonned with the following monoclonal 
antibodies (mAbs): IFN-y- allophycoctanin (APC) (BD Phanningen), CD3- phycoerytherin 
(PE) (Dako, Glostrup, Denmark); CD4-fluorescein isothiocyanate (FITC) (Dako); CD8-
peridinin chlorophyll A protein (PerCP) (BD Biosciences, San Jose, CA). Detennination of 
the TCR V~ repertoire was perfonncd by staining with TCR V~ -specific unconjugated 
mAbs, followed by incubation with aPE-labeled goat-anti-mouse IgG preparation (Dako ). A 
total of 21 mAbs against different TCR V~ domains were pooled into six separate mixes to 
limit the number of samples to be analyzed. Content of the different mixes with equivalent 
amounts ofmAbs against TCR V~ domains are as follows (indicated as [TCR (clone)]: Mix 
I [V~3 (CH92) and 5.1 (IMMUI570)], Mix-2 [V~S.l/8.2 (56C5.2), 12.2 (VER2.23.1) and 
17 (El7.5F3.15.13)], Mix-3 [V~2 (MPB2D5), 16 (TAMAYAI.2) and 23 (AHUT7)], Mix-4 
[V~6.1 (CR!304.3), 7.1 (ZOE), 9.1 (FIN9), 11.1111.2 (C21) and 14 (CASI.l.3)], Mix-5 
[V~l3.6 (JU74.3), 18 (BA62.6), 20 (ELLI.4), 21.3 (10125) and 22 (IMMU546)] and Mix-6 
[V035.2/5.3 (4Hll), 6.7 (OTI45) and 13.1/13.3 (BAMI3)]. These TCR V~ mAb mixes 
were designed to stain ~10% of CD3- cells from PBMC, covering 60-65% of all PBMC 
CD3 cells. 1/\ 
Stimulated cells were washed with PBS with 3% FCS and incubated in the dark on ice for 30 
min with the different TCR V~ mAb mixes as indicated above. After blocking of unbound 
goat antibodies with PBS containing 2% normal mouse serum, cells were similarly stained 
for the different surface markers. Cell preparations were subsequently fixed and 
permeabilized with Cytofix/Cytoperm solution (BD Phanningen) and stained for intracellular 
IFN-y according to the manufacturer's instmctions. Following another wash step, cells were 
resuspended in PBS with I% FCS and approximately 2.104- 4.104 viable cells were analyzed 
on a FACScalibur flow cytometer (Beckton Dickinson). 
RESULTS 
Phenotypic Characterization of Intracornea! TCL ofHSK Patients 
Diagnostic analyses were perfonned on corneas from 12 patients with immune- or 
necrotizing stromal keratitis (Table 1 ), immediately after therapeutic comea transplantation. 
HSK classification was defined on the basis of clinical criteria. 19 Age of the patients was 55 
± 17 (years; mean± stdev) and all except one (patient II) had a history of recurrent episodes 
of HSK (Table I). Standard diagnostic PCR analysis revealed HSV-1 DNA in 7 corneas, 
irrespective of pre-operative treatment with acyclovir (Table 1). HSV-1 DNA was detected 
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in corneas of all four patients with active disease (patients 2, 3, Sand 11) and in three with a 
quiescent disease status (patients 4, 9 and 1 0). 
To analyze the antigen-specificity and subsets ofT cells involved in human HSK, 
TCL were generated by recovery of intra-corneal T cells, which were expanded twice by 
mitogenic stimulation. Cells within the intra-corneal. TCL from all patients were 
predominantly CD3 · and contained both CDr and CDS" T cells. The ratio of CD4" and 
CDS+ T cells varied considerably between patients (Table 2). The clonality of the individual 
TCL was detennined by analyzing their TCR V~ domain usage within both CD4+ and CDS+ 
T cell populations. A panel of 21 TCR V~ domain-specific mAb were divided into 6 TCR 
V~ mAb mixes, each covering -10% of peripheral blood CD3+ T cells.'' 
Table 2. Phenotype and TCR Vj3 expression of intra-corneal TCL from HSK patients. 
%Cells with %Cells expressing TCR V domains b 
Patient phenotype a --------------'-------~----------
Mix 1 Mix 2 Mix 3 Mix 4 Mix 5 Mix 6 Total TCR+ Individual mAbsc 
~~~ ~~~ CD4 CDS CD4 CDS CD4 CDS CD4 CDS CD4 CDS CD4 CDS CD4 CDS 
1 35 43 3 6 3 7 1 3 3 3 <1 11 
2 22 74 2 <1 3 <1 4 <1 1 <1 <1 <1 
3 40 54 <1 <1 53 86 <1 <1 <1 <1 3 <1 
4' 64 19 <1 <1 7 22 5 43 <1 <1 <1 <1 
5 85 5 <1 <1 <1 <1 3 <1 <1 <1 <1 <1 
6 76 26 1 <1 80 3 1 •1 <1 <1 <1 2 
7 85 11 <1 3 3 6 9 3 2 <1 10 1 
8 41 57 <1 2 1 23 6 6 <1 <1 28 57 
9 37 60 <1 4 40 63 5 2 1 4 <1 6 
10' 62 36 <1 <1 83 2 <1 <1 <1 <1 <1 <1 
11 86 11 44 <1 12 11 8 58 <1 6 1 <1 
12' 49 50 <1 <1 8 84 <1 2 <1 <1 <1 <1 
13' 95 2 <1 3 <1 5 <1 2 <1 <1 <1 <1 
+ Gated on lrve cells 
h Gated on live cells and CD4 or CDS 
' Dominant TCR Vj3 domain identified. 
*Expression ofTCR Vj3 was analyzed in a single experiment 
NO. not done. 
72 18 83 48 
4 <1 15 <1 
3 5 59 91 
8 <1 20 66 
<1 <1 3 <1 
<1 1 83 7 
2 5 26 18 
32 24 67 106 
1 5 48 84 
<1 <1 83 2 
4 1 69 76 
5 3 14 89 
11 19 11 29 
CD4 CDS 
73 {V~13.1/13.3} 14 (Vrl13_1/13.3) 
53 (V~17) 87 (V~12.2) 
NO 
83 (V~8.1/8.2) 
19 (V~8.1/8.2) 
29 (VB13.6) 27 (VB13.6} 
26 (VB13.1/.3) 21 (VB20} 
17 {VB13.1/.3) 
42 (VB17) 62 (V~17) 
75 (V~17} 
42(VB5.1) 53 (VB2) 
NO 
NO 
Screening with the available panel of TCR V~ mAbs, indicated in most cases a 
skewing towards a particular TCR V~ mix (Table 2). Whereas in TCL from 6 patients (I, 3, 
6, 9, IO and 12) TCR V~ usage was confined to a single dominant TCR V~ mix, TCL from 
patients 4, 7, 8 and II appeared to contain a more or less oligoclonal distribution ofTCR V~ 
domains. For patients 2 and 5, no significant staining for the different TCR V~ domains 
could be detected. The most predominant TCR V~ mix staining positive in most TCL was 
mix 2, either in the CD4+ or CDS~ subset alone, or in both T cell populations (Table 2). To a 
lesser extent TCR V~ mixes 3 and 6 also appeared to stain a significant portion ofT cells 
present within several TCL. Only TCR V~ mix 4 did not show any significant staining in any 
of the TCL analyzed. Subsequently, TCL showing positive staining in dominant TCR V~ 
mixes were analyzed for their usage of individual TCR V~ domains within the relevant TCR 
V~ mixes (Table 2). Unfortunately, this analysis could not be perfonned on TCL from 
patients 4 and 12 due to limited availability of cells. This analyses indicated that positive 
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staining m the 
matching TCR V~ 
mixes was in all but 
one cases attributable 
to a single TCR V~ 
domain (Table 2). Only 
staining of TCR V~ 
mix 5 in the CDS 
fraction of TCL from 
patient 8 was caused 
by usage of two 
different TCR V~ 
domains (TCR V~ 13.6 
and TCR V~ 20), 
furthermore 
underlining the 
oligoclonality of this 
TCL. The most 
frequently observed 
TCR V~ domains used 
were TCR V~l7 (in 
HSV-1 1-JSV-2 
.·~--~ 
CD4 CD3 
cos 
Figure 1. 
Detection ofHSV-spec[jicity in the CD4+ and CD8- T subsets in intra-corneal TCL 
from HSKpatient 9. TCL were cocultivated with mock-. HSV-1 or HSV-2 -ii?fixted 
autologous BLCL. Staining of intra-cellular IFN-r was used as an activation 
marker for antigen-spec!flc T cells and TCL was analyzed by flowcJ'fometJy. 
Results shown were gated on live cell population. P/1 indicates stimulation of TCL 
with PA1A and calciwn-ionophore as a positive controlfor IFN-y production. 
patients 3, 9 and 10), TCR V~S.l/S.2 (in patients 6 and S) and TCR V~l3.lll3.3 (in patients 
1 and 8). Positive staining of both CD4' and CDS' subsets in a particular TCR V~ mix (in 
patients 1, 3 ,8 and 9) was in most cases attributable to the same individual TCR V~ domain, 
with the exception of TCL from patient 3, which expressed different TCR V~ domains in its 
CD4+ and CDS+ populations. 
Phenotypic characterization ofHSV -spec(fic intracorneal T cells. 
HSV antigen specificity of the intra-corneal TCL was analyzed by co-cultivation 
with mock-, HSV-1- or HSV-2 -infected autologous BLCL as antigen presenting cells 
(APCs). Subsequent detection of intracellular IFN-y was used as a measure for T cell 
activation to identify antigen-specific cells. Figure l shows the results of a representative 
flow cytometric analysis on the intracorneal TCL from patient 9. TCL from 10 of the 12 
patients showed reactivity against HSV-1 antigens, while 6 of the 9 TCL analyzed for HSV-2 
-specificity showed specific T cells for HSV-2 (Table 3). All TCL analyzed for both HSV-1 
and HSV-2, except one (patient 6), were reactive against both HSV serotypes. 
HSV antigen-reactivity could be attributed to the CD4+ subset (patients 2, 8 and 12), 
the CDS+ subset (patients 5, 6 and 1 0) or both (patients 3, 4, 7 and 9). While the majority of 
cells in all other TCL were capable of producing IFN-y, TCL from patient 2 only showed a 
marginal number of IFN-y producing T cells upon stimulation with P/1 in multiple 
experiments (not shown), despite the observation that cells looked healthy under normal 
light-microscopic examination and by tryphan blue staining. 
Clonal analyses of HSV-1 -specific intracorneal T cells. 
A fourth fluorescent parameter, TCR V~ domain expression, was included to 
determine the clonality of the cornea-derived HSV-1 -specific T cells. Figure 2 shows the 
results of a representative analysis of the TCL from patient 3. Analysis of 5 of the intra-
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Table 3. Phenotype ofHSV -specific intra-corneal T cells from HSK patients 
Patient 
2 
4 
5 
6' 
7 
8 
9 
11 
12' 
13' 
ND: not done 
CD4+ 
0.1 ± 0.1 
4.5 0.7 
4.3 0.9 
4.1 1.8 
0.3 :':: 0.5 
0.2 
7.5 2.2 
3.1 1.8 
17.7 3.5 
0.2 
0.3 ± 0.1 
5.3 
0.1 
HSV-1 b 
% IFN- + T cells • 
HSV-2 b 
CDS+ CD4+ CDS+ 
0.6 ± 0.7 NO NO 
0.1 ± 0.1 3.3 2.0 0.2 ± 0.2 
44.0 7.5 NO NO 
16.6 5.1 0.4 13.6 
7.1 1.6 0.4 ± 0.3 6.7 2.1 
4.6 0.0 07 
6.0 1.1 2.2 0.8 2.3 
0.7 ± 0.5 NO NO 
2.3 0.5 S.5 0.8 1.3 0.5 
20.3 ND ND 
0.0 = 0.0 0.1 ± 0.1 0.1 ± 0.1 
0.4 8.2 0.5 
0.0 0.1 0.0 
"Gated on live cells and f'f)4 or CDR I corrected for mock-infection 
corneal TCL from HSK 
patients (Table 4) 
showed that usage of a 
single TCR vp domain 
dominated the T cell 
response to HSV-1 in 2 
of these individuals 
(patient 3; CD8-N012.2 
and patient 9; 
CD4•Npl7). Despite 
the high prevalence of 
TCR V017 in the CD4-
fraction of the TCL from 
patient 3 (see Table 3), 
the antigen-reactivity m 
this fraction could not be 
assigned to a T cell 
subset using a particular 
TCR vp domain. The 
same goes for HSV-1 -specificity within the CD8+ fraction of TCL from patient 9. For the 
other 3 individuals, no predominant HSV -1 -specific TCR vp domain was detected (Table 
4). From all TCL with proven HSV -reactivity, patients 2 and 5 are not included because no 
dominant TCR vp usage could be detected in their TCL (see Table 2). Similarly, patients 6 
and 10 were excluded. Although a profound skewing ofTCR vp usage was seen in the CD4+ 
fraction of these TCL (see Table 2), HSV-reactivity was only observed in the CDS" T cell 
subset (see Table 3). Only for patient 8, the clonality of HSV -I -specific T cells could not be 
determined due to unavailability of sufficient numbers of cells. 
Table 4. TCR Vj3 usage of HSV -1 -specific intra-corneal T cells ofHSK patients . 
% IFN- . T cells expressing TCR V gene segments " 
Patient Mix I Mix2 Mix 3 Mix4 MixS Mix6 
CD4+ CD8 
. 
CD4 
. 
CDS 
. 
CD4 
. 
cos+ CD4 
. 
CDS 
. CD4+ 
3 0 0 <1 44.0 <1 0 0 
4 0 <1 <1 9.3 0 
7 <1 <1 <1 1.1 <1 <1 0 
0 <1 18.6 <1 2.7 <1 <1 
12 0 <1 <1 <1 0 0 
"Cells spec1fic for HSV -1, Gated on live cells and CD4 or CDS 
b Dominant TCR Vj3 domain identified. 
ND; not done 
<1 
<1 
0 
CD8 
. 
CD4 
. 
CD8 
0 <1 
0 
<1 
<1 <1 <1 
0 <1 0 
b 
Individual mAb> 
. CD4+ CDS+ 
45.4 (Vb 12.2) 
ND 
19.5 (Vb 17) 
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DISCUSSION 
HSK is an immunopathologic disease elicited by HSV infection of the corneal 
stroma. Both viral antigens and factors of the host immune system play crucial roles in the 
development of the inflammatory processes in HSK. Viral replication within the cornea is 
essential for the development of HSK, since UV-inactivated and replication defective HSV 
mutants fail to induce HSK in mice. 20 On the other hand, a functional T cell repertoire of the 
host's immune system is required, as T-cell deficient nude mice do not develop HSK upon 
corneal HSV infection.21 Although the crucial involvement of CD4~ Thl cells has been 
clearly established in experimental mouse models of HSK,2-4 little is known about the 
specificity and subsets ofT cells involved in the human situation. In order to make a more 
elaborate evaluation of intra-corneal T cells from HSK patients at the single-cell level, we 
used an alternative approach without the need of generating TCCs. The methodology 
developed involves four-color flowcytometric analyses of intra-comeal TCL and enables 
simultaneous analysis ofHSV-1 specificity (IFN-y production), subtype (CD4 and CDS) and 
clonality (TCR Vf.l domain) of individual cells. Staining of intracellular IFN-y was used as a 
T cell activation marker to detect HSV-specificity as previous studies have shown that both 
CD4+ and CDS' HSV-specific T cells from comeas of HSK patients secrete IFN-y upon 
antigenic stimulation. 15J 7 A similar experimental method has been used successfully before, 
as described in a recent report on the clonotypic structure of the human CD4+ memmy T cell 
response to cytomegalovirus in PBMC.22 Analysis of virus-specificity and phenotype at the 
single-cell level mainly has the advantage over T cell cloning in that vast numbers of cells 
can be screened in short time. 
A total of 12 HSK patients from whom intra-comeal TCL had been generated were 
included in this study. HSV -1 DNA could be detected in diseased comeas of 7 patients and 
intracomeal T cells of both CD4 ~ and CDS+ subsets were observed in variable ratios. The 
fact that a small por1ion of cells is neither CD3'/CD4- nor CD3+/CDS+ (see Table 2) was due 
to contamination by BLCL in the live gate set during flowcytometric analyses. In agreement 
with previous studies, 15- 17 HSV-reactive T cells were observed in corneas of most HSK 
patients included in this study, either in the CD4+ or CDS+ population alone, or in both T cell 
subsets. Surprisingly, the TCL of several of the patients we analyzed contained relatively 
high numbers of CDst· HSV -specific T cells. These data are in contrast with results from 
studies performed in experimental mouse models of HSK, which have indicated that in 
murine HSK, cornea infiltrating T cells are predominantly of the CD4- subset. 2-4 Only one 
study on intra-corneal T cells in human HSK has previously indicated the presence of HSV -I 
--specific CDS- T cells in the diseased cornea, 17 albeit in very low numbers. Recent findings 
suggest that the antigen-specific frequency in the original samples used in that study might 
have been considerably higher, pmily because CTL effectors undergo activation-induced cell 
death in limiting dilution cultures,23 as employed in the study mentioned. This might in part 
explain the discrepancy between the low percentages of HSV -specific CDS+ TCC found by 
Koelle and co-workers 17 and the relative high frequencies of HSV-specific CDS- T cells 
found in the present study. Alternatively, the mitogenic stimulation of T cells applied in 
order to obtain sufficient numbers of cells for our analyses invokes the risk of selective 
growth of ceriain T cell subtypes and clones. Similarly, the more extended growth potential 
of CDS~ over CD4+ T cells following a non-specific stimulus24 might have caused the high 
frequencies of CDS~ cells in some of our TCL On the other hand, clonal expansion of CD4+ 
T cells was also frequently observed. One explanation for this might be related to the overall 
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as in Fig I and were stainedfor: (A) different TCR VfJmAh mixes or (B) individual TCR VfJ mAbs. to idem{f~· the 
HSV-1 -.lpec[flc subset of' T cells in this TCL Cells were gated on live cells and on either CD4 or CD8. Mock 
stimulated cet!s vvere incubated with 2% normal mouse serum insteod ofo TCR VfJ mix to correct/Or bockground 
staining ofmAbs. 
age of the patients and the fact that HSK generally develops upon recunent corneal HSV 
infections over a prolonged period of time. That is, clonal expansion of pmiicularly CD4+ T 
cells requires chronic antigenic stimulation, as is the case in elderly people infected with 
herpes vimses, which are canied for longer periods of time and can regularly cause recunent 
infections. 13 
The most striking observation in our study was the skewing towards the usage of a 
limited number of TCR V~ domains by T cells present within intra-comeal TCL of the 
majority of patients. In line with a previous study, 15 HSV reactivity also appeared to be 
almost completely accountable to T cells with a single TCR V~ domain in some of the 
patients analyzed. As we did not perform sequencing analysis of the TCR V~ gene segments 
of each single cell, although likely, we cannot be certain that usage of the same TCR V~ 
domain in a particular TCL reflects a pure monoclonal T cell population. This skewing of a 
particular TCR V~ domain might have, at least in pmi, been due to the stimulation protocol 
used to grow intra-corneal T cells. On the other hand, elderly people are known to frequently 
exhibit usage of a single or few TCR vp domains in their antigen-specific T cell repertoire. 23 
A similar clonotypic dominance of virus specific T cells has also been observed by others in 
fresh PBMC obtained from cytomegalovims-infected individuals. 22 
A second limitation of this study is the fact that the available panel ofmAbs against 
the different TCR V~ domains does not cover the whole spectmm of vp gene segments 
expressed by human T cells. This imperfection probably accounts for the majority ofT cells 
from which the TCR V~ domain could not be identified. In intra-comeal TCL from some 
patients, the majority ofT cells was not recognized by any of the six TCR V~ mixes. Still, a 
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clear antigenic response against HSV could be measured in TCL from these patients (see 
Table 2), implicating that a more or less dominant HSV-specific T cell response, with a TCR 
V~ domain for which a mAb was not available to us, existed in these TCL 
Although the antigen specificity of comea infiltrating T cells in the mouse HSK 
model remains unclear, HSV-specific T cells have been observed in murine comeas.6 Few 
data however are available on the clonality of these T cells. Studies by Heiligenhaus et a!. 
though have indicated that in murine HSK, similarly to what we observed in humans in this 
study, the cornea is infiltrated with a dominant subtype ofT cells.2526 These investigators 
found mainly activated CD4+ T cells expressing the TCR V~8 domain in inflamed corneas of 
susceptible mice. They argued that this dominant and clonal T cell subtype was involved in 
mediating HSK in mice. Although in the murine HSK model HSV antigens are no longer 
detectable at the time comeal disease manifests itself, HSV antigens have been detected in 
corneas of human HSK patients during the active phase of the disease, predominantly in 
patients with ulcerative necrotizing HSK. 15·27 Especially the high frequency and clonality of 
HSV -specific T cells in some TCL in this study argues for an enrichment of HSV-specific T 
cells in HSK diseased human corneas by antigen-specific mechanisms. It remains however 
speculative whether these HSV -specific T cells are the actual trigger for the development of 
HSK in humans or whether alternative mechanisms are at work. 
In summary, the present study demonstrates that four-color flowcytometry can be 
used to analyze intra-corneal T cell fractions from HSK patients at the single cell level, 
without the need of subcloning ofT cells. HSV-specific T cells of both CD4+ and CD8+ 
subsets were observed in intra-corneal TCL from most HSK patients. Our data demonstrate 
the infiltration and local enrichment of HSV -specific T cells and indicate a profound skewing 
of TCR V~ usage by HSV -1 -specific intra-corneal T cells in these HSK patients. We 
hypothesize that HSV-specific T cells may have an important function in the development 
and/or perpetuation of the inflammatory processes in human HKS. 
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IL-17 Expression in Human Herpetic Stromal Keratitis: 
Modulatory Effects on Chemokine Production by 
Corneal Fibroblasts 
Jeroen Maer1zdorf, Albert D.M.E. Osterhaus, Georges M.G.M. Verjans 
Journal of Immunology (in press) 
ABSTRACT 
Herpetic stromal keratitis (HSK) is an immunopathologic disease triggered by 
infection of the con1ea with herpes simplex virus. Key events in HSK involve the interaction 
between comea infiltrating inflammatory cells and resident cells. This interaction in which 
macrophages, producing IL-l and TNF-a, and IFN-y producing Thl cells play a crucial role, 
results in the local secretion of immune-modulatory factors and a major influx ofneutrophils 
causing comeal lesions and blindness. The Thl-derived cytokine IL-17 has been shown to 
play an important role in several inflammatory diseases characterized by a massive 
infiltration of neutrophils into inflamed tissue. Here we show that IL-l 7 is expressed in 
corneas from patients with HSK, and that the IL-17 receptor is constitutively expressed by 
human corneal fibroblasts (HCF). IL-17 exhibited a strong synergistic effect with TNF-a on 
the induction of IL-6 and IL-8 secretion by cultured HCF. Secreted IL-8 in these cultures had 
a strong chemotactic effect on neutrophils. IL-17 also enhanced TNF-a- and IFN-y-induced 
secretion of macrophage inflammatory protein (MIP-l)a and MIP-3a, while inhibiting the 
induced secretion of RANTES. Furthennore, considerable levels of IFN-y-inducible protein 
(IP)-10 and matrix metalloproteinase (MMP)-1 were measured in stimulated HCF cultures, 
while the constitutive secretion of monocyte chemotactic protein (MCP)-1 remained 
unaffected. The data presented suggest that IL-17 may play an important role in the induction 
of the immunopathologic processes in human HSK by modulating the secretion of pro-
inflammatory and neutrophil chemotactic factors by co meal resident fibroblasts. 
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INTRODUCTION 
Herpes simples virus (HSV) infection of the co mea can lead to the development of 
a chronic inflammatory disease of the comea called herpetic stromal keratitis (HSK), a 
leading cause of non-traumatic blindness in developed countries. 1 HSK is considered to 
result from an immunopathologic process in the comea involving both innate and adaptive 
immune responses to the replicating virus. 2 Solid support for this viewpoint comes from 
studies in experimental mouse models. In immunocompetent mice the disease is associated 
with a bi-phasic cellular infiltrate in the corneal stroma. In the pre-clinical phase, when HSV-
I replicates in the comeal epithelium, neutrophils invade the underlying comeal stroma.3 
This transient response, triggered by replicating virus,4 j is thought to control HSV 
replication and limit viral spread into peripheral tissues. 6·7 During the second phase, i.e. the 
clinical phase, a second wave of inflammat01y cells, predominantly consisting of 
neutrophils, infiltrate the corneal stroma.~ An essential factor for the development of HSK is 
the involvement of IL-2- and INF-y- secreting CD4- T cells, orchestrating the extravasation 
and activation of these neutrophils. These neutrophils are considered to be directly involved 
in comeal destruction. 9- 11 Additionally, Langerhans cells (LC) and macrophages, secreting 
the pro-inflammatory cytokines IL-l and TNF-a, are essential mediators. 12. 15 
Extensive studies in murine models of HSK have provided insight into the roles 
multiple chemokines play in the development of the disease.s.s.l 6.1 7 These studies 
demonstrated the temporal expression of chemokines like IL-8, RANTES, macrophage 
inflammatory protein (MlP)-la, monocyte chemotactic protein (MCP)-1 and IFN-y-
inducible protein (IP)-1 0 in affected murine corneas. These chemokines are likely to 
contribute to the recruitment and activation of lymphocytes, dendritic cells and neutrophils, 
initiating the clinical phase ofHSK. Although the cellular source of the chemokines involved 
in HSK remains ill-defined, they may be produced by infiltrating inflammat01y cells and/or 
resident comeal cells. Several studies have implicated that the interaction with inflammatory 
cells mainly involves fibroblasts within the comeal stromal layer. The stromal cell layer of 
the comea is made up of fibroblasts providing mechanical strength to the comea by 
supporting a framework of extracellular matrix. Large numbers of IFN-y and TNF-a 
producing cells have been observed in the stromal layer of HSV -infected murine corneas but 
not in the epithelial or endothelial layers. 1::;· 19 This corresponds to the location of neutrophils 
that mainly infiltrate the stromal fibroblast cell layer of the cornea. Similarly, the induction 
of IL-8, which exhibits neutrophil chemotactic properiies, has been shown to be associated 
with HSV replication in corneal fibroblasts but not in epithelial cells. 20 
Evidence is accumulating that activated tissue resident cells, including fibroblasts, 
are involved in modulating local immune responses by expressing adhesion molecules and 
secreting regulatory factors like cytokines and chemokines. Macrophage-derived cytokines 
like IL-l and TNF-a, and Thl cytokines like !FN-y, have been shown to activate 
mesenchymal cells.21 -26 Interestingly, another recently described Thl cytokine IL-17, can 
exeri strong synergistic and/or antagonistic effects with the aforementioned pro-
inflammatory cytokines. These effects include the modulation of MHC and adhesion 
molecules, and the induction of a variety of cytokines and chemokines by mesenchymal 
cells.21 .24·27-30 This modulat01y effect of IL-17 could therefore have an indirect but profound 
effect on the recruitment and activation of different inflammatory cells into the comeal 
stroma during human HSK. To address this issue, we analyzed the induction of the cytokine 
IL-6, various chemokines and matrix metalloproteinase (MMP)-l by human corneal 
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fibroblasts (HCF) upon stimulation with IL-l~, TNF-a and IFN-y, The combinative effect of 
IL-17 with these cytokines on HCF activation was emphasized. 
Our date show that IL-17 is expressed in comeas of HSK patients and has a 
regulatory effect on the induction of immune-modulatory factors by cytokine stimulated 
HCF. These results indicate that the interaction of JL-17 with HCF may play a significant 
role in the initiation and perpetuation of the inflammatory processes in human HSK. 
MATERIALS Al\D METHODS 
Cytokines and mA bs 
Human recombinant IL-10, IL-17, TNF-o. and JFN-y were obtained from Peprotech 
(London, UK). For blocking experiments, neutralizing mAbs directed to human IL-17 (R&D 
Systems, Abingdon, UK), IL-8 and isotype matched control mAbs were used (Peprotech). 
Human intra-corneal T cell Unes and HCF cultures 
The generation ofHSV-specific T cell lines (TCL) used in this study, obtained from 
affected comeas of two HSK patients, has been described previously? To determine IL-17 
mRNA expression, TCL were either left unstimulated or stimulated with PMA (50 ng/ml) 
and ionomycin (500 ng/ml). Primary HCF cultures were generated from three individual 
donor corneas that had been rejected for transplantation use due to low endothelial cell 
counts. and from one transplanted HSK diseased comea. The central part of each comea was 
finely minced and digested with collagenase essentially as described elsewbere. 31 Adherent 
cells were cultured in 6 wells plates in medium consisting of a 1:1 ratio of DMEM and Ham 
Fl2 nutrient mixture (Gibco BRL, Breda, the Netherlands) supplemented with 10% FCS and 
antibiotics. Growing HCF cultures, with a fibroblast-like morphology, were grown in bulk in 
162 cm2 flasks and cryopreserved. All cells stained positive for vimentin by 
immunofluorescence staining, whereas almost no reactivity was found for both the acidic and 
basic subfamilies of cytokeratin (data not shown), indicating that HCF cultures were not 
contaminated with comeal epithelial or endothelial cells. Third- or fourth-passage comeal 
fibroblasts were used in all experiments. For cytokine stimulation experiments, HCF from 
donor comeas were grown in medium of DMEM and Ham F12 with 10% FCS and 
antibiotics. At confluence, medium was replaced with a serum-free medium consisting of 
DMEM supplemented with 2 mM L-glutamin, 20 >tg/ml cholesterol and 0.3 % BSA (all 
obtained from Sigma, St Louis). HCF were left for 5 days on serum-free medium prior to 
stimulation with cytokines. Serum-free medium was used to maintain a more native 
biosynthetic phenotype and appearance (32) and to reduce background levels of cytokine and 
chemokine production (data not shown). Stimulatory cytokines were added to the HCF 
cultures and supematants were collected after 48 h. All tested stimulatory conditions were 
repeated in at least eight individual experiments unless stated otherwise. For blocking 
experiments, the stimulating cocktail of cytokines \vas pre-incubated with a neutralizing anti-
IL-17 mAb ( 10 ~tg/ml) at room temperature 30 min prior to addition to the cell culture. 
Inhibition of cytokine and chemokine expression was induced by pre-treatment of HCF 
cultures with 10 ng/ml of the anti-inflammatory drug dexamethasone (Sigma) for 2 h. 
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RNA isolation and RT-PCR analyses 
Total cellular RNA was extracted from human HSK corneas, cultured HCF or intra-
corneal TCL with TriZOL reagent (Gibco BRL) according to the manufacturer's protocol. 
For RT-PCR analyses, total RNA was converted into eDNA using oligo(dT) and reverse 
transcriptase. The following synthetic oligonucleotides were used for PCR amplification: for 
IL-17 amplification, primers 5'-ATCTCCACCGCAATGAGGAC-3' and 5'-
GTGGACAATCGGGGTGACAC-3' (232-bp amplicon); for 1L-17 receptor, primers 5'-
CTAAACTGCACGGTCAAGAAT-3' and 5'-CTGAGCTCATGCATGGCGTGG-3' (456-
bp amplicon). As an internal control for the amount of eDNA, the GAPDH gene was 
amplified with primers 5-GGTGAAGGTCGGAGTCAACG-3' and 5'-
CAAAGTTGTCATGGATGACC-3' (496-bp amplicon). Amplification was performed in 
standard PCR buffer with 1 U AmpliTaq Gold DNA polymerase (Perkin Elmer, Groningen, 
The Netherlands), 20011M dNTPs and 25 pmol of each primer in a total volume of 50 11!. 
DNA amplification was started with a 5 min incubation at 95"C, followed by 35 cycles of 
denaturation at 95°C for 1 min, annealing at 50°C for 1 min, and extension at 72°C for 1 
min. The final extension was at 72°C for 7 min. PCR products were separated on a 2% 
agarose gel and visualized by ethidium bromide staining. Southern blotting and labeling with 
a specific e'PJ-labeled oligonucleotide probe was performed to confirm the specificity of the 
amplicons. 
IL-l 7 
GAPDH 
IL-l 7 
GAPDH 
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Expression of 1L-17 mRNA expression in human HSK 
corneas and intra-ocular T cell lines analyzed by RT-
PCR and southern blotting. (A) RNA was isolated 
/f'om corneas from three patients transplanted during 
active HSK {1-3) and from three healthy donor 
control corneas (4-6). (B) HSV-1-specjf/c intra-
corneal T cell linesf{'om two other HSK patients were 
cultured and R.lv'A from a total of lOr, mitogen-
stimulated (P/1) or nonstimu!atr>d (-) cells was 
extractedfor analysis. "+"indicates positive control 
on RNAfi"om mitogen-stimulated PBMCs. 
ELISA 
Culture supernatants from corneal 
fibroblasts stimulated for 48 h, referred to as 
conditioned medium, were harvested and 
cleared of cellular debris by centrifugation. 
Secretion levels of IL-6, IL-8, RANTES, 
MIP-3a, IP-10 and metalloproteinase-l 
(MMP-l) was measured with commercially 
available ELISA kits (R&D Systems). MIP-
1 a content was measured in an ELISA using 
a coating mAb, recombinant human MIP-l a 
as a standard and a HRP-conjugated 
detection mAb (R&D Systems). The amount 
of MCP-1 in culture supernatants was 
determined using a commercially available 
ELISA kit obtained from BioSource 
(Nivelles, Belgium). 
Neutrophil chemotaxis 
Polymorph mononuclear cells 
(PMN) were isolated from fresh peripheral 
blood of healthy, adult volunteers using 
Polymorph Prep (Nycomed, Oslo, Norway) 
and residual erythrocytes were lyzed. To 
analyze the chemotactic activity of 
conditioned medium of HCF, PMN were brought to a final concentration of 2xl06 cells/ml 
in serum free medium. The chemotaxis assay was perfonned in a 24-well Transwell system 
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(Costar, Badhoevedorp, Netherlands). The bottom wells of the chamber were filled with 100 
).ll of either recombinant human IL~8 (1 0 ng/ml) as a positive control for neutrophil 
chemotaxis, the control solution or conditioned medium from stimulated HCF cultures, 10 
times diluted in serum free medium. The upper wells, holding a polycarbonate filter with a 
pore size of 3 11m were placed on top and filled with 150 )ll of neutrophil suspension. The 
Transwell system was incubated in humidified air with 5% C02 at 37°C for 45 min, and the 
number of cells that had migrated through the filter into the bottom well were counted. 
Inhibition of IL-8-mediated neutrophil recruitment involved a pre-incubation of the 
conditioned medium with 10 )..tg/ml anti-IL-8 mAb 30 min prior to the experiment at room 
temperature. As a control, conditioned medium was incubated under similar conditions with 
an irrelevant isotype matched control mAb. 
RESULTS 
IL-17 expression in corneas and intra-corneal T eel/lines obtainedfrom HSK 
patients 
Whereas the nonnal healthy cornea is 
essentially devoid of T cells, HSK is 
considered an immnunopathologic disease 
orchestrated by corneal infiltrating CD4+ Thl 
cells secreting IL-2 and IFN-y.9- 11 To assess the 
possible role of the Thl cytokine IL-17 in 
human HSK, the expression of IL~ 17 mRNA 
was determined in corneas from 3 patients with 
fulminant HSK who underwent corneal 
transplantation to restore sight. IL-17 
transcripts could be detected in all HSK 
corneas, while no IL-l 7 was detected in control 
corneas (Fig. !A). Mitogenic stimulation of 2 
intra-corneal TCL generated from corneas of 
two other HSK patients induced IL~l7 mRNA 
expression. This demonstrates that corneal 
infiltrating T cells, at least in part, are able to 
express IL~ 17 mRNA upon activation (Fig. 
lB). 
HCF constitutively express the IL-17 receptor 
l 2 3 + 
IL-l7R 
GAPDH • 
Figure 2. 
Corneal stromal fibroblasts constitutively express 
IL-17 receptor mRl,iA. Corneal fibroblasts were 
'·rdturedfrom two individual healthy donor corneas 
(1 and 2) and one transplanted non-HSK cornea (3). 
RNA 11-·as isolated from 1 Or, cells from each culture 
and assayed for JL-!7R mRNA expression by RT-
PCR and southern blotting. ,._ .. indicates the water 
control. "+"indicates positive control. 
The keratogenic properties of Th 1 cytokines in HSK may in pati be due to their 
modulatory effect on corneal resident cells. Corneal infiltrating T cells are mainly observed 
in the corneal stroma, suggesting an interaction between T cells and corneal fibroblasts by 
means of direct cell~cell contact or soluble factors like IL~ 17. To evaluate whether corneal 
fibroblasts express the JL~ l 7 receptor, R T ~PCR was performed on RNA extracted from three 
primary HCF cultures. Two primary HCF cultures had been generated from two healthy 
donor corneas and one from a transplanted HSK diseased cornea. RT-PCR analysis showed 
that HCF constitutively express the IL~ 17 receptor (Fig. 2). 
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Synergistic effect of IL-
l 7 on TNF-a -induced 
IL-6 and IL-8 secretion 
byHCF 
Studies in HSK 
mouse models have 
shown a strong induction 
of IL-6 and IL-8 after 
HSV -1 infection of the 
cornea. 520 By mimicking 
the inflammatory 
situation in the comeal 
stroma during HSK 
development in vitro, we 
detem1ined the 
modulatory effect of IL-
17 (I 00 ng/ml) on IL-l~ 
(100 ng/ml), TNF-a (50 
ng/ml) and JFN-y (I 00 
U/ml) to induce 
secretion of IL-6 and IL-
8 by HCF. Optimal 
concentrations of 
stimulatmy cytokines 
bad been determined in 
preliminmy experiments 
(data not shown). 
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!L-6 and JL-8 secretion h) stimulated HCF. Cultured HCF lt'eN' stimulatedfor 
48 hr with the cytokines indicated and JL-6 and !L-8 levels in conditioned 
medium ~rere determined by ELISA. Cytokine mixtures M··ere pre-incubated. 
ho(j'an hour prior 1o addition to the eel/ cultures. >vilh an anti-JL-17 mAb or an 
isotype matched control mAb (isolype) to block JL-17 activity. Dexa indicates a 
2 hour pre-incubolion ofrhe cells with dexamethasone (10 ng!m/). Data shmvn 
ore representorivefor a total r?f'8 individual experiments. 
HCF showed a low level of background secretion of both IL-6 and IL-8, while 
stimulation with IL-17 or IFN-y alone or in combination did not show any considerable 
increase in either JL-6 or IL-8 levels (Fig. 3). Stimulation of HCF with IL-l~ or TNF-a 
however did have a clear stimulatory effect on the secretion of both factors. Although IL-17 
itself had no effect, incubation of HCF with combinations of stimulating cytokines showed 
that it had a strong synergistic effect on the TNF-a-induced secretion of both IL-6 and IL-8. 
This synergistic effect was almost completely neutralized by pre-incubating the stimulating 
cytokine cocktail with an anti-IL-17 mAb, but not with an isotype matched control mAb 
(Fig. 3). Furthermore, a 2 hr pre-treatment of HCF with dexamethasone, an 
immunosuppressive drug commonly used in treating human HSK, almost completely 
abolished the induced secretion oflL-6 and IL-8 (Fig. 3). 
Modulat01y effect~~ IL-l 7 on HCF secretion ~lchemokines and matrix 
metalloproteinase-1 
In addition to IL-6 and IL-8, several other chemokines are expressed in affected 
corneas, and are assumed to play a critical role in the development of HSK.5·~ As HCF are a 
probable cellular source for these chemokines, we also analyzed the effects of stimulation 
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with IL-l f), TNF-a, IL-l 7 and IFN-y on chemokine production (including MCP-1, 
RANTES, MIP-la, MIP-3a, IP-10) and MMP-1 by HCF. The observation by Tumpey et 
a!. 33 that MIP-1 a knockout mice fail to develop HSK suggests that this chemokine plays a 
key factor in the development of the disease. MIP-la secretion by HCF, although in low 
amounts (up to 30 pg/ml), was solely observed upon co-stimulation of IL-17 with TNF-a 
and/or IFN-y (Fig. 4). Whereas MIP-la is mainly chemotactic for neutrophils, MIP-3a is a 
powerful chemoattractant for LC precursors (34). Both IL-l fl and TNF-a induced the 
secretion of MIP-3a by HCF, whereas neither IL-17 nor IFN-y stimulated MIP-3a secretion 
(Fig. 4). IL-17 showed a clear synergistic effect with TNF-a on MIP-3a secretion by HCF, 
but not with IL-l fl or INF-y. 
Intra-comeal expression ofRANTES and IP-10 is restricted to the pre-clinical phase ofHSK. 
Both these chemokines are known to induce T cell migration.35 Secretion of RANTES could 
only be induced by TNF-a, whereas IP-10 production was augmented by TNF-a and IFN-y 
(Fig. 4). IL-17 showed a remarkable inhibition on the secretion of RANTES by HCF upon 
stimulation with TNF-a and/or IFN-y, while IP-10 production was only slightly inhibited by 
IL-17 (Fig. 4). 
Although the role ofMCP-1 is not clear at this point, it has been repm1ed to play a 
role in CD4+ T cell recmitment, and appears to be rapidly upregulated and persistently 
expressed in HSV-1 infected corneas.5 In our experiments, MCP-1 was found to be 
constitutively secreted by HCF and no evident changes were observed by incubation with 
None MlP-1a MIP-3a! MMP-1 
IL-17 
ll-1 
ll-17 + ll-1 
IFN-y 
IL-17 + IFN-·r 
TNF-a J p~o 1 
ll-17 + TNF-a 
TNF-u + IFN··r ]p<0.05 
ll-17 + TNF-u + IFN-y 
0 ~ ~ ~ 0 g § ~ 0 L g § " 8 8 g 0 0 8 {pglml) (pglml) (nglml) 
None IP-10 RANTES MCP-1 
ll-17 
ll-1 
IL-17 + ll-1 N.D. N.D. 
IFN-·r 
ll-17 + IFN-y 
ll-17 + TNF-o: 
]r<o os 1 
TNF-u + IFN-y Jo<O 05 
ll-17 + TNF-a + IFN-·t 
' 
~ B g 0 0 ~ 15 " g c 0 0 B ~ 0 
(ng/ml) (nglml) (nglml) 
Figure 4. 
Chemokine and MMP-1 secretion by stimulated HCF. Cultured HCF vvere stimulated.fOr 48 hr 11-"ith the indicated 
cytokines and chemokine and .MMP-1 levels in conditioned medium were determined by standard ELISA analyses. 
Data shown are representative/or a total of4 individual experiments. N.D. =not done. 
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stimulatory cytokines (Fig. 4). Although MMP-1 is not a chemokine, it was included in this 
study because MMP-1 is lmown to degrade fibrilar collagens,36 an essential component of the 
corneal stroma. HCF showed a constitutive secretion of MMP-l, which was not affected by 
IFN-y. Compared to the mild induction by IL-17, both IL-l~ and TNF-a induced a strong 
enhancement of MMP-1 secretion. Interestingly, IL-17 had a clear synergistic effect with 
IFN-y on MMP-1 secretion, while showing a slight inhibitory effect in combination with IL-
l~ or TNF-a (Fig. 4). 
HCF induce neutrophil recruitment through JL-8 release 
Chernokines expressed within HSV-1 infected cornea are believed to induce the 
corneal infiltration ofneutriphils involved in the development of corneallesions.3·5JU 6· 17 To 
test the PMN chemotactic properties of chemokines secreted by HCF, conditioned medium 
from control and cytokine -stimulated HCF cultures were tested in a neutrophil chemotaxis 
assay. Conditioned medium from HCF stimulated with the combination of IL-17, TNF -a and 
IFN-y was used because it contained the highest levels of!L-8 and MIP-la (see Fig. 3 and 
4 ), both potent PMN chemoattractants. Recombinant IL-8 ( 1 0 ng/ml) was used as a positive 
control, while fresh serum free medium served as background control. Compared to the 
medium control, conditioned medium from stimulated HCF induced a strong migration of 
Pl\1Ns. This effect could be blocked by pre-treatment of the conditioned medium with a 
neutralizing anti-IL-8 mAb 30 min prior to the experiment (Fig. 5). Conditioned medium 
from non-stimulated fibroblasts caused a mild migration of PI'vfNs, probably due to a low 
level of background production of!L-8 in these cultures (see Fig. 3). 
DISCUSSION 
Herpetic stromal keratitis is an HSV-induced corneal disease characterized by 
complex interactions between infiltrating inflammatory cells and corneal resident These 
cellular interactions are assumed to result in the induction and perpetuation of a chronic 
inflammatory process resulting in corneal damage. 2.J.n Stimulation of mesenchymal cells 
with pro-inflammatory cytokines of macrophage/monocyte (IL-l~ and TNF-a) or Thl cell 
(IFN-y) origin, has previously been shown to activate and modulate the secretion of 
chemokines,21 -26 suggesting a role of resident cells like fibroblasts in the recruitment and 
activation of inflammatory cells to sites of inflammation. Recent observations have 
furthermore shown that activation of resident cells can be heavily modulated by the Thl-
derived cytokine IL-17. 21 -24·27-30 Accordingly, the potential interactive role of IL-l 7 and 
corneal fibroblasts in the induction and perpetuation of inflammatory processes in human 
HSK was hypothesized. 
The expression and pathogenic properties of!L-1~, TNF-a. and IFN-y in HSK have 
been extensively studied in the experimental HSK mouse model. These pro-inflammatory 
cytokines probably do not have a direct immunopathologic effect by recruiting and 
stimulating inflammat01y cells, but rather exert their effects through interaction with comeal 
resident cells in an autocrine or paracrine fashion. Interleukin 1 7 is secreted by activated 
CD4+ T cells, mainly ThO and Th 1,27 and exhibits pleiotropic biological activities on various 
human tissue resident cells including fibroblasts. IL-17 shares mainly properties with IL-l~ 
and TNF-a in that these three cytokines activate the transcription factor NFKB in a variety of 
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cell types and all stimulate 
secretion of pro-inflammatory 
factors in mesenchymal cells.27 
The present study shows IL-17 
expression in affected comeas of 
HSK patients, while being 
undetectable in control comeas. 
Mitogenic stimulation of intra-
comeal TCL obtained from 
corneas of HSK patients induced 
IL-17 expression. The HCF 
constitutively expressed the IL-
17R, consistent with its broad 
tissue distribution.37 
IL-17 indirectly 
stimulates granulopoiesis both in 
vitro and in vivo, 37·38 and has 
also previously been marked in 
playing an important role in the 
pathogenesis of other immune-
mediated diseases associated 
with a massive infiltration of 
neutrophils into inflamed 
tissues. 39-44 The functional 
relevance of IL-17 signaling in 
host defense has recently been 
demonstrated in an experimental 
model of Klebsiella pneumoniae 
lung infection m IL-17R 
knockout mice.45 IL-17R 
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Figure 5. 
Conditioned mediumfi·om stimulated 1-!CF cultures induces neutrophil 
migration. Serum free medium served as the background control and 
rh!L-8 (10 nglml) >t:as used as a positive conrrol .fOr neurrophil 
migration. l'v'on-stimulated indicates conditioned medium ji-om cells 
incubated vvirh serum fi'ee medium alone: stimulated conditioned 
medium was obtained from cells stimulated with /L-17, TN F-a and 
!FN-y simultaneousfy. Blocking neu/rophif migration \<litiS achieved hy 
a 30 min pre-incubation r?lthe conditioned medium v,;ith an unti-/L-8 
mAb (10 pg!ml). Black and grey bars represent conditioned media 
lrom two different stimufation experimellts and are representative fOr 
4 individuaf experiments. 
signaling appeared to be critical for the local induction of G-CSF and MIP-2 and subsequent 
PMN recmitment into the alveolar space. The murine C-X-C chemokines MIP-2 and KC, 
homologues of human IL-8, have also been associated with the development of experimental 
murine HSK.5 Neutralization of MIP-2 decreased corneal PMN infiltration and significantly 
reduced corneal pathology, demonstrating that MIP-2 is the major chemokine that attracts 
Pl\AN into the HSV-1 infected cornea in mice. 17 Interestingly, in our experiments, 
conditioned medium from HCF stimulated with the combination of TNF-a, IFN-y and IL-17 
induced chemotaxis of PMN in vitro (Fig 5). Despite the presence of multiple other 
chemokines in these conditioned media, this chemotactic activity on PMN s was mainly 
induced by IL-8, since pre-incubation of conditioned medium with a neutralizing IL-8 mAb 
almost completely abrogated Pl\AN migration. 
The data presented here demonstrate that cytokine stimulated HCF secrete 
chemokines associated with HSK. Chemokine secretion was differentially regulated by Th 1 
cell- and macrophage/monocyte-derived cytokines. Compared to IFN-y and IL-17, IL-l~ and 
TNF-a were more effective in stimulating HCF to secrete IL-6, IL-8, MIP-3a and MMP-1. 
Whereas simultaneous treatment with TNF-a and IFN-y induced significant secretion of 
RANTES and IP-10 by HCF, no detectable amounts of MIP-1a were observed upon 
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stimulation with these cytokines. Neither Th 1 cell- or macrophage/monocyte-derived 
cytokine however seemed to significantly alter the constitutive expression ofMCP-1 
The induced secretion of IL-6 and IL-8 by HCF stimulated with either IL-l p or 
TNF-a was consistent with observations previously described.46A7 Similarly, induction of 
IL-6 secretion upon stimulation with IL-l~ or TNF-a has also recently been observed in 
myofibroblast cells (48). In addition, such cells do not secrete any MIP-la upon stimulation 
with IL-l~ or TNF-a,26 comparable with our results. In comparison to another report on 
chemokine production by HCF49 however, we observed some contradiction in the induction 
of RANTES and MCP-1 secretion by treatment of HCF with IL-l or TNF-a. In this report 
stimulation ofHCF with IL-la or TNF-a resulted in increased levels of RANTES and MCP-
1 production. In contrast, stimulation of HCF in our experiments with IL-l~ did not induce 
secretion of detectable amounts of RANTES, nor did IL-lP or TNF-a significantly alter 
MCP-1 secretion. Altough the different effects of IL-l a and IL-l p on HCF are 
understandable, the differential effect of TNF-a on MCP-l production might be related to 
the usage of serum in cell cultures which might contain costimulatory factors, absent in our 
experiments. In a recent repoti about rheumatoid arthritis in man, RANTES and MCP-1 have 
been shown to induce IL-6 and IL-8.50 These chemokines thus appear not to solely play a 
role in inflammatory cell migration, but also to be involved in the activation of synoviocytes. 
Consequently, the secretion of the chemokines detected in conditioned medium of cytokine-
stimulated HCF may only in part be directly induced by the cytokines added. 
As in human HSK corneas, IL-17 expression has been observed in other inflamed 
tissues like the lungs in asthma 51 and the synovium in arthritis. 52 IL-17 exerts a modulatory 
effect on IL-l-, TNF-a- and IFN-y -induced chemokine secretion by human mesenchymal 
cells. 21 -24·27"3° Fmihermore, IL-17 has been described to stimulate the secretion of IL-l~ and 
TNF-a. by macrophages.53 In our experiments, IL-17 had a synergistic effect on TNF-a -
induced HCF secretion of IL-6, IL-8 and MIP-3a, which was similar to observations by 
others. 23 ·25·27·5u 4 Additionally, a synergistic effect was observed for IL-17 with TNF-a and 
IFN-y on the induction of MIP-la., while similar to findings in keratinocytes21 IL-17 
antagonized TNF-a- and/or IFN-y-induced secretion of RANTES. In contrast however with 
some of these reports,21 •27 no synergistic effect of!L-17 with IL-l p or IFN-y was observed, 
which might be a cell type specific phenomenon. 
As its name suggests, IP-10 is known to be induced by IFN-y, as was also observed in our 
experiments. Strikingly, IP-10 secretion by HCF was strongly increased upon co-stimulation 
with both IFN-y and TNF-a., which is in accordance to a previous report. 55 Whereas a 
previous report56 showed no significant stimulatory effect of IL-17 on IP-10 induction in 
keratinocytes, our results showed a slight inhibitory effect of IL-17 on IP-10 secretion by 
HCF. Secretion of IL-6 and IL-8, induced by HCF stimulation with a combination of IL-17, 
TNF-a and IFN-y - resulting in the highest secretion levels (Fig. 2) - was inhibited by 
pretreatment with an anti-IL-17 rnAb to levels similar to those of TNF-a plus IFN-y, 
demonstrating the specific modulatory effect of IL-17. Glucocortocoids, like dexamethasone, 
are widely used in the treatment of corneal inflammatory diseases. The data presented here 
show that secretion of IL-6 and IL-8 by cytokine stimulated HCF can be completely blocked 
by pretreatment with dexamethasone. This is compatible with the idea that the beneficial 
effects of glucocortocoids in clinical practice are due to inhibition of exaggerated cytokine 
production. This effect of glucocortocoids is mediated by their antagonistic action on 
transcription factors, like NF-kB, required for cytokine transcription. 57 
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The collection of chemokines found to be secreted by HCF upon cytokine 
stimulation exhibit a broad range of leukocyte recruiting and activating potentials. These 
activities include the migration and activation ofT and NK cells (e.g. RANTES, MCP-1, 
MIP-3a and IP-10), Langerhans cells (e.g. MIP-3a), macrophages/monocytes (e.g. MCP-1) 
and PMN (e.g. IL-8 and MIP-la). Studies on expression profiles of different chemokines in 
the HSK mouse models have shown that most pro-inflammatory cytokines and chemokines 
are expressed throughout both the pre-clinical and clinical phase of HSK. s Exception to this 
are the chemokine MIP-1 a, which was only detected during the clinical phase, and the 
chemokines IP-10 and RANTES, that can only be detected early after HSV-1 infection of the 
comea, but not during the clinical phase of the disease./\ Remarkably, in the present study IL-
17 exeried a strong stimulatory signal on the induction of IL-8, MIP-la and MIP-3a, 
whereas it inhibited the secretion of RANTES and to a lesser extent IP-10. This IL-17 
specific inhibitory effect on RA._NTES and IP-10 secretion might reflect a down-regulatory 
signal by activated T cells to limit the recruitment of additional T lymphocytes, and 
corresponds with the transient detection of these chemokines in the cornea early after 
infection. On the other hand, increased secretion of IL-8 and MIP-la would create an 
inflammatory environment in the comeal stroma with a high potential for PI'v!N extravasation 
and activation, where they directly or indirectly cause tissue damage. Although MMP- 1 is 
not a chemokine, its secretion in the comeal stroma might explain some clinical aspects of 
HSK. As described previously, IL-l and TNF-a augmented secretion of MMP- J in human 
fibroblasts 5 8 MMP-1 degrades structural type I and type II collagen and its production in the 
corneal stroma during HSK might thus contribute to the development of comeal lesions. 
Accordingly, IL-17 has previously been implicated in synovium matrix destruction in 
rheumatoid arthritis by similar modes of action. 59 
In conclusion, our study shows the ability of cytokine stimulated HCF to secrete 
inflammatory mediators which are potentially involved in the immunopathogenesis of HSK. 
The Th 1 cytokine IL-17, expressed in human HSK comeas, modulated these responses in a 
synergistic or antagonistic fashion. We speculate that during the development of HSK, in 
addition to comeal infiltrating cells, comeal fibroblasts are an important cellular source of 
pro-inflammatory cytokines and chemokines. Among these IL-8, which primarily mediates 
the extravasation and activation of pathogenic PMN into the com ea. Furthermore, our results 
suggest that IL-17 might be an impmiant player in the immune activation of HCF. Future 
studies in murine models might elucidate any potential role of IL-17 in the inflammatmy 
processes leading to HSK. 
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Chapter 7 

General Discussion 
INTRA-TYPICAL DIFFERENCES AND DISCRIMINATION OF HSV-1 STRA!l'\S 
Herpes simplex virus is a ubiquitous pathogen in humans. State of the ati molecular 
biological techniques has allowed the genetic characterisation of the virus and to study the 
epidemiology of HSV infections in detail. HSV is assumed to be derived from a common 
ancestor virus, and heterogeneity among viral strains of each serotype is probably the result 
of genomic variation arisen throughout evolution. From a clinical point of view, the use of 
molecular biology is important in determining whether independently isolated HSV -I strains 
originate from the same source. Genetic differentiation and characterisation of HSV -1 strains 
can be performed in two ways. The first type of variation, i.e. distinct type variation, is based 
on the presence or absence of particular restriction endonuclease (RE) sites in the viral 
genome. Such assays, refened to as restriction fragment length polymorphism (RFLP), have 
been widely applied in studying the spread of HSV-1 in human populations. 1•3 Studies on 
HSV -1 DNA dynamics suggest a host-linked evolution of he111es viruses, and a close 
association of a cetiain HSV -1 genotype with a particular historically related human 
population4 seems thus clear. Spread of the virus within human populations can be illustrated 
by the demonstration that based on distinct type variation, different HSV -1 strains can be 
found in geographically separate countries or anthropologically different races. 2 
The second type of variation, i.e. common type variation, is characterised by 
variability in copy numbers of tandem repeats vvithin the viral genome, known as reiterated 
sequences (Re). Such sequences within the HSV-1 genome can be used as genetic markers 
for a particular HSV-1 sn·ain (ref 5 I this thesis). The accuracy of RFLP analysis depends on 
the type of restriction endonucleases (REs) used. The usage of 6-base pair recognising REs 
will result in a lower discrimination rate than with 4-base pairs recognising REs, as was also 
demonstrated for epidemiologically related HSV-1 strains in a study by Umene et a/. 6 
Restriction sites, especially those of 6-base pairs recognising REs are more or less conserved 
within a cetiain HSV -1 genotype and therefore not quite suitable for strain differentiation 
between infected individuals within a certain population. On the other hand, the differences 
in number of reiterated sequences as used in our method (described in chapter 2), probably 
are much more variable within HSV -1 strains in a cetiain human population. These 
sequences were shown to remain stable after a limited number of replication cycles (chapter 
2) and thus probably within a cetiain individual but not within a whole population. 
In conclusion, RFLP is the method of choice in large-scale epidemiological studies 
comparing HSV isolates in distinct human populations. On the other hand, our newly 
developed PCR method is more suitable for studies focusing on person-to-person 
transmission ofHSV-1 strains and spread of the virus within a single individual. 
The conventional methods of RFLP analyses and the analyses of polymmvhism on 
the basis of changes in numbers of Re as used in the past, have several major disadvantages. 
First of all, these kinds of analyses are laborious, time-consuming and expensive. Second, 
these methods depend on the isolation of the virus to be able to obtain sufficient amounts of 
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viral DNA. Several important questions concerning the spread and transmission of HSV -1 
still remain that can not be answered by traditional methods. Such methods of strain 
discrimination like RFLP can only be used when virus can be isolated during active 
replication. Characterisation of the strains involved is thus not possible when HSV -1 is latent 
in its human host or infectious virus has been cleared from the tissue of interest. 
For this reason, we set out to develop a new method to discriminate between HSV -1 strains 
based on PCR amplification of Re. This approach obviates the disadvantages mentioned 
above in traditional methods of strain differentiation. The development and evaluation of this 
new approach as described in chapter 2 has an accuracy of discriminating up to 92% of 
HSV -1 strains from unrelated sources. The fact that this approach can also be used on 
samples from which virus could not be isolated is demonstrated by its successful use in the 
studies described in chapter 3 and 4. 
Our method is based on PCR amplification of RelY and ReVII within the HSV-1 
genome. ln accordance with studies by Umene et a/., 5 RelY and ReVII appeared to be 
variable enough to discriminate between different HSV -1 strains. At the same time, these 
sequences also remained stable after a limited period of viral replication, indicating their 
usefulness to function as genetic markers. This observation was further strengthened by the 
finding that both RelY and Re VII remained stable over prolonged periods of time in patients 
with recurrent herpetic keratitis (see also chapter 4). In contrast, Rei and Reiii were 
discarded as genetic markers as they were found to be too unstable after even several rounds 
of viral replication to function as proper genetic markers. The variability of RelY appeared to 
be much more pronounced than that seen in Re VII. This is not surprising considering that 
RelY is located within the introns of HSV- I genes US I and US I 2, while Re VII is part of the 
coding sequence of gene USl0/11. By using ReiV and ReVII as genetic markers, we 
genotyped 37 unrelated clinical HSV-1 isolates from corneal swabs of herpetic keratitis 
patients. Combining the analysis of RelY and Re VII for each clinical sample showed that 34 
out of these 37 isolates displayed a unique combination ofPCR fragments. It should be noted 
that HSV-1 strain differentiation based on PCR amplification alone does not suffice for 
conclusive evidence of virus transmission. A differentiation rate of92% in our method gives 
a good indication for whether a single or different HSV -1 strains are involved. However, 
PCR amplification should be complemented with detailed nucleotide sequencing analysis to 
obtain conclusive evidence for virus transmission. 
Such nucleotide sequencing analysis also revealed the presence of a newly identified Re, 
referred to as ReVIll (see chapter 3). ReVIll is located between RelY and the startcodon of 
genes US 1 and US 12. Besides their role in genomic recombination processes, Re may also 
have a modulatory role on the transcription and/or translation of proteins encoded by 
flanking genes. Considering the importance of the proteins encoded by genes USl and US12 
(ICP22 and ICP47 resp.) in immune evasion of the virus, ReVIll might thus have a profound 
impact on the function of these proteins and persistence of the virus in its host. 
One might ask what the clinical or scientific significance is to know whether HSV -1 
infections are caused by endogenous virus reactivated from latency or reinfection with a new 
exogenous virus (i.e. superinfection). First of all, by differentiating HSV-1 strains on the 
basis of a viral DNA fingerprint is probably the only decisive method of indicating direct 
person-to-person transmission of the vims. It also enables more detailed study on viral 
recombination processes and its consequences. For example, recombination of two different 
HVS-1 strains infecting the same anatomical site might give rise to new and more virulent 
strains.7 Similarly, recombination between intertypic viruses has been observed, which can 
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result in the rise ofvimses with new pathogenic properties.8 The acquirement ofHSV strains 
resistant against antiviral therapy is another aspect to be considered in HSV superinfection. 
Any potential clinical consequences for ocular HSV superinfections have been illustrated by 
studies in rabbits showing that different HSV -1 strains can cause different types of ocular 
lesions. 9 
HSV-1 TRANSLOCATION FROM BRAIN TO EYE 
Both HSV serotypes can infect humans at various anatomical sites resulting in 
distinct disease entities. Translocation of HSV -1 within an individual is generally considered 
to occur by cell-to-cell spread within the same tissue or through auto-inoculation from a 
lesion to an anatomically different site. Alternatively, HSV may spread within a single 
individual by transneural transport and cause distinct infections. Such spread of a single 
HSV -1 strain within the human host was demonstrated using our newly developed PCR 
method for differentiation of HSV -1 strains. In chapter 3 we describe brain-to-eye 
transmission of HSV-1 in two patients who suffered from acute retinal necrosis (ARN), 
which is induced by HSV-1, following a previous episode of herpes simplex encephalitis 
(HSE). The pathway by which the infecting vims reaches the eye is usually unclear in 
patients with ARN. In this study, we concluded that in each patient the vims had most likely 
translocated from the brain to the eye, possibly through the optic nerve. This conclusion was 
partially based on findings in experimental mouse models. Investigations by two different 
groups have shown that in mice HSV -1 can spread through the central nervous system and 
travel up the optic nerve to the eye. 10- 12 
Another explanation for our findings could be that ARN in these patients resulted 
from reactivation of the same HSV -1 strain that had been in a latent state on a different 
anatomical location within the patient. Seemingly abeiTant from this theory however is that, 
despite the fact that ARN is a very rare disease, a high percentage of patients with HSV- I 
induced ARN have a history of HSE13 A correlation between HSV -induced ARN and a 
previous episode of HSE has also been indicated in multiple case reports. 13 • 18 Also 
considering the fact that in most of these cases ARN disease developed only short after HSE 
suggests that both disease manifestations are at least closely linked. Although we can not 
formaly exclude the hypothesis of reactivation from a different anatomical site, the usually 
short time-interval between HSE and ARN and the demonstration of viral translocation in the 
mouse model suggests that brain-to-eye transmission through the optic nerve remains a 
probable explanation. One should not exclude however that the HSV-1 infections in HSE 
and ARN might have been caused by a vims that originated from the eye. In concuiTence 
with findings in the experimental mouse model, the infecting vims might have originated 
from one of the eyes, spread to the brain and subsequently travelled back up the optical nerve 
to the retina of the contra-lateral eye. 
Regardless of which route the infecting vims might have followed, the clear link between 
ARN and a previous episode of HSE should provide a warning for clinicians. Both 
physicians and ophthalmologists should be aware that persons with a history of HSE are at 
risk for developing ARN. On the other hand, neurologists treating patients with HSE should 
point out the increased risk of future ocular complications due to HSV. Awareness of this 
risk may improve early recognition and prompt specialised medical care to prevent loss of 
sight in such patients. 
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CORNEAL SUI'ER!NFECTIONS 
In contrast to HSV infections at different sites of the body, recurrent HSV infections 
at the same anatomical location are more common and pose a serious health problem in 
clinical practise. In such cases of recurrent HSV disease, infections may be caused by 
reactivation of endogenous virus or reinfection with an exogenous virus, referred to as HSV 
superinfection. Superinfections by different viral strains of both HSV serotypes have been 
demonstrated in humans before. 19"21 In contrast to the low frequency of superinfection 
described in these studies, our data, as presented in chapter 4, indicate that HSV -1 
superinfections of the cornea occur in at least one third of individuals with herpetic corneal 
disease. 
Part of this discrepancy may be explained by the method used to discriminate 
between different virus strains. \Vc used a PCR method based variation in Re as described in 
chapter 2, in contrast to other studies that have used conventional RFLP analyses. As stated 
in the previous section, RFLP patterns are quite stable within a population and mutations 
outside RE recognition sites are missed in this procedure. Thus, the actual rate of 
superinfection in humans is probably higher than estimates based on conventional distinct 
type variation by RFLP analyses. A second explanation for this high frequency of 
superinfection in our patient cohort would be selection of individuals with a higher 
susceptibility for corneal HSV-1 reinfection. This might be related to the predominantly 
severe entities of herpetic keratitis in this group of patients. Alternatively, the location of the 
HSV -I infections from which isolates were obtained, i.e. the cornea, may be more vulnerable 
to HSV superinfections than other anatomical sites. 
Apart from the surprisingly high percentage of superinfections observed in our 
study, the data also suggest that individuals with corneal herpetic disease have a higher risk 
of acquiring a superinfection after cornea transplantation (PKPL). Four out of the 11 patients 
with different HSV -1 strains in subsequent episodes of co meal infection had undergone 
PKPL in betvveen these episodes. In contrast, in the group of 19 patients with recurrent 
infections with the same viral strain, none had undergone PKPL in between episodes of 
corneal infection. As indicated previously, superinfections with a new HSV strain increases 
the risk for the patient of acquiring strains resistant to antiviral drugs or more vimlent HSV 
strains with a different disease pattern. From a bealtbcare point of view, such superinfections 
may pose new or additional complications in diagnosis and treatment of corneal HSV 
disease. 
Remains the question what the origin and route of infection of this new virus (HSV-
strain) was. The most obvious explanation would be an infection with exogenous virus. In 
general, exogenous corneal infections occur on the corneal surface in the epithelial layer. 
Especially the severe disease entities in our patient cohmi might render the cornea more 
susceptible for new infections. This would suggest however, that both groups of patients, 
either undergoing PKPL or not, are equally at risk of acquiring superinfections. The data 
however suggest that recurrent infections in the patient group without PKPL between viral 
isolations are all attributable to reactivation of latent HSV-1 strains. So, apparently, PKPL 
leads to an increased susceptibility ofHSV-1 superinfection of the comea. 
One explanation might be that the natural defence of the cornea against HSV infection is 
distorted after surgical intervention in PKPL or due to cmiicosteroid treatment. One of the 
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components of this natural defence of the cornea is the secretion of HSV neutralising 
antibodies of the IgA isotype in the tear fluid. There are however no indications that IgA 
levels in tear fluid and comeal defence are decreased after PKPL. Still, exogenous virus 
probably is in most cases the cause of corneal superinfection in these patients. 
Alternatively, these patients may have been latently infected with multiple HSV-l strains 
simultaneously. Multiple HSV-1 strains may reside in a latent form either within distinct 
parts of the innervating sensmy ganglion (trigeminal ganglion) or even extraneural in the 
cornea or eyelids. Studies in rabbits and rats have indicated that corneal trauma like con1eal 
transplantation is a powerful inducer of viral reactivation.22. 23 Subsequent corneal HSV-1 
infection after PKPL might then be caused by any of the latent HSV -I sh·ains present in the 
host. An alternative route of co meal infection could involve the transmission of a new HSV-
1 strain through the comeal graft itself. Studies in animal models have shown that donor-to-
acceptor transmission of HSV -1 through the corneal graft is probable?4 Clinical observations 
in humans also have shown that some patients may develop corneal HSV -1 infections after 
PKPL performed for reasons unrelated to HSV. 25"27 
The data presented in chapter 4 show that donor-to-acceptor transmission through a 
corneal graft with subsequent replication of HSV-1 also occurs in humans. Although PKPL 
is nowadays a routine and frequent procedure, the risk of acquiring an HSV -1 infection 
through PKPL is probably low. In contrast to this is the relative high percentage of HSV-
positive donor grafts. In eye banks, up to 38% of donor corneas have been reported to 
harbour HSV -1 DNA, although in very few cases viral replication could be demonstrated 
upon culturing.2s.30 Moreover, most of these HSV-1 positive donor comeas are rejected for 
transplantation due to endothelial abnonnalities. Nevertheless, despite critical screening in 
eye banks, HSV-1 can be latently present in corneal tissue and corneal grafts containing 
HSV-l DNA are occasionally transplanted. 31 • 32 Thus the risk remains that HSV is 
transmitted through PKPL and can reactivate in the recipient. 
Our data clearly show that transmission of HSV -I through corneal grafting does occur. More 
impm1antly, they indicate that HSV-1 transmission through PKPL can be followed by active 
viral replication, inducing a new infection and comeal disease. In the patient described, 
comeal disease resulted in complete loss of vision. These findings stress the potential 
hazardous consequences of HSV -1 transmission through a corneal graft. It is not clear 
whether in this case the HSV -1 superinfection resulted from actual latent virus or from a 
low-level replication in the comea. 
The patient concemed was sero-negative for both serotypes of HSV at the time of 
corneal surgery and consequently probably more vulnerable for infection. It remains 
questionable however, whether pre-existing antibodies against HSV -1 in sero-positive 
individuals can protect against superinfection. Protection against exogenous infection on the 
comeal surface is a role for virus neutralising IgA in tear fluid. Such antibodies however do 
not help against vims directly introduced into the comea through an infected corneal graft. 
There is no doubt that pre-existing immunity against HSV -1 surely aids in limiting the 
spread of the virus after inoculation through the corneal graft. On the other hand, the lack of 
blood vessels in the healthy cornea hampers the contribution of virus neutralising antibodies 
in limiting viral replication in the cornea. Moreover, virus neutralising antibodies can not 
prevent direct cell-to-cell spread of the virus within the tissue. Furthermore, it should be 
noted that the cornea, and especially its epithelial layer, is one of the tissues most densely 
innervated with neuron endings. This dense innervation gives the virus all oppmiunities to 
infect neurons and establish a latent infection in the trigeminal ganglion. Vaccination studies 
in mice and rabbits have actually indicated that pre-existing immunity and anti-HSV-1 
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antibodies are correlated with decreased severity, recurrence of corneal HSV -l infection and 
establishment of latency.33-37 Complete protection against infection and establishment of 
latency by an exogenous vims is though highly unlikely. Individuals susceptible for recurrent 
corneal HSV -1 infections will therefore never be fully protected against the risk of acquiring 
HSV-1 through a comeal graft. 
ANALYSIS OF INTRA-CORNEAL T CELLS IN HUMAN HSK 
Studies in the experimental mouse models of HSK have indisputably demonstrated 
the essential role ofT cells in the development of HSK. This critical involvement ofT cells 
has been apparent ever since the observation that HSK did not develop in T-cell-deficient, 
athymic (nude) mice.3H Nevertheless, it has taken over a decade before more clarity emerged 
on which T cell subset is of primary importance in the pathogenesis of HSK. Studies by the 
groups of B.T. Rouse and R.L. Hendricks have been the main contributors to the agreement 
that CD4- Th1 cells are the major inducers ofpathogenicity39-42 The cytokine 1L-12, which 
is closely linked to induction of Th 1 rather than Th2 cells, appeared to be upregu1ated very 
early in HSV-infected corneas43 The same investigators also showed that CTL function in 
HSK diseased corneas is mainly executed by CD4+ T cells. In contrast, others found that Th2 
cells are equally well capable of inducing HSK.44· 45 They showed that CD4+ Th2 clones 
from CAL-20 mice rendered HSK-resistant C.B-17 mice susceptible after transfer into these 
animals. 
During the resolution phase of the disease, the intra-corneal T cell response is more 
Th2-like. 46 Treatment of HSK diseased corneas with the Th2 cytokine IL-10 minimises 
ocular inflammation, indicating the central role of this cytokine to initiate the resolution 
phase of HSK.47 More recent reports also suggest that HSK is not initiated by a classic Th l 
response, but rather caused by a mixed Th 1 and Th2 infiltrate in recurrent HSK.33 · 4~ 
The antigen specificity of the T cells that initiate HSK in these experimental mouse models is 
still a matter of debate. Triggering T cells may be solely directed to viral antigens or may be 
crossreactive to both the HSV-1 UL-6 protein and a corneal auto-antigen. A more detailed 
outline on this issue is discussed in the final section of this chapter. 
Due to the scarce availability of HSK diseased corneal tissue from humans and the 
imperfect methods to efficiently isolate and expand T cells from these biopsies, functional 
studies on cornea infiltrating T cells in human HSK are limited. More so, comea 
transplantation in HSK patients is not carried out at fixed time points after onset of disease, 
making interpretation of the data precarious. 
Verjans and co-workers observed that intra-corneal T cell lines (TCL) from the majority of 
HSK patients contained HSV-1 reactive T cells.49 50 These TCLs consisted of both CD4' and 
CD8" T cells. HSV-1 specific T cell clones (ICC), generated from intra-corneal TCL of 2 
HSK patients, were all CD4 ~ ThO cells. Detailed analyses of the T cell receptor (TCR) a and 
P hypervariable regions of these TCC suggested that the intra-corneal T cell response was 
oligoclonal.49 Similar experiments performed by Koelle et a!. indicated that amongst a 
majority of HVS-1 -specific CD4+ T cells, human HSK comeas are also infiltrated by CD8+ 
T cells reactive to HSV -1." ICC in these experiments tlrmed out to be of the Th I phenotype. 
Studies from both groups failed to provide evidence for potential comea autoreactive intra-
comeal T cells in human HSK.50· 51 
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The above mentioned studies however have several limitations that should be noted. 
First of all, the studies focusing on analyses of TCC contained limited numbers of patients.49· 
51 Second, The limited number ofTCC analysed may not be expected to provide an accurate 
insight into what kind of T cell responses dominate the inflammatory processes in human 
HSK. In the other sh1dy on TCL by Ve1jans et a/., 50 although a larger group of patients was 
studied, no discrimination could be made on what cell types were specific for HSV-1 
antigens. 
In chapter 6 we aimed to make a more elaborate analysis of the HSV-reactive T 
cells in TCLs generated from the comea of human HSK patients. The methodology 
developed involves four-colour flowcytometric analyses of TCL incubated with autologous 
mock- and HSV -infected BLCL. HSV -reactivity was monitored by intracellular IFN-y 
production, combined with phenotypic (CD3, CD4 and CDS) and clonal (TCR V~ gene 
expression) analysis of T cells. This approach enabled simultaneous analysis of HSV -1 
specificity, subtype and TCR usage of individual cells within the intra-comeal TCL. 
Analysis of virus-specificity and phenotype on a single-cell level has advantages overT cell 
cloning in that vast numbers of cells can be screened in short time. 
Out of a total of 12 intra-corneal TCLs from HSK patients analysed, 10 showed 
reactivity against HSV antigens as determined by intra-cellular detection of IFN-y 
production. Most of these TCLs showed reactivity against both serotypes of HSV, although 
the fi·equency ofT cells specific for HSV-2 appeared to be lower than for HSV-L This 
suggests that if the development of HSK in these patients was a viral antigen specific event, 
corneal infection by HSV -1 was most likely the antigenic trigger. Cross-reactivity with HSV-
2 is in that case most likely the result of epitope similarity bet\veen both HSV serotypes. 
HSV reactivity in these TCLs was attribtued to T cells of both CD4' and CD8+ subsets. 
Although few HSV-1 specific CDS+ TCC had also been observed by Koelle et a/.,51 TCLs 
from some patients in our study appeared to contain solely cos·· HSV -specific T cells. 
These data oppose results from studies perfonned in experimental mouse models of HSK,52-
54 which have indicated that in murine HSK, cornea infiltrating T cells are predominantly of 
the CD4' subset 
Our data furthermore indicate a remarkable skewing of the usage of a limited 
number ofTCR V~ gene segments by the T cells in these TCLs. In some patients, the HSV-
specificity in their TCLs appears to be dominated by a single subset ofT cells expressing one 
particular TCR V~ gene segment. Because we did not perform sequencing analysis of the 
TCR V~ regions of each single cell, we cannot be ce1iain however that usage of a single 
TCR V~ gene segment reflects a pure monoclonal T cell response. 
In general, the high frequency and clonality of HSV -specific T cells in some TCLs suggests 
that clonal expansion and T cell activation within the comea might have been an antigen-
specific phenomenon. 
Some critical remarks about these findings should however be made. First of all, in 
order to obtain sufficient numbers of cells, the initial T cells obtained from the HSK diseased 
corneas had to be stimulated twice in a non-specific fashion. Such non-specific stimulation 
ofTCL invokes the risk of selective growth of certain T cell subtypes and clones. Similarly, 
the more extended growth potential of CDS+ over CD4+ T cells following a non-specific 
stimulus) 55 might have caused the surprising high frequencies of cos- cells in some of our 
TCLs. The relative high frequencies ofHSV-speeific T cells of both CD4' and CD8- subsets 
detected after expansion of the TCL nevetiheless argues for an enrichment of HSV -specific 
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T cells in HSK diseased human corneas. As on the skewing of TCR V~ usage in the TCLs 
examined, one explanation for this might be related to the age of the patients in our study and 
the observation that HSK generally develops upon recurrent corneal HSV infections over a 
prolonged period of time. Earlier studies have indicated that, as in mice, aged humans 
frequently exhibit expansion of one or several TCR V~ families which is most prominent 
among CD8+ cells_so-sR On the other hand, clonal expansion of CD4+ T cells in pa1iicular 
requires chronic antigenic stimulation, as is the case in elderly people infected with herpes 
viruses which are canied for longer periods of time. 59 A second limitation in this study is the 
fact that the available mAbs against the different TCR vp regions did not cover the whole 
spectrum of V~ gene segments expressed by human T cells. This imperfection may well 
have accounted for the percentage of T cells from which the TCR V~ usage could not be 
identified. 
ROLE OF IL-171N THE IMMUNOPATHOGENESIS OF HSK 
HSK is an immunopathologic disorder, triggered by HSV infection of the cornea 
that leads to the development of corneal int1ammation and eventually comeal blindness. 
Replication of the virus within the co mea is essential since UV -inactivated and replication 
defective mutants fail to induce HSK in mice. 00· 61 Viral replication within the cornea triggers 
the influx of inflammatory cells into the corneal stroma, initiating an immunopathologic 
process in the comea characteristic for HSK. 
The development and maintenance of a chronic inflammatory response requires a distmied 
balance between leukocyte recruitment, retention and proliferation versus cell death and 
efflux. The pro-inflammatory microenvironment in the cornea, which develops after HSV-
infection, induces the recruitment and retention of inflammatory cells in the stromal layer. 
These inflammatory cells, most notably I cells of the Th 1 phenotype, induce the activation 
of resident fibroblasts and their secretion of multiple chemokines that enhance further 
recruitment and retention of neutrophils and T cells within the corneal stroma. Thus, the 
inflammatory process in HSK appears to persist as a direct result of sustained recruitment, 
retention and survival of mainly Thl cells mediated, at least in part, by stromal fibroblast-
derived factors. 
Previous studies have indicated the crucial interaction of co meal resident cells with 
T cells and macro phages in the development of HSK in the mouse model.40· 42· 54· 62· 63 Several 
studies have implicated that the interaction of inflammatory cells mainly involves fibroblasts 
within the corneal stromal layer. Large numbers of IFN-y and TNF-a producing cells have 
been observed in the stromal layer of HSV-infected murine corneas but not in the epithelial 
or endothelial layers.4:-:. 64 This corresponds to the location of neutrophils that predominantly 
infiltrate the stromal fibroblast cell layer of the comea.65 Similarly, the induction of IL-8, 
which exhibits neutrophil chemotactic propetiies, has been shown to be associated with HSV 
replication in human corneal fibroblasts but not in epithelial cells.66 Considering this, corneal 
fibroblasts are a potential source of the chemokines responsible for the recruitment of 
inflammatmy cells, i.e. T cells, macrophages, Langerhans cells and neutrophils, within the 
cornea during HSK. 
We have tried to extend these views to the human situation by analysing the 
cytokine and chemokine secretion profiles of cultured human comeal fibroblasts stimulated 
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with Tb 1- and monocyte/macrophage-specific cytokines (Chapter 5). Our results indicate 
that the secretion of pro-inflammatory cytokines and chemokines by human comeal 
fibroblasts reflects the elaborate network of factors found in HSK mouse models. 
Furthem1ore, we found that IL-17, which is produced by activated T cells, has a strong 
modulatory effect on the secretion of most of these factors. These findings are in agreement 
with other observations indicating a role for IL-17 in other immunopathologic diseases 
characterised by a major influx of neutrophils. 67-71 
The IL-l 7 receptor (!L-1 7R) is expressed in a wide variety of tissues," whereas IL-17 itself 
is strictly confined to activated T cells, mainly of the Thl or ThO phenotype. 73-75 Considering 
this distribution of the IL-l7R and IL-17 secretion, this cytokine probably plays a distinct 
role in local inflammatory processes. In this respect, IL-17 probably does not play a direct 
potent pro-inflammatory role but might rather act as a "fine-tuning" cytokine in 
infiammatmy microenvironments. 
We speculate that during the development of HSK, in addition to comea infiltrating cells, 
corneal fibroblasts are an impotiant cellular source of pro-inflammatory cytokines and 
chemokines. Furthermore, our results suggest that IL-17 might be an important player in the 
immune activation of human corneal fibroblasts. Future studies in murine models of HSK 
might elucidate a potential role ofiL-17 in the inflammatmy processes leading to HSK. 
It is clear that HSK represents a vety complex immunopathological process. The 
genotype of the host and the virus can quantitatively and qualitatively influence the 
inflammatmy processes that occur in the HSV-1 infected comea. Factors within the 
microenvironment of the infected comea are cmcial to the development and outcome of 
disease. Factors such as cytokine and chemokine production, expression of adhesion 
molecules and antigen presentation all appear to contribute significantly to HSK 
susceptibility. Approaches designed to modify cytokine and chemokine expression and APC 
function within the microenvironment of the HSV-1 infected cornea may have therapeutic 
value in treating HSK. Individuals with HSK can benefit from topical treatment with 
co1iicosteroids,76 as is cunently standard clinical practice. The use of coriicosteroids to treat 
HSK however has the disadvantage of thinning of the epithelium layer and an increased risk 
for oppmiunistic infections. 
GENERAL CONSIDERATIONS ON HSK IN MICE Ai\D HUMA:-.IS 
HSV is a virus typically adjusted to the human host. The evolutionaty co-existence 
of HSV and its human host has resulted in adaptation of both the human immune system to 
challenge HSV infections and the virus to persist in its natural host. As a consequence, the 
infectious process of HSV and the fine-tuning of the host's immune response might be quite 
distinct from the situation in experimental mouse models. 
In most cases, the pathogenesis of experimental comeal HSV -1 infection in the mouse is not 
the same as that seen in humans (reviewed in ref. 77). HSV -1 infection is usually lethal in the 
mouse, and secondaty or recunent infections in surviving mice cannot always be induced 
consistently. Qualitative and quantitative responses might also be quite different between 
mice and humans. ADCC for example has a far more potent effect on antibodies and cells in 
humans. Furthermore, it is not unrealistic to suppose that relevant antigenic targets in mice 
are quite distinct from the targets of human CD4 and CD8 T cells. The basic genetic 
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difference between humans and mice might well account for such differences in epitope 
recognition. 
Finally, these animal studies were pe1formed using inbred mouse strains with distinct 
genotypes, which does not resemble the genetically heterogeneous human population. 
Why certain strains of mice develop HSK after comeal HSV infection while others 
appear resistant remains yet to be defined. Thomas et a!. did however indicate that resistant 
strains of mice do possess potentially pathogenic CD4+ T cells. 61 Transfer ofCD4+ cells from 
resistant C.B-17 mice can induce HSK in SCID mice that are themselves incapable of 
inducing inflammatory responses in the cornea. 
Another puzzling observation in experimental murine HSK which needs clarification is that 
the severity of HSK and the type ofT cells involved, also vary between mouse strains and 
the HSV -1 strains used. 39-42, 44· 45 The initiation and severity of HSK and the type ofT cells 
involved also vary between mouse strains and with the HSV-1 strains used. While Rouse and 
colleagues used BALB/C mice, infected with HSV-1 KOS andRE strains, others found that 
Th2 cells are equally well capable of inducing HSK.44· 45 They showed that CD4+ Th2 clones 
from CAL-20 mice rendered HSK-resistant C.B-17 mice susceptible after transfer into these 
animals. 
Although little is known about the characteristics of HSK development in humans, 
they seem to resemble those found in the mouse model. Several differences however have 
been observed and there are some impmiant uncertainties to keep in mind. For example, ·in 
the HSK mouse model, replicating virus and/or viral antigens are absent in the cornea after 
about five to seven days post infection at the time of onset of lesion progression. 42· 7,; In 
human HSK diseased comeas, viral antigens in contrast have been demonstrated weeks after 
onset of disease. so. 79 
Second, there are differences in the mouse models used to study comeal HSV -1 infection. 
Most research groups, like those from Rouse et a/., 39-41 ·43 Hendricks et a/.,42 and 
Heiligenhaus et al. 44-4 1i have used a model of primary corneal HSV -1 infection, while others 
have focused on recunent infection.33· 4s. so HSK in humans generally develops upon 
reactivation of latent virus, and the characteristics as observed in the mouse model on 
recurrent infection appear to more closely resemble the human situation.g 1 
Despite the fact that there is general agreement about the triggering agent that 
causes HSK, there is still controversy about the immunopathologic processes involved in 
HSK development. Though most investigators in the field agree that HSK is triggered by 
HSV infection, there are partially conflicting theories concerning the antigen specificity of 
the T cells initiating and perpetuating the inflammatory processes within the cornea. 
The most general theory implies the basic immunological principle that the inflammatory 
process is initiated and enduringly mediated by viral antigen-specific T cells. Arguing 
against lasting inflammation in this theory is that virus replication and consequently 
production of viral antigen is no longer detectable in the murine comea around the time T 
cells infiltrate the cornea. On the other hand, low amounts of viral antigen might still be 
present in the stroma, sufficient to activate infiltrating virus-specific T cells but undetectable 
by immunohistology. 
Another theory, put fmward by the group of Cantor and co-workers, proposes that 
HSK is rather an autoimmune disease. They found that HSK-inducing CD4' T cell clones in 
mice were reactive against both a co meal tissue autoantigen and an epitope within the HSV-
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1 UL6 peptide. 82 The authors proposed that the inflammatory process is induced by the 
release of a sequestered keratogenic peptide in the comea sharing molecular mimicry with an 
epitope of the HSV-1 UL6 protein. They also stated that resistance for HSK in ce11ain mouse 
strains is associated with allotypic variation in immunoglobulin genes. ln resistant mice 
bearing the IgG2ab allotype, T cells specific for corneal tissue autoantigens were probably 
cross-tolerised by IgG2ab -derived pep tides. 83 Susceptibility for or resistance to HSK is thus 
based on what the authors define as "three pmiy molecular min1icry" between an HSV -1 
UL6 peptide, a comeal autoantigen and a peptide in a pmiicular IgG2a allotype. Although 
this tantalising theory as an HSK-inducing mechanism is supporied by solid evidence, a 
potential similar mechanism for the induction of HSK in humans remains to be explored. So 
far, no reactivity against the HSV -1 UL6 protein could be detected in intra-corneal T cells 
from human HSK patients. 49· 50 
A third theory, as proposed by the group of Rouse and co-workers, emphasises an 
inflammat01y process in HSK in the absence of antigen recognition by virus-specific T cells, 
refened to as "bystander activation" of non-specific T cells.::;4-::;7 They used transgenic mice 
back-crossed with SCID mice, bearing a TCR specific for a single ovalbumin peptide. 
Although these n1ice failed to recognise HSV-1 antigens, they still showed a major influx of 
T cells in the comea and development of HSK lesions upon corneal HSV-1 infection. The 
investigators propose a mechanism of inflammation by cytokine/chemokine -induced 
bystander activation of CD4+ Thl cells in a virus-induced inflammatory environment 
As suppOiiers of each of the above theories continue to dispute each other's ideas, 
conclusive evidence on which of the above theories most accurately approximates the in vivo 
situation remains to be elucidated. Recently, the latter research groups seem to come to some 
agreement that though molecular mimiCiy might play a role in the induction of disease in 
mice, the inflammatOiy process may well be proceeded and perpetuated via a bystander 
mechanism.::;::;. 09 
As for the human situation, there is no clear indication what processes lead toT cell 
activation. Although HSV-1 specific T cells in human HSK have been described (refs. 49-51 
I this thesis), the role of cross-reactivity with a potential corneal autoantigen and T cell 
activation through a bystander effect can not be ruled out. Notably, not all intra-comeal TCL 
from HSK patients tested showed HSV-speeific T cell reactivity (ref. 50 I this thesis). 
Irrespective of the antigenic stimulus for activation of comea infiltrating T cells in the onset 
to human HSK, the perpetuation of the intra-comeal inflammatory process is probably not so 
much the result of ongoing antigen presentation but rather of the lack of inhibitory signals in 
a pro-inflammatOiy microenvironment 
In humans, HSK is frequently associated with bacterial superinfection. This is most 
likely due to breakdown of the comeal epithelial integrity and disturbed lachtymal immunity. 
As a matter of fact, bacterial infiltrates have been observed during pathological examination 
in some of the corneas ofHSK patients we studied in chapter 5. Various bacteria are known 
to produce and secrete superantigens. Superantigens are proteins with a high activating 
potential on T cells in an antigen-independent fashion. Unlike conventional antigens, 
superantigens bind to MHC class II molecules and particular TCR V~ gene segments, 
resulting in proliferation and activation ofT cells expressing these TCR V~ gene segments. 90 
As a consequence, superantigens stimulate a substantial repetioire of the host's T-cell 
repertoire. This results in a massive release of pro-inflammatOiy cytokines which play a 
pivotal role in the pathogenesis of diseases provoked by superantigen-producing 
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microorganisms. The frequent association of human HSK with corneal bacterial 
superinfection might thus suggest a potential role of superantigen in the activation ofT cells 
in the HSV -infected co mea. Bacterial superinfections of the cornea might thus, rather than 
trigger, perpetuate or increase the severity of the inflammatory process and deteriorate the 
clinical outcome of HSK. 
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Summary 
Herpes simplex virus (HSV) infections of the human eye can cause a variety of 
disease manifestations. Generally, the infecting pathogen in ocular HSV infections is of the 
first subtype (HSV-1). A common site of HSV infection of the eye is the cornea. HSV 
infections of the superficial epithelial layer of the cornea are usually transient and without 
pennanent ocular damage. However, when the infection involves the stromal layer of the 
cornea, a chronic inflammatory disease called herpetic stromal keratitis (HSK), can develop. 
This type of ocular disease is a leading cause of non-traumatic blindness in developed 
countries. 
Although HSK is a relatively rare disease, patients with recunent and severe episodes of 
epithelial HSV infections have an increased risk of stromal involvement. Recurrent corneal 
HSV infections can be caused either by reactivation of a latent vims, or by a re-infection 
with a new viral strain. Such infections are referred to as endogenous or exogenous viral 
infections, respectively. In the light of medical care for patients with corneal HSV infections, 
it can be of importance for an ophthalmologist or physician to know which type of infection 
(either endogenous or exogenous) is involved in recurrent corneal disease. To date, recurrent 
corneal HSV-1 infections are commonly considered to be caused by an endogenous, latent 
viral strain. 
In chapter 2, we describe the development of a PCR-based molecular technique, 
which allows the distinction between both types ofHSV-1 infection. This technique provides 
a genetic "fingerprint" of each HSV-1 strain and enables to track whether recurrent HSV-1 
infections are caused by the same or a different vims. Evaluation of this technique showed 
that it provides a discrimination rate of 92% of unrelated clinical HSV-1 isolates. This 
technique provides a quick and convenient method for detennining the origin of HSV -1 
infections. Combined with amino acid sequence analysis of the targeted genomic region of 
HVS-1, an even much more accurate and higher rate of discrimination can be achieved. 
Moreover, this PCR-based technique obsoletes the need for isolation of the infectious agent, 
as is required for conventional methods. 
The method was successfi.Jlly employed in a study, described in chapter 3. This 
study involved t\vo patients with another type of ocular HSV disease, known as acute retinal 
necrosis (ARN), and a previous episode of herpes simplex encephalitis (HSE). Our PCR-
based "fingerprinting" technique enabled to provide a direct relation between the HSV-1 
infections in the eye and the brain. The data suggested transmission of the vims from the 
brain to the eye, a route of HSV-1 translocation within a host, which has been clearly 
demonstrated in an experimental mouse model. Our data, together with multiple similar 
clinical cases described in literature should warn neurologists and ophthalmologists that 
individuals with HSE have an increased risk of developing ARN. 
In chapter 4, we investigated the frequency of endogenous and exogenous 
infections in patients with recurrent corneal HSV -1 infections. Besides showing a strikingly 
high frequency of exogenous re-infections in recurrent corneal HSV -1 infections, our data 
implicated that corneal transplantation increases the risk of acquiring an exogenous HSV -1 
strain. This finding suggested the possibility of donor-to-host transmission of HSV -1 through 
corneal grafting. Our suspicion was validated, as shown in the second report described in 
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chapter 4. This repmi involves a case study of an individual who suffered from comea 
epithelial defects, caused by an HSV -1 infection, shortly after receiving a comeal 
transplantation. This corneal HSV-1 infection subsequently led to the development of HSK, 
leaving this patient permanently blind. Employment of our PCR-based technique as 
described in chapter 1 and subsequent DNA sequencing revealed that the donor graft 
contained the same HVS-1 strain as the one causing comea epithelial defects in the recipient 
shortly after transplantation. 
The clinical presentation of HSK is considered to result from an immunopathologic 
process in the comea involving both innate and adaptive immune responses to the replicating 
virus. Solid support for this viewpoint comes from studies in experimental mouse models. In 
immunocompetent mice the disease is associated with a bi-phasic cellular infiltrate in the 
comeal stroma after comeal HSV infection. While the first- smaller and transient- infiltrate 
is not associated with any clinical symptoms, a massive cellular infiltrate of mainly 
neutrophils invades the comeal stroma several days later, initiating the clinical phase of 
HSK. These neutrophils are considered to be directly involved in the disruption of the 
stromal tissue integrity. Such tissue damage can lead to corneal scarring and comeal 
blindness. 
An essential factor for the development of HSK is the involvement of cornea 
infiltrating CD4.,. T cells with a Th 1 phenotype. These cells orchestrate the extravasation and 
activation of infiltrating neutrophils during the clinical phase of the disease. 
The antigen specificity of these infiltrating T cells, which drive the immunopathological 
process in the comea, however remains a mystery. There are several (pmiially) conflicting 
theories on the antigen specificity of these T cells involved in HSK as seen in experimental 
mouse models. And although multiple reports have addressed this issue, the controversy still 
remains. In contrast, only very few data are available on the antigen-specificity of comea 
infiltrating T cells in HSK in humans. In chapter 5 we describe a more detailed study on the 
specificity, subtype and clonality ofT cells invading the cornea in patients with HSK. We 
found that comea-derived T cell lines (TCL) from the majority of HSK patients contained 
high numbers of HSV-specific T cells. HSV-reactivity was HSV type common, and the 
majority of the TCL showed a restricted usage ofT cell receptor V~ domains (TCR V~)- Our 
data demonstrate that both CD4' and CDS+ T cells are potentially involved in the intra-
corneal HSV-specific T cell response in comeas ofHSK patients, and suggest restricted TCR 
V~ usage of comea residing HSV -specific T cells. 
Key events in the development of HSK involve the interaction between cornea 
infiltrating inflammatory cells and resident corneal tissue cells. This interaction, in which 
macrophages and Th1 cells play a crucial role, results in the local secretion of immune-
modulatory factors. Secretion of these factors results in the recruitment and retention of 
additional inflammatory cells m the comeal stroma and perpetuation of the 
immunopathological processes. 
In chapter 6 we show that macrophage and/or Thl cell -derived cytokines induce 
the secretion of these pro-inflammatory cytokines and chemokines by resident corneal 
fibroblasts. We found that the induction and secretion of some of these immune-modulatory 
factors was strongly modulated by another Thl cell-derived cytokine, IL-17. We also found 
IL-17 mRNA expression in comeas of HSK patients, while no IL-17 mRNA was observed in 
control comeas. The IL-17 receptor was constitutively expressed by comeal fibroblasts. The 
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data presented indicate that IL-17 has strong modulatory effects on the production of pro-
inflammatory cytokines and chemokines by resident corneal fibroblasts and that lL-8 is the 
main chemotactic factor for neutrophils secreted by these cells. 
Our results suggest that IL-1 7 may play an important role in the induction of the 
immunopathologic processes in human HSK by modulating the secretion of pro-
inflammatory and neutrophil chemotactic factors by resident cornea fibroblasts. 
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Samenvatting 
Een infectie van het menselijk oog door een Herpes Simplex Virus (HSV) kan een 
verscheidenheid aan ziektebeelden veroorzaken. In de meeste gevallen is subtype 1 van HSV 
(HSV-1) de veroorzaker van herpetische oog-infecties en regelmatig betreft hct hierbij een 
infectie van het hoomvlies. Een HSV infectie van de oppervlakkige epitheel eel laag van het 
hoomvlies is meestal van kmie duur en blijft zonder permanente schade aan het oog. 
Wanneer echter de dieper gelegen stromale eel laag van het hoornvlies gelnfecteerd raakt, 
kan zich een chronische ontstekingsreactie van het hoomvlies voor doen. Dit ziektebeeld 
wordt omschreven als herpetische stromale keratitis (HSK) en is een van de meest 
voorkomende oorzaken van non-traumatische blindheid in de Westerse wereld. 
Hoewel HSK een relatief zeldzame ziekte is, !open met name patienten met 
veelvuldig terugkerende en ernstige vormen van epitheliale HSV infecties een verhoogd 
risico een stromale infectie te ontwikkelen. Terugkerende HSV infecties van het hoomvlies 
kunnen veroorzaakt worden door reactivatie van een latent virus, of door een infectie met 
een nieuwe virus stam. Zulke infecties worden respectievelijk aangeduid als endogeen en 
exogeen. In het kader van de medische bebandeling van patienten met een terugkerende HSV 
infectie van het hoornvlies, kan bet voor een oogmis van belang zijn te weten met welk type 
infectie men van doen heeft. In het algemeen wordt bij terugkerende HSV infecties van het 
hoornvlies aangenomen dat het een endogeen, gereactiveerd virus betreft. 
Hoofdstuk 2 beschrijft de ontwikkeling van een moleculaire techniek, gebaseerd op 
PCR amplificatie van de len van bet HSV -1 genoom, waarmee een onderschcid kan worden 
gemaakt tussen beide vormen van infectie. Deze techniek \eve1i een zgn. 11 fingerprint" op van 
individuele virus stammen en kan uitwijzen of terugkerende HSV -1 infecties veroorzaakt 
worden door hetzelfde virus of door een andere virus stam. Evaluatie toonde aan dat met 
deze nieuwe techniek een onderscbeidend vermogen van 92% voor nict gerelateerde HSV -1 
isolaten kan worden behaald. Daam1ee leve1i deze techniek een snelle en eenvoudige 
methode om de oorsprong van HSV -1 infecties te achterbalen. Om een nog nauwkeuriger 
beeld te verkrijgen, kan in combinatie met DNA sequentie analyse een nog groter 
onderscbeidend vermogen worden bereikt. Bovenal vervalt bij deze techniek de noodzaak 
om bet virus in kwestie te isoleren, hetgeen voor conventionele technieken wei vereist is. 
Deze methode werd met succes toegepast in de studie beschreven in hoofdstuk 3. 
Deze studie ombelsde de analyse van twee patienten met een ander type HSV -gernduceerde 
oog ziekte, aangeduid als acute retina necrose (ARN). Beide individuen hadden een 
voorgescbicdenis van herpes simplex encefalitis (HSE), een HSV infectie van de herscnen. 
Toepassing van onze nieuwe techniek leverde een directe relatie op tussen de HSV infecties 
in het oog en de bersenen: de resultaten wijzen op transmissie van het virus tussen de 
hersenen en het oog. Een vergelijkbare transmissieroute is duidelijk aangetoond in muizen 
waarbij het vims vanuit de hersenen via de oogzenuw het netvlies kan bereiken. In de 
literatuur zijn bovendien een aanzienlijk aantal gevallen bescbreven van individuen met 
ARN, vooraf gegaan door een episode van HSE. Met dit in het acbterhoofd zouden onze 
resultaten een waarscbuwing moeten afgeven naar neurologen en oog misen dat patienten 
met HSE een verhoogd risico !open voor het ontwikkelen van ARN. 
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Hoofdstuk 4 handelt over een onderzoek naar de frequentie van endogene en 
exogene HSV-1 infecties in patienten met temgkerende infecties van het hoomvlies. Ooze 
data laten een verrassend hoog aantal exogene her-infecties zien bij deze terugkerende HSV-
1 infecties van het hoomvlies. Bovendien suggereren deze resu1taten dat de kans om een 
infectie met een nieuwe (exogene) HSV-1 stam op te !open wordt vergroot wanneer de 
patient een hoomvlies transplantatie ondergaat. Deze bevinding suggereerde dat er in 
sommige gevallen mogelijk sprake was van transmissie van HSV-1 van de donor naar de 
patient via het transplantaat. Deze hypothese werd bevestigd in een ander onderzoek welk 
eveneens in hoofdstuk 4 beschreven staat. Dit onderzoek betreft een individu dat kOii na een 
hoomvlies transplantatie last kreeg van emstige defecten aan het hoomvlies epitheel, 
veroorzaakt door een HSV -1 infectie. Deze infectie leidde vervolgens tot de ont\vikkeling 
van HSK, waardoor deze persoon pem1anent blind werd. Toepassing van de PCR-techniek, 
als beschreven in hoofdstuk 1, toonde aan dat de virus stam die HSK veroorzaakte in de 
patient die de hoomvlies transplantatie onderging dezelfde was als de stam die aanwezig was 
in bet donor-materiaal. 
Het kliniscbe beeld van HSK wordt veroorzaakt door een immuunpatbologisch 
proces in bet boomvlies, waarbij zowel primaire als adaptieve immuun reacties tegen bet 
vims een rol spelen. Het overgrote dee] van de kennis omtrent deze immuunpathologische 
reacties is afkomstig uit studies gebruikmakend van experimentele muis modellen. In 
immuun competente muizen wordt de ziekte gekarakteriseerd door een twee-ledige infiltratie 
van immuun cellen in het hoornvlies na infectie door HSV. Tijdens de eerste fase, direct na 
HSV infectie van het boomvlies, is een milde en tijdelijke infiltratie van cellen te zien, 
hetgeen geen klinisch ziektebeeld veroorzaakt. Enkele dagen later echter, tijdens de tweede 
fase, treedt er een vee] massalere infiltratie van immuun cellen in het hoornvlies op. Dit 
infiltraat bestaat voomamelijk uit neutrofielen en luidt de klinische fase van HSK in. Men 
gaat er van uit dat deze neutrofielen direkt betrokken zijn bij de verstoring van de integriteit 
van bet stromale weefsel van het hoornvlies. Dergelijke schade aan het weefsel kan leiden tot 
de vonning van littekenweefsel, met als gevolg een vetiroebeling van het hoomvlies en 
blindheid. 
Essentieel voor de ontvvikkeling van het ziektebeeld van HSK is de infiltratie van 
bet hoomvlies door CD4- T ce\len met een Th 1 fenotype. Deze cellen zorgen voor de 
infiltratie en activatie van neutrofielen tijdens de klinische fase van de ziekte. Alhoewel er 
algemene consensus is over de rol van deze cellen in de ontwikkeling van het 
immuunpathologische proces in het hoomvlies, blijft de antigeen specificiteit van deze T 
cellen ondetwerp van discussie. Zo zijn er verschillende theorieen over de aard en oorsprong 
van de antigenen wamiegen de T cellen in de HSK muizen modellen gericht zijn. En 
ondanks het grate aantal studies waarin getracht is een eenduidig antwoord op dit vraagstuk 
te vinden blijft de controverse bestaan. In tegenstelling tot het grate aantal studies in muizen 
modellen van HSK zijn er zeer weinig data voorhanden over de antigeen specificiteit van T 
cellen bij de ontvvikkeling van HSK in mensen. Hoofdstuk 5 beschrijft een meer 
gedetailleerde studie aangaande de antigeen specificiteit, klonaliteit en bet subtype van T 
cellen die werden geisoleerd uit humaan hoomvlies met HSK. Onze resultaten Iaten zien dat 
T eel lijnen (TCL) gegenereerd uit deze humane hoomvliezen een relatief hoog percentage 
HSV-specifieke T cellen bevatten. Deze TCL bevatten zowel CD4- als CD8+ HSV-
specifieke T cellen. De meerderheid van deze HSV-specifieke T cellen vertoonde bovendien 
een beperkte expressie in het repertoire van T eel receptor vp (TCR VP) genen. Deze studie 
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geeft aan dat zowe1 CD4~ a1s CD8+ T cellen een mogelijke ro1 spe1en in de HSV-specifieke T 
eel respons in bet hoornvlies van HSK patienten. Verder lijken deze responsen een min of 
meer k1onaa1 karakter te hebben. 
In de ontwikkeling van het ziektebeeld van HSK speelt de interactie tussen 
infiltrerende cell en van bet immuun systeem en weefsel van bet hoornvlies zelf een cmciale 
rol. Deze interactie, waarbij Thl cellen en macrofagen een centrale rol vervullen, resulteert 
in lokale secretie van irnmuun modulerende factoren. Deze factoren zijn op hun beurt 
verantwoordelijk voor de verdere infiltratie van immuun cellen in bet stroma van bet 
hoomvlies en daarmee voor de voortzetting en versterking van bet immuunpathologische 
proces. 
De studie beschreven in hoofdstuk 6 toont aan dat bepaalde factoren, welke door 
macrofagen en Th 1 cell en uitgescheiden worden, de secretie van zulke cytokinen en 
chemokinen induceren. Onze resultaten tonen aan dat de inductie en secretie van enkele van 
deze immuun-modulerende factoren sterk beinvloed worden door een ander cytokine, IL-17, 
dat uits1uitend wordt geproduceerd door geactiveerde T cellen. Expressie van IL-17 mRNA 
werd aangetoond in hoomvliezen van HSK patienten, teiWijl controle hoomvliezen geen 
expressie van dit mRNA lieten zien. De teceptor voor IL-17 werd bovendien constitutief ge-
expresseerd door fibroblasten afkomstig uit bet stroma van verschillende humane 
hoomvliezen. De data beschreven in hoofdstuk 6 geven aan dat IL-l 7 een sterk modulerend 
effect heeft op de lokale productie van cytokinen en chemokinen door fibroblasten in bet 
hoornvlies. Van deze factoren blijkt verder met name IL-8 een voorname rol te spelen in de 
rekmtering van neutrofielen. 
Onze bevindingen omtrent de modulatie van de secretie van ontsteking inducerende en 
neutrofiel rekruterende factoren door fibroblasten in bet hoomvlies geven aan dat IL-17 
mogelijk een belangrijke rol speelt m de inductie en continuering van de 
immuunpatbologiscbe processen bij HSK in de mens. 
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voor je hulp met alle hoomvliesjes, discussies en klinische inzichten. Dit proefschrift was 
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onderzoek. 
Oak veel dank aan al mijn coil ega's van de afdeling virologic voor aile hulp, discussies, 
de gezellige bonels en bovenal een bijzonder aangename werksfeer. Daarbij wil ik wel nag 
even de mensen van ons lunch-groepje extra bedanken voor alle gezelligheid tijdens het 
nuttigen van mijn saucijzebroodje. 
AI mijn vrienden en vriendinnen voor ruim voldoende plezier in en buiten de Zaak, op 
feestjes en festivals, overheerlijke barbecues en ontspannende vakanties in de bergen. En 
ondanks aile geroddel en geouwehoer draaide het regelmatig tach oak uit op nachtelijke 
discussies over T cell en, virus sen of wetenschap in het algemeen. Geloof het of niet, maar 
ook dat alles heeft een wezen1ijke bijdrage ge1everd aan dit proefschrift. 
En waar zou ik zijn zonder mijn Broer en grate Zus! Die bijzondere en hechte band onder 
ons drieen za1 altijd blijven. 
Maar de meeste dank zal tach altijd blijven uitgaan naar mijn lieve ouders, die mij altijd 
volop gesteund hebben en zonder wie ik nooit zover was gekomen. 
Ans en Wiel, deze is voor jullie! 
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